result_id,cdm_name,result_type,package_name,package_version,group_name,group_level,strata_name,strata_level,variable_name,variable_level,estimate_name,estimate_type,estimate_value,additional_name,additional_level
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Soft tissues,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Soft tissues,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Benign paroxysmal positional vertigo or nystagmus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Benign paroxysmal positional vertigo or nystagmus,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Osteochondritis of carpal lunate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4280587
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Osteochondritis of carpal lunate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4280587
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma not disturbing sleep,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma not disturbing sleep,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pregnant,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pregnant,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Viral disease,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Viral disease,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of foot region,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of foot region,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cough,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cough,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Chest pain,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Chest pain,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Vertigo,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Vertigo,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Molluscum contagiosum infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Molluscum contagiosum infection,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Foot pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Foot pain,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Swelling / lump finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Swelling / lump finding,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Insomnia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Insomnia,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Wheezing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Wheezing,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lesion of ulnar nerve,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lesion of ulnar nerve,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Furuncle,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4220002
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Furuncle,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4220002
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Migraine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Migraine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ulnar nerve entrapment at elbow,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4043721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ulnar nerve entrapment at elbow,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4043721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of pulse rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of pulse rate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Menopausal flushing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4113666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Menopausal flushing,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4113666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Talipes planus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Talipes planus,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Carpal tunnel syndrome,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Carpal tunnel syndrome,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise grading,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise grading,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute tonsillitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute tonsillitis,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Absence of sensation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4141128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Absence of sensation,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4141128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injury of knee,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injury of knee,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Upper respiratory infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Upper respiratory infection,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Open wound of forearm,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4053599
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Open wound of forearm,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4053599
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Headache,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Headache,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ear symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ear symptom,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Premature menopause,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 198715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Premature menopause,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 198715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - negative,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - negative,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient self-report,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient self-report,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Achilles tendinitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Achilles tendinitis,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intermenstrual bleeding - irregular,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intermenstrual bleeding - irregular,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain in upper limb,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4009890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain in upper limb,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4009890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tremor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tremor,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Wrist joint pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4115367
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Wrist joint pain,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4115367
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Chronic granular pharyngitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4126438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Chronic granular pharyngitis,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4126438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urticaria,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urticaria,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dyspnea,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dyspnea,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic reaction to drug,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic reaction to drug,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain of breast,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain of breast,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Disorder of eyelid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Disorder of eyelid,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Abdominal pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Abdominal pain,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depressive disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depressive disorder,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ankle pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ankle pain,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Musculoskeletal chest pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4092930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Musculoskeletal chest pain,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4092930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Costal chondritis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4272340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Costal chondritis,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4272340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma not limiting activities,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma not limiting activities,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sprain of ankle,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sprain of ankle,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hemorrhoids,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195562
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hemorrhoids,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195562
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,African,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003600
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,African,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003600
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's condition improved,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's condition improved,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute viral pharyngitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4112343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute viral pharyngitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4112343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not disturbing sleep,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not disturbing sleep,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of region of thorax,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4185503
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of region of thorax,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4185503
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical lymphadenopathy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical lymphadenopathy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abscess,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abscess,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic sinusitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic sinusitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Female infertility,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201909
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Female infertility,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201909
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cough,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cough,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpes simplex,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444429
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpes simplex,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444429
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trauma to perineum and/or vulva during delivery,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432975
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trauma to perineum and/or vulva during delivery,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432975
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cyst of oral soft tissue,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cyst of oral soft tissue,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bronchitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256451
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bronchitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256451
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Swelling of bilateral lower limbs,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 42538916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Swelling of bilateral lower limbs,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 42538916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smear normal - patient notified,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44791066
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smear normal - patient notified,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44791066
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Normal pulse rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4026687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Normal pulse rate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4026687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma disturbing sleep,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma disturbing sleep,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vertigo,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vertigo,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Swelling,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4275722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Swelling,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4275722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Threatened miscarriage,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Threatened miscarriage,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per month,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4156136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per month,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4156136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nightmares,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170260
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nightmares,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170260
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foot pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foot pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nausea,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nausea,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abrasion and/or friction burn with infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abrasion and/or friction burn with infection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute cholecystitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 198809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute cholecystitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 198809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ligament of lumbosacral joint,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4018504
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ligament of lumbosacral joint,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4018504
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative hypothyroidism,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative hypothyroidism,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Burn of upper limb,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Burn of upper limb,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wheezing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wheezing,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Productive cough -green sputum,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060051
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Productive cough -green sputum,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060051
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Migraine,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Migraine,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infestation by Sarcoptes scabiei var hominis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140949
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infestation by Sarcoptes scabiei var hominis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140949
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Morbid obesity,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Morbid obesity,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loin pain,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loin pain,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Perianal abscess,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 199861
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Perianal abscess,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 199861
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Irregular periods,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Irregular periods,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never disturbs sleep,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never disturbs sleep,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wax in ear canal,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wax in ear canal,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infective otitis externa,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381859
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infective otitis externa,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381859
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Open wound of scalp,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4051004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Open wound of scalp,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4051004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hearing loss,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hearing loss,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,External hordeolum,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,External hordeolum,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute laryngitis,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 30133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute laryngitis,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 30133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tympanosclerosis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tympanosclerosis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of size of gravid uterus,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of size of gravid uterus,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Painless rectal bleeding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4212456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Painless rectal bleeding,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4212456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Renal pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4167250
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Renal pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4167250
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopausal flushing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4113666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopausal flushing,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4113666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressed mood,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressed mood,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Carpal tunnel syndrome,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Carpal tunnel syndrome,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute lower respiratory tract infection,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute lower respiratory tract infection,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise grading,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise grading,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bruising symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058577
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bruising symptom,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058577
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ligament,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4160875
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ligament,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4160875
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Absence of sensation,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4141128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Absence of sensation,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4141128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore nipple,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4083763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore nipple,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4083763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Panic attack,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021498
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Panic attack,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021498
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tingling of skin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4171909
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tingling of skin,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4171909
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute bronchitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute bronchitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute left otitis media,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4110795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute left otitis media,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4110795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tachycardia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tachycardia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Diarrhea and vomiting, symptom",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Diarrhea and vomiting, symptom",-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Morning sickness,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Morning sickness,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysmenorrhea,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysmenorrhea,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tired all the time,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tired all the time,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Flushes/goes red,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4148891
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Flushes/goes red,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4148891
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in toe,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111231
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in toe,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111231
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Headache,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Headache,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral labyrinthitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral labyrinthitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smear abnormal - patient told,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44790031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smear abnormal - patient told,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44790031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suprapubic pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012498
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suprapubic pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012498
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syphilis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syphilis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endometritis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endometritis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dizziness,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dizziness,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma treatment compliance satisfactory,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma treatment compliance satisfactory,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor oral aphthous ulceration,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4146778
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor oral aphthous ulceration,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4146778
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acne,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141095
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acne,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141095
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently not sexually active,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently not sexually active,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eczema,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eczema,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enterobiasis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197223
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enterobiasis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197223
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stress-related problem,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stress-related problem,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lower respiratory tract infection,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4175297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lower respiratory tract infection,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4175297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spasmodic torticollis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spasmodic torticollis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute viral tonsillitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4110361
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute viral tonsillitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4110361
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No abnormality detected - examination result,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4086701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No abnormality detected - examination result,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4086701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Victim of domestic violence,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44789589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Victim of domestic violence,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44789589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vulval and/or perineal noninflammatory disorders,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195603
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vulval and/or perineal noninflammatory disorders,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195603
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Common cold,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Common cold,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Relationship problems,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Relationship problems,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Brachial (cervical) neuritis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Brachial (cervical) neuritis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibromyalgia,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40405599
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibromyalgia,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40405599
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Anemia in mother complicating pregnancy, childbirth AND/OR puerperium",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Anemia in mother complicating pregnancy, childbirth AND/OR puerperium",-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Break-through bleeding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4206906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Break-through bleeding,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4206906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pustule,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158333
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pustule,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158333
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Community acquired pneumonia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4293463
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Community acquired pneumonia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4293463
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Skin symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4202477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Skin symptom,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4202477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infertile,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4311387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infertile,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4311387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nasal congestion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4195085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nasal congestion,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4195085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of breast,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of breast,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdomen examined - NAD,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdomen examined - NAD,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of knee region,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 604801
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of knee region,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 604801
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of foot,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of foot,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vulvovaginitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4180978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vulvovaginitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4180978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery normal,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441641
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery normal,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441641
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Palpitations,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Palpitations,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pityriasis rosea,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pityriasis rosea,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obstetric pelvic finding,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095947
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obstetric pelvic finding,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095947
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleep apnea,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 313459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleep apnea,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 313459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding related to pregnancy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding related to pregnancy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpes labialis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4033227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpes labialis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4033227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tight chest,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tight chest,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wishes to postpone menstruation,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wishes to postpone menstruation,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epidermoid cyst of skin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epidermoid cyst of skin,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not limiting activities,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not limiting activities,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopausal symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4071683
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopausal symptom,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4071683
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore mouth,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012068
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore mouth,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012068
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non-suppurative otitis media with eustachian tube disorders,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non-suppurative otitis media with eustachian tube disorders,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hemorrhoids,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195562
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hemorrhoids,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195562
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ulcer of mouth,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4094986
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ulcer of mouth,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4094986
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menorrhagia,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menorrhagia,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Otitis media,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372328
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Otitis media,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372328
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pruritus of skin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 136184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pruritus of skin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 136184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Papilloma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 46273955
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Papilloma,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 46273955
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vasomotor rhinitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4305500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vasomotor rhinitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4305500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mild pre-eclampsia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mild pre-eclampsia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Musculoskeletal pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4150129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Musculoskeletal pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4150129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emotional problems,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4305081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emotional problems,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4305081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Positive reversibility test to corticosteroids,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Positive reversibility test to corticosteroids,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gallstone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gallstone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of sacroiliac ligament,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of sacroiliac ligament,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bacterial vaginosis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4303258
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bacterial vaginosis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4303258
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Feeling feverish,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4011766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Feeling feverish,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4011766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heartburn,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 23325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heartburn,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 23325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endogenous depression first episode,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4333679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endogenous depression first episode,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4333679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ear and auditory finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4042141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ear and auditory finding,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4042141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood coagulation disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood coagulation disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger - pollen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792264
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger - pollen,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792264
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of toe,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4114311
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of toe,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4114311
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ca cervix screening normal,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4064368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ca cervix screening normal,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4064368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tinea pedis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tinea pedis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abnormal uterine bleeding unrelated to menstrual cycle,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4195179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abnormal uterine bleeding unrelated to menstrual cycle,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4195179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood group A,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4008253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood group A,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4008253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical spondylosis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4308802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical spondylosis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4308802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic reaction,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40589905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic reaction,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40589905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contact dermatitis of eyelid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4286048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contact dermatitis of eyelid,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4286048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postpartum hemorrhage,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postpartum hemorrhage,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Molluscum contagiosum infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Molluscum contagiosum infection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breath sounds - finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4278456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breath sounds - finding,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4278456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General pathology,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059238
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General pathology,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059238
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acne vulgaris,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acne vulgaris,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posttraumatic stress disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posttraumatic stress disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Candidiasis,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Candidiasis,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of skin and/or subcutaneous tissue,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of skin and/or subcutaneous tissue,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Benign neoplasm of skin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138102
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Benign neoplasm of skin,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138102
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Less than 30 minutes a day of at least moderate intensity physical activity on five or more days of the week,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Less than 30 minutes a day of at least moderate intensity physical activity on five or more days of the week,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of soft tissue,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376208
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of soft tissue,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376208
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Backache,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Backache,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insomnia,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insomnia,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinary tract infectious disease,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinary tract infectious disease,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysfunction of eustachian tube,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381877
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysfunction of eustachian tube,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381877
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tension-type headache,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tension-type headache,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Respiratory crackles,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4167669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Respiratory crackles,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4167669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inflammatory disorder of breast,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inflammatory disorder of breast,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Parity finding,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Parity finding,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Burn,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Burn,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,RhD positive,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4013995
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,RhD positive,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4013995
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Type 2 diabetes mellitus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201826
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Type 2 diabetes mellitus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201826
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger - airborne dust,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger - airborne dust,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,6/60 visual acuity of right eye,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3655400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,6/60 visual acuity of right eye,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3655400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Joint pain,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Joint pain,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Itching,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Itching,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Atopic dermatitis,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133834
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Atopic dermatitis,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133834
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal tear resulting from childbirth,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal tear resulting from childbirth,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscular rheumatism,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4001804
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscular rheumatism,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4001804
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pediculosis capitis,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 132835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pediculosis capitis,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 132835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fear of flying,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4085062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fear of flying,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4085062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's condition deteriorating,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's condition deteriorating,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fracture of lower limb,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4187096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fracture of lower limb,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4187096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Paresthesia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4236484
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Paresthesia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4236484
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bleeding from nose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096682
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bleeding from nose,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096682
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of knee,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of knee,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized aches and pains,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 438867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized aches and pains,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 438867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loss of hair,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4175525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loss of hair,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4175525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,30 minutes a day of at least moderate intensity physical activity on five or more days of the week,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,30 minutes a day of at least moderate intensity physical activity on five or more days of the week,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mood swings,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4078201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mood swings,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4078201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Joint swelling,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4154927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Joint swelling,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4154927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdomen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37303867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdomen,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37303867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear result,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear result,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute thoracic back pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute thoracic back pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peripheral edema,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peripheral edema,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Secondary female infertility,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192370
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Secondary female infertility,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192370
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute endometritis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4194612
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute endometritis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4194612
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sensation of blocked ear,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4011332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sensation of blocked ear,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4011332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-inf to -366,count,numeric,24,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-inf to -366,percentage,percentage,57.1428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sinusitis,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4283893
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sinusitis,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4283893
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Beta thalassemia trait,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149681
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Beta thalassemia trait,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149681
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439502
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439502
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endogenous depression,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4114950
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endogenous depression,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4114950
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of head,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of head,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,European,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,European,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in face,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4317968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in face,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4317968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microcytic hypochromic anemia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4262948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microcytic hypochromic anemia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4262948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute conjunctivitis,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute conjunctivitis,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Concussion injury of brain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4001336
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Concussion injury of brain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4001336
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neck pain,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neck pain,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic rhinitis,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic rhinitis,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bacterial conjunctivitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4028254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bacterial conjunctivitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4028254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nocturnal cough / wheeze,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nocturnal cough / wheeze,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spontaneous vertex delivery,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spontaneous vertex delivery,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eating disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439002
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eating disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439002
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laceration - injury,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laceration - injury,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in thoracic spine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312998
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in thoracic spine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312998
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dermal mycosis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dermal mycosis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437474
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative infection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437474
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Moderate major depression, single episode",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4049623
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Moderate major depression, single episode",-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4049623
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urticaria,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urticaria,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal colic,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4322528
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal colic,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4322528
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endometriosis (clinical),-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433527
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endometriosis (clinical),-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433527
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Furuncle of buttock,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 198822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Furuncle of buttock,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 198822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discharge symptom,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discharge symptom,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysuria,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysuria,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menstrual period late,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4224178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menstrual period late,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4224178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abscess of vulva,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abscess of vulva,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postpartum depression,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4239471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postpartum depression,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4239471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Supraspinatus tendinitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4000967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Supraspinatus tendinitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4000967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adverse reaction,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4105886
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adverse reaction,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4105886
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hyperemesis gravidarum,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4030872
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hyperemesis gravidarum,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4030872
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade III with severe dysplasia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4098948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade III with severe dysplasia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4098948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obesity,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obesity,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpes zoster,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpes zoster,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dry cough,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4038519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dry cough,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4038519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - borderline changes,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - borderline changes,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spasm,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spasm,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic mucoid otitis media,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381592
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic mucoid otitis media,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381592
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fatigue,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fatigue,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General body state finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221108
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General body state finding,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221108
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never restricts exercise,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never restricts exercise,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic urticaria,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic urticaria,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Musculoskeletal chest pain,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4092930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Musculoskeletal chest pain,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4092930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic rhinitis due to pollen,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic rhinitis due to pollen,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Missed period,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Missed period,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Traumatic ulcer of oral mucosa,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4175613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Traumatic ulcer of oral mucosa,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4175613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma treatment compliance unsatisfactory,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152420
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma treatment compliance unsatisfactory,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152420
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chondromalacia of patella,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chondromalacia of patella,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nummular eczema,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4216188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nummular eczema,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4216188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein test = +,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4042241
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein test = +,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4042241
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Constipation,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Constipation,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety disorder,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety disorder,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pharyngitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4226263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pharyngitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4226263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic contact dermatitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4031019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic contact dermatitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4031019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes daytime symptoms most days,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152911
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes daytime symptoms most days,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152911
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Benign paroxysmal positional vertigo or nystagmus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Benign paroxysmal positional vertigo or nystagmus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never causes daytime symptoms,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never causes daytime symptoms,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dermatophytosis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dermatophytosis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chilblains,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chilblains,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute respiratory infections,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4112341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute respiratory infections,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4112341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sciatica,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sciatica,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Persistent cough,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4109381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Persistent cough,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4109381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menstruation postponed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058441
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menstruation postponed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058441
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnant,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnant,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dependent drug abuse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4275756
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dependent drug abuse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4275756
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute sinusitis,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute sinusitis,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: active,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: active,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Folliculitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4029295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Folliculitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4029295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excessive flatus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4197640
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excessive flatus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4197640
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Paronychia,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137057
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Paronychia,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137057
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Major depression, single episode",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4282096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Major depression, single episode",-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4282096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chest pain,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chest pain,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes night time symptoms 1 to 2 times per week,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44805087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes night time symptoms 1 to 2 times per week,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44805087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Genuine stress incontinence,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 193871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Genuine stress incontinence,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 193871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes symptoms most nights,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44805089
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes symptoms most nights,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44805089
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Otalgia,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Otalgia,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,All pulses present in right lower limb,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,All pulses present in right lower limb,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal discomfort,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal discomfort,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,All pulses present in left lower limb,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,All pulses present in left lower limb,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast finding,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022933
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast finding,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022933
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Panic disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Panic disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gestational diabetes mellitus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gestational diabetes mellitus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fracture of fibula,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436209
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fracture of fibula,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436209
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hyperhidrosis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138565
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hyperhidrosis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138565
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger - exercise,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger - exercise,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mnire's disease,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mnire's disease,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epidermal nevus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4343223
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epidermal nevus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4343223
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Temporomandibular joint disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74396
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Temporomandibular joint disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74396
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery by elective cesarean section,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4061457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery by elective cesarean section,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4061457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diarrhea,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diarrhea,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Simple goiter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141825
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Simple goiter,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141825
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bursitis of hip,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4216972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bursitis of hip,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4216972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent depression,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4098302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent depression,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4098302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Substance abuse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4279309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Substance abuse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4279309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chlamydial cervicitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4127403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chlamydial cervicitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4127403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Conjunctivitis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 379019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Conjunctivitis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 379019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic fatigue syndrome,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic fatigue syndrome,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trying to conceive,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059958
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trying to conceive,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059958
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discomfort,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012205
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discomfort,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012205
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of length of gestation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432441
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of length of gestation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432441
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stridor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 253321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stridor,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 253321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent upper respiratory tract infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4110479
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent upper respiratory tract infection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4110479
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Varicose veins of lower extremity,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Varicose veins of lower extremity,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Miscarriage,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4067106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Miscarriage,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4067106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent urinary tract infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent urinary tract infection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute pharyngitis,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 25297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute pharyngitis,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 25297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tendinitis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tendinitis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Impetigo,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Impetigo,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior rhinorrhea,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257683
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior rhinorrhea,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257683
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion of head and/or neck,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 618696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion of head and/or neck,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 618696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptom: chest wall,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptom: chest wall,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Upper respiratory infection,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Upper respiratory infection,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441737
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441737
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Melanocytic nevus of skin,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Melanocytic nevus of skin,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dermatographic urticaria,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 132983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dermatographic urticaria,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 132983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of finger,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4100908
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of finger,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4100908
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibroadenoma of breast,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibroadenoma of breast,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastroenteritis,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101468
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastroenteritis,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101468
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast neoplasm screening normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast neoplasm screening normal,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Rectal examination - NAD,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Rectal examination - NAD,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion of finger,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73649
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion of finger,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73649
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low back pain,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low back pain,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cutaneous hypersensitivity,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4070025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cutaneous hypersensitivity,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4070025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diarrhea symptom,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diarrhea symptom,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in pelvis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in pelvis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpetic gingivostomatitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpetic gingivostomatitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,-inf to -366,count,numeric,32,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,-inf to -366,percentage,percentage,76.1904761904762,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Greater trochanteric pain syndrome,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4297894
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Greater trochanteric pain syndrome,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4297894
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tooth symptoms,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tooth symptoms,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Rectal hemorrhage,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4026112
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Rectal hemorrhage,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4026112
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Left iliac fossa pain,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Left iliac fossa pain,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Deviated nasal septum,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377910
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Deviated nasal septum,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377910
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal bleeding,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129155
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal bleeding,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129155
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood group B,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4009006
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood group B,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4009006
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urge incontinence of urine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 193326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urge incontinence of urine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 193326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore throat symptom,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore throat symptom,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative wound infection,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4237450
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative wound infection,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4237450
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cellulitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cellulitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asymptomatic bacteriuria,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 36714969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asymptomatic bacteriuria,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 36714969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contact dermatitis,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contact dermatitis,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wound finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wound finding,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Iron deficiency anemia,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Iron deficiency anemia,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Catarrhal otitis media,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4163038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Catarrhal otitis media,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4163038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic reaction to drug,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic reaction to drug,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of eyelid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of eyelid,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mixed anxiety and depressive disorder,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mixed anxiety and depressive disorder,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amenorrhea,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amenorrhea,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dental abscess,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dental abscess,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressive disorder,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressive disorder,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cystitis,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cystitis,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body pale,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4164646
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body pale,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4164646
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza-like illness,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4319159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza-like illness,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4319159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insect bite - wound,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4173025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insect bite - wound,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4173025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute asthma,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute asthma,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleep terror disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4232324
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleep terror disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4232324
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vagina finding,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4088777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vagina finding,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4088777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Respiratory tract infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Respiratory tract infection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Joint structure of wrist and/or hand,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4209986
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Joint structure of wrist and/or hand,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4209986
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heart sounds normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heart sounds normal,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Macrocytic anemia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4308125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Macrocytic anemia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4308125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion of foot,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion of foot,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Worried,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193634
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Worried,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193634
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral exanthem,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral exanthem,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low blood pressure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317002
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low blood pressure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317002
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,White,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 8527
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,White,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 8527
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in lower limb,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in lower limb,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastroesophageal reflux disease,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastroesophageal reflux disease,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stomach cramps,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4196986
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stomach cramps,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4196986
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Croup,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Croup,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematuria syndrome,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematuria syndrome,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient condition unchanged,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient condition unchanged,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral disease,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral disease,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - inadequate specimen,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - inadequate specimen,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptoms of depression,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4191716
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptoms of depression,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4191716
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Facial swelling,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Facial swelling,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of hip,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of hip,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Verruca plantaris,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Verruca plantaris,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plain X-ray spine normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plain X-ray spine normal,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cholecystitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cholecystitis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral gastroenteritis,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4008724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral gastroenteritis,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4008724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4329041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4329041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cobalamin deficiency,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4100822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cobalamin deficiency,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4100822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Genital herpes simplex,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74855
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Genital herpes simplex,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74855
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Feeling of lump in throat,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Feeling of lump in throat,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Unprotected sexual intercourse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4046817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Unprotected sexual intercourse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4046817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body fluid retention,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body fluid retention,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to psychosocial functioning,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4107655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to psychosocial functioning,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4107655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stomatitis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stomatitis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Furuncle,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4220002
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Furuncle,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4220002
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nail deformity,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4067078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nail deformity,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4067078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical Research Council Dyspnoea scale grade 1,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4310059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical Research Council Dyspnoea scale grade 1,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4310059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal irritation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal irritation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vomiting,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vomiting,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Unplanned pregnancy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Unplanned pregnancy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inguinal pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4010361
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inguinal pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4010361
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Legal termination of pregnancy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Legal termination of pregnancy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of breast,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77030
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of breast,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77030
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contact dermatitis due to nickel,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4247582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contact dermatitis due to nickel,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4247582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ear discharge symptoms,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4037310
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ear discharge symptoms,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4037310
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Night sweats,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Night sweats,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute infection of pinna,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374947
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute infection of pinna,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374947
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General health good,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4047705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General health good,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4047705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopause present,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4128329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopause present,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4128329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in elbow,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4253797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in elbow,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4253797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Shoulder pain,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Shoulder pain,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fracture of metacarpal bone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015352
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fracture of metacarpal bone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015352
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ganglion cyst,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40481632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ganglion cyst,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40481632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seizure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377091
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seizure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377091
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biliary colic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4291807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biliary colic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4291807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys moderate exercise,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys moderate exercise,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Talipes planus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Talipes planus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast lump,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast lump,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Premature rupture of membranes,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194702
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Premature rupture of membranes,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194702
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tobacco dependence syndrome,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437264
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tobacco dependence syndrome,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437264
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uterine leiomyoma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uterine leiomyoma,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute tonsillitis,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute tonsillitis,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphadenopathy,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphadenopathy,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Skin structure of face,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4250773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Skin structure of face,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4250773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Indigestion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Indigestion,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger - respiratory infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788779
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger - respiratory infection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788779
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Skin lesion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4316083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Skin lesion,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4316083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Moderate depression,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4151170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Moderate depression,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4151170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plantar fasciitis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plantar fasciitis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psychotic disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436073
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psychotic disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436073
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ear symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ear symptom,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Female genitalia finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Female genitalia finding,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intentional overdose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 607149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intentional overdose,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 607149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sinus headache,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sinus headache,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Burn of hand,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Burn of hand,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Keratosis pilaris,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4197127
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Keratosis pilaris,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4197127
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Boils of multiple sites,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4080184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Boils of multiple sites,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4080184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysphagia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysphagia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evaluation finding,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40480457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evaluation finding,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40480457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Raynaud's disease,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Raynaud's disease,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - negative,-inf to -366,count,numeric,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - negative,-inf to -366,percentage,percentage,59.5238095238095,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of ear structure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103476
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of ear structure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103476
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys light exercise,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys light exercise,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastritis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastritis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,-inf to -366,count,numeric,18,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,-inf to -366,percentage,percentage,42.8571428571429,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical finding,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical finding,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Labyrinthitis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Labyrinthitis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hip pain,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hip pain,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stiff neck symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stiff neck symptom,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intermenstrual bleeding - irregular,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intermenstrual bleeding - irregular,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pleuritic pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4330445
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pleuritic pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4330445
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyrotoxicosis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyrotoxicosis,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Missed miscarriage,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 76482
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Missed miscarriage,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 76482
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spontaneous bruising,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059014
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spontaneous bruising,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4059014
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wrist joint pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4115367
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wrist joint pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4115367
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Hydatidiform mole, benign",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Hydatidiform mole, benign",-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Severe depression,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Severe depression,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,6/6 visual acuity of left eye,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3654499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,6/6 visual acuity of left eye,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3654499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Solitary cyst of breast,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Solitary cyst of breast,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of menstruation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of menstruation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscle pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442752
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscle pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442752
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eye symptom,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205680
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eye symptom,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205680
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dyspnea,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dyspnea,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Retrosternal pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4164298
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Retrosternal pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4164298
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine pregnancy test positive,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine pregnancy test positive,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Candidiasis of vagina,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 198363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Candidiasis of vagina,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 198363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of systemic arterial pressure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4117138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of systemic arterial pressure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4117138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic reaction to insect bite,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3661861
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic reaction to insect bite,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3661861
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Altered bowel function,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Altered bowel function,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lower abdominal pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4182562
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lower abdominal pain,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4182562
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discomfort,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discomfort,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mass of skin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mass of skin,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute abdomen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4241033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute abdomen,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4241033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vasovagal symptom,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4087470
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vasovagal symptom,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4087470
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal pain,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal pain,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression resolved,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788804
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression resolved,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788804
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Shoulder joint painful on movement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Shoulder joint painful on movement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ankle pain,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ankle pain,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in throat,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 259153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in throat,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 259153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of ankle,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77162
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of ankle,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77162
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Whiplash injury to neck,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4218389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Whiplash injury to neck,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4218389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epigastric pain,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epigastric pain,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inflammation of rotator cuff tendon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40483628
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inflammation of rotator cuff tendon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40483628
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ankle,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ankle,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of finger,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81454
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of finger,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81454
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Irritable bowel syndrome,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Irritable bowel syndrome,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sweating,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4188566
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sweating,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4188566
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Helminth infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Helminth infection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abnormal granulation tissue,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 136185
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abnormal granulation tissue,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 136185
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Productive cough,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4102774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Productive cough,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4102774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma daytime symptoms,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma daytime symptoms,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ear examination - normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4039300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ear examination - normal,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4039300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient condition unchanged,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient condition unchanged,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acute secretory otitis media,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acute secretory otitis media,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Viral disease,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Viral disease,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of foot region,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of foot region,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cough,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cough,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Chest pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Chest pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - inadequate specimen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - inadequate specimen,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cataract,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cataract,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Molluscum contagiosum infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Molluscum contagiosum infection,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4329041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4329041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Open wound of head,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4243161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Open wound of head,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4243161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diaper rash,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diaper rash,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acne vulgaris,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acne vulgaris,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Foot pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Foot pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Wheezing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Wheezing,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mediastinal emphysema,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4057432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mediastinal emphysema,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4057432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinary tract infectious disease,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinary tract infectious disease,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Subcutaneous emphysema resulting from a procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Subcutaneous emphysema resulting from a procedure,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 138056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lesion of ulnar nerve,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lesion of ulnar nerve,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Migraine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Migraine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ulnar nerve entrapment at elbow,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4043721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ulnar nerve entrapment at elbow,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4043721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of pulse rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of pulse rate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Wax in ear canal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Wax in ear canal,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Olecranon bursitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134452
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Olecranon bursitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134452
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fracture of metacarpal bone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015352
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fracture of metacarpal bone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015352
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Talipes planus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Talipes planus,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Exercise physically impossible,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052468
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Exercise physically impossible,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052468
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Carpal tunnel syndrome,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Carpal tunnel syndrome,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Uterine leiomyoma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Uterine leiomyoma,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fracture of phalanx of hand,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4226282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fracture of phalanx of hand,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4226282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Edema,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Edema,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Upper respiratory infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Upper respiratory infection,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Melanocytic nevus of skin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Melanocytic nevus of skin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Headache,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Headache,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ear symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ear symptom,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Throat examination - normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4039427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Throat examination - normal,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4039427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Low back pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Low back pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,European,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,European,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eruption,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eruption,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diarrhea symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diarrhea symptom,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acute conjunctivitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acute conjunctivitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - negative,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - negative,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Neck pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Neck pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood pressure finding,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood pressure finding,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient self-report,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient self-report,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Has an itchy eye,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4037888
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Has an itchy eye,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4037888
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Intermenstrual bleeding - irregular,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Intermenstrual bleeding - irregular,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Open wound of thumb,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4054064
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Open wound of thumb,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4054064
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Chronic granular pharyngitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4126438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Chronic granular pharyngitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4126438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Common cold,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Common cold,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Relationship problems,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Relationship problems,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eye symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205680
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eye symptom,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205680
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Break-through bleeding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4206906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Break-through bleeding,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4206906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Perennial allergic rhinitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40486433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Perennial allergic rhinitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40486433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Skin symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4202477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Skin symptom,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4202477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergic reaction to drug,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergic reaction to drug,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Closed fracture of clavicle,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Closed fracture of clavicle,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Disorder of eyelid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Disorder of eyelid,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fever,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fever,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient feels well,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4143069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient feels well,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4143069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cystitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cystitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza-like illness,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4319159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza-like illness,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4319159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine looks normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine looks normal,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Costal chondritis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4272340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Costal chondritis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4272340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Menorrhagia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Menorrhagia,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood in urine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood in urine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Onychomycosis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4215978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Onychomycosis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4215978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,White,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 8527
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,White,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 8527
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma daytime symptoms,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma daytime symptoms,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ureteric colic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4066163
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ureteric colic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4066163
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Atopic conjunctivitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4335888
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Atopic conjunctivitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4335888
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Expiratory wheezing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4321739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Expiratory wheezing,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4321739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma never causes daytime symptoms,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma never causes daytime symptoms,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of hip region,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 193666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of hip region,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 193666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition improved,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition improved,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not disturbing sleep,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not disturbing sleep,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neurofibromatosis type 1,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neurofibromatosis type 1,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Jaw pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168686
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Jaw pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168686
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Illness,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4192174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Illness,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4192174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient condition unchanged,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient condition unchanged,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cough,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cough,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seborrheic dermatitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137053
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seborrheic dermatitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137053
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Molluscum contagiosum infection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Molluscum contagiosum infection,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acne vulgaris,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acne vulgaris,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022933
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast finding,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022933
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contusion of toe,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contusion of toe,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Foot pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Foot pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vitamin deficiency,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vitamin deficiency,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contusion of anterior abdominal wall,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056006
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contusion of anterior abdominal wall,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056006
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Swelling / lump finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Swelling / lump finding,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Positive reversibility test to salbutamol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193158
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Positive reversibility test to salbutamol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193158
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diverticular disease,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diverticular disease,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hiatal hernia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4224004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hiatal hernia,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4224004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Verruca vulgaris,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140641
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Verruca vulgaris,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140641
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Backache,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Backache,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diarrhea,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diarrhea,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Internal hordeolum,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377560
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Internal hordeolum,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377560
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Productive cough -green sputum,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060051
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Productive cough -green sputum,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060051
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rate,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rate,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Chronic diarrhea,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4340521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Chronic diarrhea,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4340521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cracked lips,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4093822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cracked lips,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4093822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Respiratory crackles,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4167669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Respiratory crackles,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4167669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vomiting,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vomiting,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,CVS examined - NAD,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060461
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,CVS examined - NAD,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060461
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anal fissure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 76725
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anal fissure,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 76725
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,MSU = no abnormality,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4055276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,MSU = no abnormality,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4055276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Irregular periods,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Irregular periods,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysphonia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40326053
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysphonia,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40326053
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Traumatic or non-traumatic injury,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Traumatic or non-traumatic injury,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pyelitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4098854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pyelitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4098854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition worsened,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4150631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition worsened,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4150631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,GIT examined - NAD,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,GIT examined - NAD,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition deteriorating,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition deteriorating,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast tenderness,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4208409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast tenderness,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4208409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise grading,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise grading,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast lump,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast lump,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis = no abnormality,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4042233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis = no abnormality,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4042233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Indigestion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Indigestion,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Upper respiratory infection,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Upper respiratory infection,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Skin lesion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4316083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Skin lesion,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4316083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Diarrhea and vomiting, symptom",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Diarrhea and vomiting, symptom",-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Headache,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Headache,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nervous system examination NAD,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4039098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nervous system examination NAD,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4039098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sinusitis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4283893
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sinusitis,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4283893
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Headache caused by drug,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 46270383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Headache caused by drug,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 46270383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low back pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low back pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysphagia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysphagia,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma treatment compliance satisfactory,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma treatment compliance satisfactory,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dizziness,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dizziness,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hematoma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299449
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hematoma,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299449
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,European,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,European,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eruption,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eruption,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diarrhea symptom,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diarrhea symptom,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute conjunctivitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute conjunctivitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cervical smear - negative,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cervical smear - negative,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contusion of wrist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81186
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contusion of wrist,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81186
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Joint normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4182029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Joint normal,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4182029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eczema,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eczema,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient self-report,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient self-report,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Larynx normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4117279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Larynx normal,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4117279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nocturnal cough / wheeze,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nocturnal cough / wheeze,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pyoderma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pyoderma,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Syncope,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Syncope,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contusion of forearm,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140273
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contusion of forearm,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140273
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Strabismus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4329707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Strabismus,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4329707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abnormal involuntary movement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376229
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abnormal involuntary movement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376229
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sore throat symptom,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sore throat symptom,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Right iliac fossa pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Right iliac fossa pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urticaria,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urticaria,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dyspnea,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dyspnea,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysuria,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysuria,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of upper extremity,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4130851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of upper extremity,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4130851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Malignant neoplasm of female breast,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4157332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Malignant neoplasm of female breast,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4157332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergic reaction to drug,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergic reaction to drug,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal pain,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal pain,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Flexural eczema,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4210912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Flexural eczema,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4210912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cystitis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cystitis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ankle edema,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4094513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ankle edema,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4094513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Infantile eczema,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4236759
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Infantile eczema,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4236759
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain in throat,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 259153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain in throat,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 259153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Polyp of vocal cord,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4233816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Polyp of vocal cord,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4233816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fatigue,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fatigue,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Musculoskeletal chest pain,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4092930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Musculoskeletal chest pain,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4092930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergic rhinitis due to pollen,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergic rhinitis due to pollen,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not limiting activities,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not limiting activities,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Catarrh - eustachian,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4143491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Catarrh - eustachian,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4143491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Closed fracture of radius,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439166
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Closed fracture of radius,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439166
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of wrist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of wrist,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Irritable bowel syndrome,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Irritable bowel syndrome,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pupil reactions normal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4304930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pupil reactions normal,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4304930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anxiety disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anxiety disorder,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Meibomianitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4146941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Meibomianitis,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4146941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cough,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cough,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Otalgia,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Otalgia,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Rhinophyma,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Rhinophyma,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic disposition,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 43530807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic disposition,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 43530807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diarrhea,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diarrhea,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of pulse rate,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of pulse rate,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Myogenic ptosis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381569
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Myogenic ptosis,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381569
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Joint pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Joint pain,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blepharitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blepharitis,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise grading,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise grading,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute tonsillitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute tonsillitis,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Upper respiratory infection,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Upper respiratory infection,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Plantar fasciitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Plantar fasciitis,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gastro-esophageal reflux disease with esophagitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 30437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gastro-esophageal reflux disease with esophagitis,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 30437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low back pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low back pain,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,European,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,European,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,-365 to -31,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient self-report,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient self-report,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Vaginal bleeding,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129155
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Vaginal bleeding,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129155
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Wound finding,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Wound finding,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gout,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gout,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Heel pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4099171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Heel pain,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4099171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute asthma,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute asthma,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tight chest,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tight chest,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Respiratory tract infection,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Respiratory tract infection,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,African,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003600
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,African,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003600
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in lower limb,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in lower limb,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gallstone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gallstone,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196456
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not disturbing sleep,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not disturbing sleep,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Radiologic finding,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Radiologic finding,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sciatica,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sciatica,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ca cervix screening normal,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4064368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ca cervix screening normal,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4064368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic pain,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral disease,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral disease,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440029
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cough,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cough,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chest pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chest pain,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smear normal - patient notified,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44791066
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smear normal - patient notified,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44791066
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foot pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foot pain,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Candidiasis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Candidiasis,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hiatal hernia,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4224004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hiatal hernia,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4224004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266367
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266367
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Migraine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Migraine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptom of skin and integumentary tissue,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4154931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptom of skin and integumentary tissue,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4154931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Polyp of cervix,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4280498
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Polyp of cervix,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4280498
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inflammatory disorder of breast,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inflammatory disorder of breast,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vomiting,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vomiting,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loin pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loin pain,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vitamin D deficiency,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vitamin D deficiency,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Burn,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Burn,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causing night waking,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015947
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causing night waking,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015947
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nonvenomous insect bite without infection,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nonvenomous insect bite without infection,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infective otitis externa,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381859
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infective otitis externa,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381859
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys moderate exercise,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys moderate exercise,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute pharyngitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 25297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute pharyngitis,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 25297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fear of flying,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4085062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fear of flying,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4085062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute lower respiratory tract infection,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute lower respiratory tract infection,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hand pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4204199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hand pain,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4204199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast lump,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast lump,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise grading,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise grading,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: moderately active,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: moderately active,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Impetigo,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Impetigo,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Indigestion,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Indigestion,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uterine cervix visualized,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4194451
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uterine cervix visualized,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4194451
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Upper respiratory infection,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Upper respiratory infection,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,10g monofilament sensation R foot normal,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,10g monofilament sensation R foot normal,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tired all the time,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tired all the time,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Melanocytic nevus of skin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Melanocytic nevus of skin,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear result,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear result,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peripheral edema,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peripheral edema,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plantar fasciitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plantar fasciitis,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sensation of blocked ear,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4011332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sensation of blocked ear,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4011332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-365 to -31,count,numeric,14,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-365 to -31,percentage,percentage,29.1666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Beta thalassemia trait,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149681
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Beta thalassemia trait,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149681
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Female genitalia finding,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Female genitalia finding,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,All pulses present in right foot,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,All pulses present in right foot,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast neoplasm screening normal,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast neoplasm screening normal,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Coronary arteriosclerosis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Coronary arteriosclerosis,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evaluation finding,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40480457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evaluation finding,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40480457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,European,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,European,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,10g monofilament sensation L foot normal,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4215145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,10g monofilament sensation L foot normal,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4215145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in pelvis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in pelvis,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microcytic hypochromic anemia,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4262948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microcytic hypochromic anemia,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4262948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - negative,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - negative,-365 to -31,percentage,percentage,14.5833333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical finding,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical finding,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes night symptoms 1 to 2 times per month,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes night symptoms 1 to 2 times per month,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in upper limb,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4009890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in upper limb,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4009890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non-alcoholic fatty liver,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4026131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non-alcoholic fatty liver,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4026131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal bleeding,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129155
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal bleeding,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129155
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obsessive-compulsive disorder,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obsessive-compulsive disorder,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore throat symptom,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore throat symptom,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscle pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442752
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscle pain,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442752
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dyspnea,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dyspnea,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discharge symptom,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discharge symptom,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,All pulses present in left foot,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,All pulses present in left foot,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of breast,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of breast,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of knee region,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 604801
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of knee region,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 604801
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery normal,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441641
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery normal,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441641
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal pain,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal pain,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Palpitations,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Palpitations,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized anxiety disorder,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized anxiety disorder,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Human papillomavirus deoxyribonucleic acid test negative,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37206941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Human papillomavirus deoxyribonucleic acid test negative,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37206941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleep apnea,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 313459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleep apnea,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 313459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fatigue,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fatigue,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General body state finding,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221108
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General body state finding,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221108
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vagina finding,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4088777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vagina finding,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4088777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Missed period,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Missed period,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not limiting activities,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not limiting activities,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopausal symptom,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4071683
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopausal symptom,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4071683
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - mild dyskaryosis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155377
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - mild dyskaryosis,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155377
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Closed fracture of base of fifth metatarsal bone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4173917
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Closed fracture of base of fifth metatarsal bone,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4173917
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Folic acid deficiency,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Folic acid deficiency,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma daytime symptoms,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma daytime symptoms,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Meibomianitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4146941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Meibomianitis,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4146941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cough,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cough,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Rhinophyma,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Rhinophyma,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of pulse rate,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of pulse rate,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Myogenic ptosis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381569
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Myogenic ptosis,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381569
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Joint pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Joint pain,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blepharitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blepharitis,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Melanocytic nevus of skin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Melanocytic nevus of skin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Plantar fasciitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Plantar fasciitis,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood pressure finding,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood pressure finding,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Wound finding,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Wound finding,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Heel pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4099171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Heel pain,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4099171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Tight chest,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Tight chest,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition improved,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition improved,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain in lower limb,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain in lower limb,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Chronic sinusitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Chronic sinusitis,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient condition unchanged,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient condition unchanged,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cough,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cough,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Chest pain,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Chest pain,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acne vulgaris,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acne vulgaris,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diarrhea,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diarrhea,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medical Research Council Dyspnoea scale grade 1,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4310059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medical Research Council Dyspnoea scale grade 1,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4310059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rate,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rate,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma never disturbs sleep,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma never disturbs sleep,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal breath sounds,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal breath sounds,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Atopic dermatitis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133834
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Atopic dermatitis,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133834
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fracture of metacarpal bone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015352
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fracture of metacarpal bone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015352
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Upper respiratory infection,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Upper respiratory infection,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Melanocytic nevus of skin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Melanocytic nevus of skin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Flushes/goes red,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4148891
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Flushes/goes red,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4148891
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of head,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of head,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eruption,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eruption,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prickly heat,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137627
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prickly heat,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137627
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient self-report,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient self-report,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Solar erythema,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4300442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Solar erythema,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4300442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Mass of axilla,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4115109
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Mass of axilla,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4115109
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Closed fracture of metacarpal bone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436839
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Closed fracture of metacarpal bone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436839
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sore throat symptom,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sore throat symptom,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gout,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gout,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 317009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart sounds normal,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart sounds normal,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medical Research Council Dyspnoea scale grade 2,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medical Research Council Dyspnoea scale grade 2,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tenderness,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4082445
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tenderness,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4082445
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,European,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,European,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Enjoys light exercise,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Enjoys light exercise,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain in upper limb,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4009890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain in upper limb,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4009890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ankle pain,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ankle pain,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnant,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnant,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vitamin D deficiency,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vitamin D deficiency,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epidermoid cyst,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epidermoid cyst,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Tenderness,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4082445
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Tenderness,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4082445
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ankle pain,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ankle pain,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Skin lesion,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4316083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Skin lesion,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4316083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discharge from penis,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4104349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discharge from penis,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4104349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Heartburn,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 23325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Heartburn,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 23325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acne vulgaris,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acne vulgaris,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise grading,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise grading,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - negative,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - negative,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tremor,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tremor,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnant,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnant,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysplasia of cervix,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192367
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysplasia of cervix,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192367
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute sinusitis,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute sinusitis,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute pyelonephritis,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4280571
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute pyelonephritis,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4280571
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nuclear abnormality on smear,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077517
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nuclear abnormality on smear,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077517
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - moderate dyskaryosis,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152694
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - moderate dyskaryosis,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152694
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressed mood,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressed mood,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise grading,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise grading,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,1 to 30,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,1 to 30,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nail changes,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4211923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nail changes,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4211923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - borderline changes,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - borderline changes,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in throat,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 259153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in throat,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 259153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast normal,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast normal,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Heartburn,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 23325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Heartburn,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 23325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Trauma to perineum and/or vulva during delivery,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432975
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Trauma to perineum and/or vulva during delivery,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432975
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Term infant,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4212260
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Term infant,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4212260
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Placenta healthy,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4122735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Placenta healthy,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4122735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Menorrhagia,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Menorrhagia,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vulval irritation,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vulval irritation,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute sinusitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute sinusitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Abnormal uterine bleeding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 45757810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Abnormal uterine bleeding,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 45757810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acne vulgaris,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acne vulgaris,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diverticular disease,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diverticular disease,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tension-type headache,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tension-type headache,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of pulse rate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of pulse rate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Osteopenia,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4195039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Osteopenia,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4195039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dysmenorrhea,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dysmenorrhea,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ear symptom,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ear symptom,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - negative,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - negative,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute severe exacerbation of asthma,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 45769438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute severe exacerbation of asthma,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 45769438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Left eye visual acuity finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Left eye visual acuity finding,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Burn of upper arm,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 76304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Burn of upper arm,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 76304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gout,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gout,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic reaction to drug,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic reaction to drug,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Joint British Societies cardiovascular disease risk less than ten percent over next ten years,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Joint British Societies cardiovascular disease risk less than ten percent over next ten years,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute asthma,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute asthma,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Right eye visual acuity finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Right eye visual acuity finding,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic rhinitis due to pollen,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic rhinitis due to pollen,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diverticulitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4141224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diverticulitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4141224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,White,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 8527
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,White,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 8527
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Benign paroxysmal positional vertigo or nystagmus,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Benign paroxysmal positional vertigo or nystagmus,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never causes daytime symptoms,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never causes daytime symptoms,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not disturbing sleep,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not disturbing sleep,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heartburn,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 23325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heartburn,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 23325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prolapse of female genital organs,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 199876
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prolapse of female genital organs,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 199876
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute sinusitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute sinusitis,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ca cervix screening normal,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4064368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ca cervix screening normal,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4064368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tinea pedis,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tinea pedis,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collapse,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collapse,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chest pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chest pain,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No response to bowel cancer screening programme invitation,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44793084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No response to bowel cancer screening programme invitation,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44793084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma disturbing sleep,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma disturbing sleep,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - human papillomavirus positive,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - human papillomavirus positive,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion of toe,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contusion of toe,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - human papillomavirus negative,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810558
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - human papillomavirus negative,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810558
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uses contraceptive sheath,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4061677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uses contraceptive sheath,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4061677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Backache,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Backache,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insomnia,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insomnia,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinary symptoms,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinary symptoms,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loin pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loin pain,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vitamin D deficiency,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vitamin D deficiency,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Female genital tract normal,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129495
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Female genital tract normal,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129495
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of size of gravid uterus,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of size of gravid uterus,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Miscarriage,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4067106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Miscarriage,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4067106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seizure,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377091
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seizure,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377091
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys moderate exercise,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys moderate exercise,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anemia,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anemia,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressed mood,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressed mood,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Swollen ankle region,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4144411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Swollen ankle region,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4144411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary malignant neoplasm of lung,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 258369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary malignant neoplasm of lung,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 258369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute tonsillitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute tonsillitis,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: moderately active,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: moderately active,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Iron deficiency,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4146209
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Iron deficiency,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4146209
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tired all the time,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tired all the time,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear result,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear result,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Regular periods,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4120163
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Regular periods,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4120163
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Headache,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Headache,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peripheral edema,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peripheral edema,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastroenteritis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101468
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastroenteritis,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101468
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evaluation finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40480457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evaluation finding,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40480457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diarrhea symptom,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diarrhea symptom,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - negative,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - negative,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dry eyes,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4036620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dry eyes,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4036620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,31 to 365,count,numeric,8,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,31 to 365,percentage,percentage,16.3265306122449,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Poor concentration,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Poor concentration,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical finding,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical finding,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade 2,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade 2,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Rectal hemorrhage,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4026112
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Rectal hemorrhage,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4026112
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - low grade dyskaryosis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810846
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - low grade dyskaryosis,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810846
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spontaneous vertex delivery,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spontaneous vertex delivery,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Right iliac fossa pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Right iliac fossa pain,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore throat symptom,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore throat symptom,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscle pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442752
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscle pain,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442752
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cellulitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cellulitis,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade 1,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade 1,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discharge symptom,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discharge symptom,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade III with severe dysplasia,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4098948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade III with severe dysplasia,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4098948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdomen examined - NAD,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdomen examined - NAD,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal pain,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal pain,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressive disorder,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressive disorder,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ankle pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ankle pain,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glossitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glossitis,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pruritic rash,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135618
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pruritic rash,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135618
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vagina finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4088777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vagina finding,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4088777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not limiting activities,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not limiting activities,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ankle,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ankle,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Corneal abrasion,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4312493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Corneal abrasion,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4312493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Productive cough,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4102774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Productive cough,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4102774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma daytime symptoms,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma daytime symptoms,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diarrhea and vomiting,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4091519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diarrhea and vomiting,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4091519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma not disturbing sleep,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma not disturbing sleep,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pelvic phleboliths,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4109889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pelvic phleboliths,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4109889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cyst of skin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4112141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cyst of skin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4112141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Molluscum contagiosum infection,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Molluscum contagiosum infection,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 141216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Nausea,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Nausea,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Backache,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Backache,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Loin pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Loin pain,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of measures of body temperature,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4118266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of measures of body temperature,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4118266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Osteopenia,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4195039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Osteopenia,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4195039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Intra-abdominal and pelvic swelling, mass and lump",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Intra-abdominal and pelvic swelling, mass and lump",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Increased frequency of urination,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Increased frequency of urination,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hearing loss,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hearing loss,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Joint pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Joint pain,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cloudy urine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4298419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cloudy urine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4298419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Recurrent urinary tract infection,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Recurrent urinary tract infection,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Depressed mood,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Depressed mood,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Moderate asthma,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Moderate asthma,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sensorineural hearing loss,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374366
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sensorineural hearing loss,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 374366
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Paronychia of finger,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40480261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Paronychia of finger,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40480261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ear symptom,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Ear symptom,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4199813
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Female genitalia finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Female genitalia finding,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Low back pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Low back pain,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,European,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,European,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acute conjunctivitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acute conjunctivitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - negative,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - negative,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood pressure finding,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood pressure finding,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient self-report,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient self-report,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Left eye visual acuity finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Left eye visual acuity finding,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinary incontinence,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinary incontinence,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Vaginal discharge symptom,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Vaginal discharge symptom,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dysuria,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dysuria,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Abdominal pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Abdominal pain,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cellulitis and abscess of finger,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79898
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cellulitis and abscess of finger,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79898
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Malaise,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4272240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Malaise,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4272240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Right eye visual acuity finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Right eye visual acuity finding,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergic rhinitis due to pollen,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergic rhinitis due to pollen,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma not limiting activities,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma not limiting activities,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma daytime symptoms,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma daytime symptoms,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not disturbing sleep,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not disturbing sleep,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acid reflux,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44783954
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acid reflux,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44783954
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Restless legs,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Restless legs,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma trigger - pollen,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792264
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma trigger - pollen,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792264
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute sinusitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute sinusitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diverticular disease,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diverticular disease,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Increased frequency of urination,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Increased frequency of urination,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sprain of spinal ligament,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sprain of spinal ligament,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise grading,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise grading,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute tonsillitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute tonsillitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Upper respiratory infection,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Upper respiratory infection,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Headache,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Headache,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Rigor - symptom,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4087631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Rigor - symptom,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4087631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma treatment compliance satisfactory,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma treatment compliance satisfactory,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,European,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,European,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Arthritis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4291025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Arthritis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4291025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cellulitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cellulitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysuria,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysuria,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gout,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gout,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain of breast,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain of breast,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal pain,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cystitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cystitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diverticulitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4141224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diverticulitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4141224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not limiting activities,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not limiting activities,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Irritable bowel syndrome,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Irritable bowel syndrome,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Non-suppurative otitis media with eustachian tube disorders,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Non-suppurative otitis media with eustachian tube disorders,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abrasion and/or friction burn of lower limb without infection,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 43530827
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abrasion and/or friction burn of lower limb without infection,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 43530827
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Parotitis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4032796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Parotitis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4032796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eye / vision finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4038502
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eye / vision finding,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4038502
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma daytime symptoms,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma daytime symptoms,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4161595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Atopic conjunctivitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4335888
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Atopic conjunctivitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4335888
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma never causes daytime symptoms,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma never causes daytime symptoms,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient's condition improved,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient's condition improved,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma not disturbing sleep,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma not disturbing sleep,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sciatica,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sciatica,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol dependence,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435243
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol dependence,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435243
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: active,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: active,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Elevated blood pressure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4086587
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Elevated blood pressure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4086587
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cough,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cough,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - inadequate specimen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - inadequate specimen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Abnormal uterine bleeding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 45757810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Abnormal uterine bleeding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 45757810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Verruca plantaris,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Verruca plantaris,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Otalgia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Otalgia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,At risk of dementia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44784331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,At risk of dementia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44784331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma disturbing sleep,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma disturbing sleep,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acne vulgaris,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acne vulgaris,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Foot pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Foot pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute iritis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4104039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute iritis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4104039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diarrhea,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diarrhea,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Wheezing,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Wheezing,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 314754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Burn of upper limb,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Burn of upper limb,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of pulse rate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of pulse rate,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute exacerbation of chronic obstructive airways disease,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute exacerbation of chronic obstructive airways disease,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Burn,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Burn,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hearing loss,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hearing loss,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 377889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Postcoital bleeding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Postcoital bleeding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient's condition worsened,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4150631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient's condition worsened,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4150631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Enjoys moderate exercise,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Enjoys moderate exercise,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depressed mood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depressed mood,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute lower respiratory tract infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute lower respiratory tract infection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise grading,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise grading,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Bruising symptom,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058577
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Bruising symptom,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058577
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma resolved,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4036799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma resolved,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4036799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Osteoarthritis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Osteoarthritis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: moderately active,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: moderately active,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Bleeding from nose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096682
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Bleeding from nose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096682
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute bronchitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute bronchitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Upper respiratory infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Upper respiratory infection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tachycardia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tachycardia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Headache,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Headache,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Vasovagal syncope,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4162976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Vasovagal syncope,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4162976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Candidiasis of mouth,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 29735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Candidiasis of mouth,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 29735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Impaired fasting glycemia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4308509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Impaired fasting glycemia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4308509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low back pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low back pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 45766466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red eye,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 45766466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injury of head,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injury of head,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dizziness,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dizziness,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pernicious anemia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pernicious anemia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain in face,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4317968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain in face,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4317968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Loss of vision,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44790784
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Loss of vision,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44790784
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - negative,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - negative,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood pressure finding,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient self-report,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient self-report,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of wound healing,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4177611
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding of wound healing,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4177611
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General symptom,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General symptom,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Left eye visual acuity finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Left eye visual acuity finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Vaginal bleeding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129155
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Vaginal bleeding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4129155
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Disorder of menstruation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Disorder of menstruation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cellulitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cellulitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 435613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dyspnea,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dyspnea,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic reaction to drug,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergic reaction to drug,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pain of breast,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Abscess of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4153106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Abscess of breast,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4153106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - borderline changes,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - borderline changes,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma disturbs sleep weekly,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma disturbs sleep weekly,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depressive disorder,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depressive disorder,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ankle pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Ankle pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4090553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute asthma,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Acute asthma,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 257581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Right eye visual acuity finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Right eye visual acuity finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tight chest,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Tight chest,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Fatigue,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Fatigue,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pruritic rash,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135618
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pruritic rash,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 135618
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma not limiting activities,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma not limiting activities,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thoracic cage structure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4244854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thoracic cage structure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4244854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Menorrhagia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Menorrhagia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Productive cough,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4102774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Productive cough,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4102774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Coronavirus infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Coronavirus infection,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never causes daytime symptoms,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma never causes daytime symptoms,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Swelling of structure of eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Swelling of structure of eye,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 381299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's condition improved,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's condition improved,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in lower limb,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in lower limb,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diarrhea and vomiting,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4091519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diarrhea and vomiting,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4091519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Liver function tests abnormal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 438878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Liver function tests abnormal,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 438878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not disturbing sleep,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not disturbing sleep,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in wrist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4208857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in wrist,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4208857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of sebaceous cyst,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4110712
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection of sebaceous cyst,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4110712
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sciatica,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sciatica,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 372409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent cyst of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4196431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent cyst of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4196431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in finger,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077895
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in finger,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077895
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnant,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnant,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ca cervix screening normal,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4064368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ca cervix screening normal,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4064368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Polycystic ovary,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 36683296
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Polycystic ovary,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 36683296
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient condition unchanged,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient condition unchanged,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4231763
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collapse,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collapse,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cough,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cough,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chest pain,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chest pain,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 77670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seborrheic dermatitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137053
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seborrheic dermatitis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137053
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptoms of depression,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4191716
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptoms of depression,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4191716
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Subarachnoid hemorrhage,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Subarachnoid hemorrhage,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Elbow joint pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116166
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Elbow joint pain,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116166
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microscopic hematuria,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78472
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microscopic hematuria,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78472
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematemesis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 26727
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematemesis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 26727
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Facial swelling,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Facial swelling,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No response to bowel cancer screening programme invitation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44793084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No response to bowel cancer screening programme invitation,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44793084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Otalgia,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Otalgia,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vertigo,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vertigo,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Streptococcal infectious disease,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437779
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Streptococcal infectious disease,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437779
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Backache with radiation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058580
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Backache with radiation,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058580
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal discomfort,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal discomfort,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in buttock,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in buttock,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nausea,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nausea,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 31967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear transformation zone cells present,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4260744
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear transformation zone cells present,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4260744
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Candidiasis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Candidiasis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hypertrichosis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hypertrichosis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diverticular disease,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diverticular disease,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - human papillomavirus negative,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810558
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - human papillomavirus negative,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810558
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Backache,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Backache,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Normal blood pressure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4065875
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Normal blood pressure,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4065875
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chlamydial infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 438066
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chlamydial infection,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 438066
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinary tract infectious disease,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinary tract infectious disease,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Migraine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Migraine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptom of skin and integumentary tissue,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4154931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptom of skin and integumentary tissue,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4154931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tension-type headache,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tension-type headache,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - high grade dyskaryosis (severe),366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - high grade dyskaryosis (severe),366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44810424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinary symptoms,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinary symptoms,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of pulse rate,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infestation by Sarcoptes scabiei var hominis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140949
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infestation by Sarcoptes scabiei var hominis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140949
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inflammatory disorder of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inflammatory disorder of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loin pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Loin pain,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vitamin D deficiency,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vitamin D deficiency,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 436070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to sexuality and sexual activity,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to sexuality and sexual activity,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastroscopy normal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4065515
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gastroscopy normal,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4065515
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Irregular periods,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Irregular periods,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wax in ear canal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wax in ear canal,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal tenderness,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal tenderness,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopause present,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4128329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopause present,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4128329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Itching,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Itching,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Coating of mucous membrane of tongue,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44784165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Coating of mucous membrane of tongue,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44784165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of size of gravid uterus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of size of gravid uterus,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent urinary tract infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrent urinary tract infection,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopausal flushing,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4113666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menopausal flushing,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4113666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys moderate exercise,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys moderate exercise,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute pharyngitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 25297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute pharyngitis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 25297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's condition deteriorating,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's condition deteriorating,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4077493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressed mood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depressed mood,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Carpal tunnel syndrome,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Carpal tunnel syndrome,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380094
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute lower respiratory tract infection,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute lower respiratory tract infection,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4307774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise grading,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise grading,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hand pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4204199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hand pain,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4204199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast lump,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast lump,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ligament,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4160875
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sprain of ligament,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4160875
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uterine leiomyoma,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uterine leiomyoma,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute tonsillitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute tonsillitis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dyspareunia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dyspareunia,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hemangioma,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hemangioma,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute bronchitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute bronchitis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Edema,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Edema,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 433595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptom: chest wall,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Symptom: chest wall,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4145822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tired all the time,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tired all the time,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Melanocytic nevus of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Melanocytic nevus of skin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear result,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear result,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in toe,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111231
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in toe,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111231
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Headache,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Headache,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibroadenoma of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibroadenoma of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic low back pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4132891
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic low back pain,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4132891
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Papilloma of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Papilloma of skin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Beta thalassemia trait,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149681
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Beta thalassemia trait,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149681
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sinus headache,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sinus headache,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast neoplasm screening normal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast neoplasm screening normal,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4062647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low back pain,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low back pain,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Livebirth,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4092289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Livebirth,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4092289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,European,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,European,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in face,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4317968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in face,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4317968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute conjunctivitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Acute conjunctivitis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in pelvis,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain in pelvis,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - negative,366 to inf,count,numeric,9,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - negative,366 to inf,percentage,percentage,25.7142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neck pain,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neck pain,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 24134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,366 to inf,count,numeric,13,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood pressure finding,366 to inf,percentage,percentage,37.1428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys light exercise,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enjoys light exercise,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Has an itchy eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4037888
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Has an itchy eye,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4037888
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical finding,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Paronychia of toe,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Paronychia of toe,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes night symptoms 1 to 2 times per month,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes night symptoms 1 to 2 times per month,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hip pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hip pain,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4170554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultant unit birth,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultant unit birth,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4015159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Soft tissue swelling,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4185199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Soft tissue swelling,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4185199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Streptococcal sore throat,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 28060
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Streptococcal sore throat,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 28060
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Left eye visual acuity finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Left eye visual acuity finding,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laceration - injury,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laceration - injury,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psoriasis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psoriasis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Solitary cyst of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Solitary cyst of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore throat symptom,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sore throat symptom,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of menstruation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of menstruation,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eye symptom,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205680
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eye symptom,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205680
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade 1,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade 1,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anterior chest wall pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anterior chest wall pain,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dyspnea,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dyspnea,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discharge symptom,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vaginal discharge symptom,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysuria,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dysuria,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibrocystic disease of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78804
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibrocystic disease of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 78804
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast infection,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of breast,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pain of breast,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 73819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of lower limb,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4130852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of lower limb,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4130852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of foot,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injury of foot,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 444130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Joint British Societies cardiovascular disease risk less than ten percent over next ten years,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Joint British Societies cardiovascular disease risk less than ten percent over next ten years,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of eyelid,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disorder of eyelid,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal pain,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominal pain,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery normal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441641
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery normal,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441641
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mixed anxiety and depressive disorder,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mixed anxiety and depressive disorder,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Palpitations,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Palpitations,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amenorrhea,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amenorrhea,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dental abscess,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dental abscess,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscle strain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Muscle strain,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized anxiety disorder,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized anxiety disorder,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434613
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fully conscious,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158186
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fully conscious,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4158186
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dermatitis herpetiformis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dermatitis herpetiformis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpes labialis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4033227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Herpes labialis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4033227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tight chest,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tight chest,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4034235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Right eye visual acuity finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Right eye visual acuity finding,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fatigue,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fatigue,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Whiplash injury to neck,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4218389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Whiplash injury to neck,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4218389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vagina finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4088777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vagina finding,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4088777
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Costal chondritis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4272340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Costal chondritis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4272340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic rhinitis due to pollen,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergic rhinitis due to pollen,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 256439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not limiting activities,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma not limiting activities,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heart sounds normal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heart sounds normal,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4116639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lumbago with sciatica,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4001450
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lumbago with sciatica,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4001450
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Otitis externa,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380731
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Otitis externa,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380731
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menorrhagia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menorrhagia,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eyelid structure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4196657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eyelid structure,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4196657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety disorder,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anxiety disorder,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 442077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Nasal symptom,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4091808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Nasal symptom,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4091808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient's condition improved,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient's condition improved,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Torticollis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Torticollis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 440814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Bacterial vaginosis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4303258
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Bacterial vaginosis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4303258
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Infection of skin and/or subcutaneous tissue,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201093
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Malignant neoplasm of brain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Malignant neoplasm of brain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pregnant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pregnant,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Tinea pedis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Tinea pedis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cough,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cough,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - inadequate specimen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - inadequate specimen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 439652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sore lip,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4150132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sore lip,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4150132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Not pregnant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4243056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Not pregnant,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4243056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Early stage of pregnancy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Early stage of pregnancy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acne vulgaris,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acne vulgaris,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinary symptoms,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinary symptoms,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74174
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of pulse rate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of pulse rate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dyskaryosis on cervical smear,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dyskaryosis on cervical smear,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095039
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Clicking joint,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4066502
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Clicking joint,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4066502
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Viral upper respiratory tract infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4085100
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Viral upper respiratory tract infection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4085100
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Clouded consciousness,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4164633
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Clouded consciousness,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4164633
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dysphasia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dysphasia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of visual field,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4201690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of visual field,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4201690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,External hordeolum,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,External hordeolum,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Atopic dermatitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133834
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Atopic dermatitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 133834
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Recurrent urinary tract infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Recurrent urinary tract infection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Died in community hospital,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37016900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Died in community hospital,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37016900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Glenohumeral joint structure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4310972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Glenohumeral joint structure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4310972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Depressed mood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Depressed mood,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hand pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4204199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hand pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4204199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Memory finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Memory finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4021900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acute bronchitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Acute bronchitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Upper respiratory infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Upper respiratory infection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Melanocytic nevus of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Melanocytic nevus of skin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4221679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Headache,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Headache,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Plantar fasciitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Plantar fasciitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4002650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Female genitalia finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Female genitalia finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4095793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fracture of phalanx of thumb,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166901
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fracture of phalanx of thumb,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166901
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Gastroenteritis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101468
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Gastroenteritis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101468
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Gynecomastia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Gynecomastia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,European,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,European,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 38003614
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - negative,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical smear - negative,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood pressure finding,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood pressure finding,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient self-report,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient self-report,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Swollen calf,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4083665
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Swollen calf,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4083665
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Closed fracture of one or more phalanges of hand,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 72465
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Closed fracture of one or more phalanges of hand,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 72465
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Victim of domestic violence,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44789589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Victim of domestic violence,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44789589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Malignant neoplasm of main bronchus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4157333
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Malignant neoplasm of main bronchus,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4157333
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of power of skeletal muscle,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4154799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of power of skeletal muscle,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4154799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sore throat symptom,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sore throat symptom,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eye symptom,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205680
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eye symptom,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4205680
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade 1,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical intraepithelial neoplasia grade 1,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 192676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dysgraphia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4339222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dysgraphia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4339222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Structure of articular capsule,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4137606
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Structure of articular capsule,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4137606
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Abdomen examined - NAD,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Abdomen examined - NAD,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,General finding of observation of patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041283
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,General finding of observation of patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4041283
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mass of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mass of skin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4183953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Abdominal pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Abdominal pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Muscle strain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Muscle strain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cystitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cystitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient feels well,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4143069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient feels well,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4143069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine looks normal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine looks normal,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Missed period,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Missed period,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sprain of ankle,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sprain of ankle,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 81151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Non-suppurative otitis media with eustachian tube disorders,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Non-suppurative otitis media with eustachian tube disorders,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4111114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hemorrhoids,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195562
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hemorrhoids,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195562
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Menorrhagia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Menorrhagia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,First trimester bleeding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3657563
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,First trimester bleeding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3657563
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Atypical facial pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137856
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Atypical facial pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137856
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Varicose eczema,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4182772
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Varicose eczema,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4182772
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain in lower limb,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain in lower limb,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4024561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition improved,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient's condition improved,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Candidiasis of mouth and esophagus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4142836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Candidiasis of mouth and esophagus,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4142836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not disturbing sleep,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma not disturbing sleep,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pregnant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pregnant,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4299535
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute sinusitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute sinusitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 260123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Folliculitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4029295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Folliculitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4029295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute bronchitis co-occurrent with wheeze,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37206139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute bronchitis co-occurrent with wheeze,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37206139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of foot region,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of foot region,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cough,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cough,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 254761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal chest,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3654258
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal chest,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3654258
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Romberg sign,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4162564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Romberg sign,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4162564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cyst of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4112141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cyst of skin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4112141
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,At risk of dementia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44784331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,At risk of dementia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44784331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,All pulses present in right lower limb,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,All pulses present in right lower limb,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4329041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4329041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute appendicitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4310400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute appendicitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4310400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal ocular motility,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal ocular motility,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acne vulgaris,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acne vulgaris,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4227594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,All pulses present in left lower limb,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,All pulses present in left lower limb,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 37312545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022933
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4022933
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per month,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4156136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per month,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4156136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Backache,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Backache,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 134736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Temporomandibular joint disorder,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74396
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Temporomandibular joint disorder,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74396
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diarrhea,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diarrhea,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 196523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hernia of abdominal cavity,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 199860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hernia of abdominal cavity,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 199860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rate,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rate,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Infestation by Sarcoptes scabiei var hominis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140949
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Infestation by Sarcoptes scabiei var hominis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140949
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vomiting,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vomiting,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,6/9 visual acuity of right eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3663208
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,6/9 visual acuity of right eye,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3663208
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysphasia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysphasia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Type 2 diabetes mellitus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201826
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Type 2 diabetes mellitus,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201826
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma never disturbs sleep,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma never disturbs sleep,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4017184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Wax in ear canal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Wax in ear canal,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155902
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night sweats,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night sweats,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of visual field,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4201690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of visual field,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4201690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Increased frequency of urination,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Increased frequency of urination,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012368
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal tenderness,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal tenderness,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal breath sounds,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal breath sounds,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4168007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Itching,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Itching,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4302654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Shoulder pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Shoulder pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4166666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Varicose veins of lower extremity,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Varicose veins of lower extremity,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 318169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Recurrent urinary tract infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Recurrent urinary tract infection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4056621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Enjoys moderate exercise,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Enjoys moderate exercise,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4058139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Depressed mood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Depressed mood,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 40546087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast lump,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast lump,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 80767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise grading,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise grading,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4052467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Miliaria crystallina,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4196222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Miliaria crystallina,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4196222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphadenopathy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphadenopathy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 315085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: moderately active,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General practice physical activity questionnaire physical activity index: moderately active,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44792781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Bleeding from nose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096682
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Bleeding from nose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4096682
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rhythm,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4115241
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of pulse rhythm,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4115241
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Upper respiratory infection,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Upper respiratory infection,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4181583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Skin lesion,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4316083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Skin lesion,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4316083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Tired all the time,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Tired all the time,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4149857
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Headache,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Headache,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 378253
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal distension symptom,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012079
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal distension symptom,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4012079
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vasovagal syncope,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4162976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vasovagal syncope,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4162976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Melena,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Melena,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4103703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Painful rectal bleeding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4189790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Painful rectal bleeding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4189790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Impaired fasting glycemia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4308509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Impaired fasting glycemia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4308509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low back pain,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low back pain,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 194133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of head,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injury of head,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 375415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dizziness,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dizziness,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pernicious anemia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pernicious anemia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 432295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eruption,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eruption,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 140214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pharynx normal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101209
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pharynx normal,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4101209
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute conjunctivitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Acute conjunctivitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 376707
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cervical smear - negative,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cervical smear - negative,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4155376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pins and needles,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266682
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pins and needles,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4266682
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood pressure finding,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4214962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Greater trochanteric pain syndrome,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4297894
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Greater trochanteric pain syndrome,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4297894
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gastritis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gastritis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 201340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient self-report,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient self-report,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Clinical finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Clinical finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 441840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Swollen calf,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4083665
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Swollen calf,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4083665
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lower respiratory tract infection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4175297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lower respiratory tract infection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4175297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Benzodiazepine dependence,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Benzodiazepine dependence,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4338026
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding related to coordination / incoordination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4179301
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding related to coordination / incoordination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4179301
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Intermenstrual bleeding - irregular,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Intermenstrual bleeding - irregular,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pleuritic pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4330445
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pleuritic pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4330445
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Tremor,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Tremor,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 443782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Left eye visual acuity finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Left eye visual acuity finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4172201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lump on finger,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4094015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lump on finger,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4094015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain in thoracic spine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312998
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain in thoracic spine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 312998
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Scar of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4323280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Scar of skin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4323280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sore throat symptom,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sore throat symptom,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4147326
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dermal mycosis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dermal mycosis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 137213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urticaria,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urticaria,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 139900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Deep venous thrombosis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Deep venous thrombosis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4133004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Complaining of weight loss,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Complaining of weight loss,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44788734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Anemia in mother complicating pregnancy, childbirth AND/OR puerperium",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Anemia in mother complicating pregnancy, childbirth AND/OR puerperium",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 434701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysuria,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dysuria,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 197684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dry skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4039266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dry skin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4039266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdomen examined - NAD,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdomen examined - NAD,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4060865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal pain,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Abdominal pain,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 200219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Plantar reflex finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4273330
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Plantar reflex finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4273330
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Muscle tone - finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4273609
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Muscle tone - finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4273609
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cystitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cystitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 195588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lip swelling,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44783305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lip swelling,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 44783305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vasculitis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4137275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vasculitis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4137275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Right eye visual acuity finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Right eye visual acuity finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4169942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fatigue,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fatigue,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4223659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thoracic spondylosis without myelopathy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thoracic spondylosis without myelopathy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 74130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ataxia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ataxia,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 437584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thoracic cage structure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4244854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thoracic cage structure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4244854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Otitis externa,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380731
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Otitis externa,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 380731
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pupil reactions normal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4304930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pupil reactions normal,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4304930
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Muscle weakness,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79908
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Muscle weakness,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 79908
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pruritus of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 136184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pruritus of skin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 136184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Productive cough,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4102774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Productive cough,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4102774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Constipation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Constipation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 75860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Worried,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193634
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Worried,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4193634
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,6/9 visual acuity of left eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3654444
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,6/9 visual acuity of left eye,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 3654444
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma causes daytime symptoms most days,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152911
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma causes daytime symptoms most days,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,condition_occurrence &&& event &&& standard &&& 4152911
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,-inf to -366,percentage,percentage,83.3333333333333,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,-inf to -366,count,numeric,42,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,-inf to -366,percentage,percentage,100,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,-inf to -366,percentage,percentage,100,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,-inf to -366,percentage,percentage,100,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,-365 to -31,percentage,percentage,87.5,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,-365 to -31,count,numeric,44,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,-365 to -31,percentage,percentage,91.6666666666667,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,-365 to -31,percentage,percentage,77.7777777777778,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,-365 to -31,percentage,percentage,77.7777777777778,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,-30 to -1,count,numeric,5,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,-30 to -1,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,-30 to -1,count,numeric,20,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,-30 to -1,percentage,percentage,40.8163265306122,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,-30 to -1,count,numeric,4,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,-30 to -1,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,-30 to -1,count,numeric,3,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,-30 to -1,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,0 to 0,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,1 to 30,count,numeric,6,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,1 to 30,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,1 to 30,count,numeric,26,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,1 to 30,percentage,percentage,53.0612244897959,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,1 to 30,count,numeric,4,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,1 to 30,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,1 to 30,count,numeric,4,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,1 to 30,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,31 to 365,count,numeric,8,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,31 to 365,percentage,percentage,88.8888888888889,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,31 to 365,count,numeric,44,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,31 to 365,percentage,percentage,89.7959183673469,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,31 to 365,count,numeric,9,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,31 to 365,percentage,percentage,100,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,31 to 365,percentage,percentage,77.7777777777778,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Outpatient Visit,366 to inf,percentage,percentage,88.8888888888889,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,366 to inf,count,numeric,31,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient Visit,366 to inf,percentage,percentage,88.5714285714286,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,366 to inf,count,numeric,9,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Outpatient Visit,366 to inf,percentage,percentage,100,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,366 to inf,count,numeric,9,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Outpatient Visit,366 to inf,percentage,percentage,100,table_name &&& type &&& analysis &&& concept,visit_occurrence &&& event &&& standard &&& 9202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Peak flow rate (respiratory),-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197461
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Peak flow rate (respiratory),-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197461
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sperm concentration measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sperm concentration measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid panel,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid panel,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total white blood count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total white blood count,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Complete blood count,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Complete blood count,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Follicle stimulating hormone measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Follicle stimulating hormone measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urea and electrolytes,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urea and electrolytes,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Monocyte count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Monocyte count,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,T4 free measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,T4 free measurement,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gonadotropin peptide measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gonadotropin peptide measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,New patient screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064504
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,New patient screening,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064504
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Luteinizing hormone measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Luteinizing hormone measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell count,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Height centile,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Height centile,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse rate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High vaginal swab culture,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High vaginal swab culture,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lymphocyte count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lymphocyte count,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eosinophil count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eosinophil count,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lipids measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lipids measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Basophil count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Basophil count,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Packed cell volume measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Packed cell volume measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Glucose measurement, blood",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Glucose measurement, blood",-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smooth muscle antibody measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4179789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smooth muscle antibody measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4179789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Glomerular filtration rate testing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Glomerular filtration rate testing,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ANA measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4234268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ANA measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4234268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Platelet count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Platelet count,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inspiratory capacity Predicted,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3028425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inspiratory capacity Predicted,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3028425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Antimitochondrial antibody titer,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Antimitochondrial antibody titer,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Neutrophil count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Neutrophil count,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body height,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body height,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte sedimentation rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte sedimentation rate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self measured blood pressure reading,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44792136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self measured blood pressure reading,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44792136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-inf to -366,count,numeric,30,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-inf to -366,percentage,percentage,71.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Forced vital capacity,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176265
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Forced vital capacity,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176265
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,-inf to -366,count,numeric,33,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,-inf to -366,percentage,percentage,78.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,-inf to -366,count,numeric,33,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,-inf to -366,percentage,percentage,78.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of feces,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of feces,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,-inf to -366,count,numeric,20,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,-inf to -366,percentage,percentage,47.6190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epworth Sleepiness Scale,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46273534
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Epworth Sleepiness Scale,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46273534
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology screening test,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology screening test,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum fasting glucose measurement,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum fasting glucose measurement,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microbiology,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microbiology,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening - health check,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4077808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening - health check,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4077808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Chlamydia antibody,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Chlamydia antibody,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for protein,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for protein,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,-inf to -366,count,numeric,16,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,-inf to -366,percentage,percentage,38.0952380952381,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Flexible sigmoidoscopy Study observation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3017418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Flexible sigmoidoscopy Study observation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3017418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sperm concentration measurement,-inf to -366,count,numeric,22,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sperm concentration measurement,-inf to -366,percentage,percentage,52.3809523809524,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,-inf to -366,count,numeric,23,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,-inf to -366,percentage,percentage,54.7619047619048,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine leukocyte test,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4190448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine leukocyte test,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4190448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sputum smear examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4039896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sputum smear examination,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4039896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Liquid based cervical cytology screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4220448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Liquid based cervical cytology screening,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4220448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",-inf to -366,count,numeric,19,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",-inf to -366,percentage,percentage,45.2380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Respiratory rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4313591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Respiratory rate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4313591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood gas measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood gas measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for blood,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for blood,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control test,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40481511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control test,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40481511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prothrombin time,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prothrombin time,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum globulin measurement,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum globulin measurement,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progesterone measurement,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progesterone measurement,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibrinogen measurement,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094436
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibrinogen measurement,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094436
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid panel,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid panel,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression screening using questions,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44788755
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression screening using questions,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44788755
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Procedure Endoscopy,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Procedure Endoscopy,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control questionnaire,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40483854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control questionnaire,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40483854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood group antibody screening test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood group antibody screening test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,-inf to -366,count,numeric,30,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,-inf to -366,percentage,percentage,71.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tumor marker measurement,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tumor marker measurement,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clostridium difficile toxin detection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397771
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clostridium difficile toxin detection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397771
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-inf to -366,count,numeric,30,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-inf to -366,percentage,percentage,71.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density lipoprotein measurement,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density lipoprotein measurement,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B antigen screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37394207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B antigen screening,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37394207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total protein measurement,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total protein measurement,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal RhD antibody screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4060266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal RhD antibody screening,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4060266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enzyme/specific protein level measurement,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enzyme/specific protein level measurement,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum total cholesterol measurement,-inf to -366,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum total cholesterol measurement,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Testosterone measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4020107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Testosterone measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4020107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,-inf to -366,count,numeric,24,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,-inf to -366,percentage,percentage,57.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum prolactin measurement,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197603
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum prolactin measurement,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197603
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follicle stimulating hormone measurement,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follicle stimulating hormone measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serologic test for rubella,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4321890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serologic test for rubella,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4321890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,-inf to -366,count,numeric,33,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,-inf to -366,percentage,percentage,78.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma folate measurement,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma folate measurement,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood grouping,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood grouping,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,-inf to -366,count,numeric,29,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,-inf to -366,percentage,percentage,69.0476190476191,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinalysis,-inf to -366,count,numeric,17,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinalysis,-inf to -366,percentage,percentage,40.4761904761905,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sex hormone binding globulin measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4082602
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sex hormone binding globulin measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4082602
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FAST - Fast Alcohol Screening Test,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44791753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FAST - Fast Alcohol Screening Test,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44791753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Triiodothyronine, free measurement",-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Triiodothyronine, free measurement",-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma screening,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062501
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma screening,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062501
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low density lipoprotein measurement,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low density lipoprotein measurement,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum alpha foetoprotein mean of median,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37399586
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum alpha foetoprotein mean of median,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37399586
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HIV antigen test,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HIV antigen test,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for pH,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154501
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for pH,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154501
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Helicobacter blood test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Helicobacter blood test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum ferritin measurement,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum ferritin measurement,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Waist circumference,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Waist circumference,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",-inf to -366,count,numeric,23,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",-inf to -366,percentage,percentage,54.7619047619048,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chemical function tests,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chemical function tests,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amylase measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4276028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amylase measurement,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4276028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematology screening test,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4198132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematology screening test,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4198132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,T4 free measurement,-inf to -366,count,numeric,19,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,T4 free measurement,-inf to -366,percentage,percentage,45.2380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum iron tests,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum iron tests,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Edinburgh postnatal depression scale,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4164838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Edinburgh postnatal depression scale,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4164838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062484
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062484
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for nitrite,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4120299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for nitrite,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4120299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gonadotropin peptide measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gonadotropin peptide measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chlorhexidine radioallergosorbent test (RAST),-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176294
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chlorhexidine radioallergosorbent test (RAST),-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176294
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum vitamin B12 measurement,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum vitamin B12 measurement,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spirometry,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4133840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spirometry,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4133840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urate measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4156643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urate measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4156643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral temperature,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral temperature,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient screening,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064504
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient screening,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064504
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology laboratory test,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology laboratory test,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Last menstrual period -1st day,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Last menstrual period -1st day,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium measurement,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium measurement,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bicarbonate measurement,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bicarbonate measurement,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FBC - full blood count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FBC - full blood count,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Luteinizing hormone measurement,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Luteinizing hormone measurement,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology test,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology test,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hemoglobin variant test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4118981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hemoglobin variant test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4118981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,-inf to -366,count,numeric,28,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell size determination,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell size determination,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cerebrospinal fluid index,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136730
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cerebrospinal fluid index,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136730
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Syphilis test, quantitative",-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4103678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Syphilis test, quantitative",-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4103678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heaf test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4092972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heaf test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4092972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",-inf to -366,count,numeric,23,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",-inf to -366,percentage,percentage,54.7619047619048,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ambulatory blood pressure recording,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ambulatory blood pressure recording,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein measurement,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein measurement,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spirometry screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Spirometry screening,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,-inf to -366,count,numeric,28,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of level of substance in blood,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of level of substance in blood,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of ketones in urine using dipstick,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of ketones in urine using dipstick,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High vaginal swab culture,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High vaginal swab culture,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HLA tissue typing,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HLA tissue typing,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bone density quantitative measurement by DXA panel,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 42529473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bone density quantitative measurement by DXA panel,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 42529473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,-inf to -366,count,numeric,30,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,-inf to -366,percentage,percentage,71.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Colonoscopy Study observation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Colonoscopy Study observation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol use disorders identification test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4157230
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol use disorders identification test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4157230
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Partial thromboplastin time ratio,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Partial thromboplastin time ratio,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening procedure,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4063579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening procedure,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4063579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triglycerides measurement,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triglycerides measurement,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dorsalis pedis pulse rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4324890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dorsalis pedis pulse rate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4324890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triiodothyronine measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triiodothyronine measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior tibial pulse rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4180591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior tibial pulse rate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4180591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clotting screening test,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clotting screening test,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-inf to -366,count,numeric,23,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-inf to -366,percentage,percentage,54.7619047619048,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ABO blood group,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ABO blood group,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,-inf to -366,count,numeric,29,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,-inf to -366,percentage,percentage,69.0476190476191,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma viscosity measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma viscosity measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Frailty Index,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37017370
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Frailty Index,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37017370
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Reticulocyte count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Reticulocyte count,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Differential white blood cell count procedure,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Differential white blood cell count procedure,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipids measurement,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipids measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal blood tests,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4207466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal blood tests,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4207466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,-inf to -366,count,numeric,29,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,-inf to -366,percentage,percentage,69.0476190476191,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,QRISK2 cardiovascular disease 10 year risk score,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397449
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,QRISK2 cardiovascular disease 10 year risk score,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397449
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,-inf to -366,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,-inf to -366,percentage,percentage,42.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum parathyroid hormone measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum parathyroid hormone measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estradiol measurement,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4292703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estradiol measurement,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4292703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Human chorionic gonadotropin measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4285271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Human chorionic gonadotropin measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4285271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium level,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37394189
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium level,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37394189
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroxine measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4248132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroxine measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4248132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-inf to -366,count,numeric,28,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total immunoglobulin measurement,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total immunoglobulin measurement,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal screening for human immunodeficiency virus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4191703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal screening for human immunodeficiency virus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4191703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,-inf to -366,count,numeric,23,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,-inf to -366,percentage,percentage,54.7619047619048,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma total iron binding capacity,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307154
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma total iron binding capacity,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307154
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histopathology test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histopathology test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral studies,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4191852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Viral studies,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4191852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,-inf to -366,count,numeric,29,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,-inf to -366,percentage,percentage,69.0476190476191,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Glucose measurement, blood",-inf to -366,count,numeric,21,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Glucose measurement, blood",-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Creatine kinase measurement,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4265595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Creatine kinase measurement,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4265595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of respiratory function,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4052083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of respiratory function,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4052083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood group antibodies identified in Serum or Plasma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036472
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood group antibodies identified in Serum or Plasma,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036472
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smooth muscle antibody measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4179789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smooth muscle antibody measurement,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4179789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse oximetry,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse oximetry,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,-inf to -366,count,numeric,23,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,-inf to -366,percentage,percentage,54.7619047619048,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alpha-1-Fetoprotein measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alpha-1-Fetoprotein measurement,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Forced expired volume in 1 second,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4241837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Forced expired volume in 1 second,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4241837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network score,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44799709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network score,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44799709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,-inf to -366,count,numeric,21,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occult blood panel - Stool,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occult blood panel - Stool,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipid level,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393729
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipid level,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393729
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for glucose,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for glucose,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspartate aminotransferase measurement,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspartate aminotransferase measurement,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ANA measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4234268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ANA measurement,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4234268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,-inf to -366,count,numeric,30,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,-inf to -366,percentage,percentage,71.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inspiratory capacity Predicted,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3028425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inspiratory capacity Predicted,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3028425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,-inf to -366,count,numeric,33,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,-inf to -366,percentage,percentage,78.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum lipids level,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37398521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum lipids level,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37398521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antimitochondrial antibody titer,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antimitochondrial antibody titer,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FEV1/FVC,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3011505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FEV1/FVC,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3011505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glucose tolerance test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4012477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glucose tolerance test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4012477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,OB ultrasound panel,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,OB ultrasound panel,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12/folate level,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12/folate level,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,-inf to -366,count,numeric,30,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,-inf to -366,percentage,percentage,71.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B e antigen test,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B e antigen test,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum inorganic phosphate measurement,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum inorganic phosphate measurement,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Rheumatoid factor, quantitative",-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Rheumatoid factor, quantitative",-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,-inf to -366,count,numeric,28,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-inf to -366,count,numeric,30,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-inf to -366,percentage,percentage,71.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complement assay,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4105757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complement assay,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4105757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screening for glucose,-inf to -366,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screening for glucose,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,-inf to -366,count,numeric,23,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,-inf to -366,percentage,percentage,54.7619047619048,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte sedimentation rate,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte sedimentation rate,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child head circumference centile,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child head circumference centile,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Systolic blood pressure,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Systolic blood pressure,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body weight,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body weight,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sperm concentration measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sperm concentration measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Potassium measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Potassium measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hypertension screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hypertension screening,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Microscopy, culture and sensitivities",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Microscopy, culture and sensitivities",-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total white blood count,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total white blood count,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diastolic blood pressure,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diastolic blood pressure,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Monocyte count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Monocyte count,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Creatinine measurement, serum",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Creatinine measurement, serum",-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,T4 free measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,T4 free measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell count,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hepatic function panel,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hepatic function panel,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Spirometry screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Spirometry screening,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Height centile,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Height centile,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pulse rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pulse rate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lymphocyte count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lymphocyte count,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eosinophil count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eosinophil count,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Basophil count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Basophil count,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood urea measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood urea measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Framingham coronary heart disease 10 year risk score,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Framingham coronary heart disease 10 year risk score,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Packed cell volume measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Packed cell volume measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sodium measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sodium measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Glomerular filtration rate testing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Glomerular filtration rate testing,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Platelet count,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Platelet count,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight centile,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight centile,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Framingham coronary heart disease 10 year risk score,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 42872767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Framingham coronary heart disease 10 year risk score,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 42872767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Neutrophil count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Neutrophil count,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body height,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body height,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Forced vital capacity,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176265
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Forced vital capacity,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176265
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,-inf to -366,percentage,percentage,75,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prealbumin measurement,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prealbumin measurement,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum fasting glucose measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum fasting glucose measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening - health check,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4077808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening - health check,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4077808
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum C reactive protein level,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum C reactive protein level,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Flexible sigmoidoscopy Study observation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3017418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Flexible sigmoidoscopy Study observation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3017418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Potassium measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Potassium measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sperm concentration measurement,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sperm concentration measurement,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum globulin measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum globulin measurement,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid panel,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid panel,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte sedimentation rate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393853
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte sedimentation rate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393853
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Procedure Endoscopy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Procedure Endoscopy,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total white blood count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total white blood count,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum total cholesterol measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum total cholesterol measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Complete blood count,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Complete blood count,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Large unstained cell count,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Large unstained cell count,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serologic test for rubella,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4321890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serologic test for rubella,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4321890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urea and electrolytes,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urea and electrolytes,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood grouping,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood grouping,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Monocyte count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Monocyte count,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Haemoglobin estimation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Haemoglobin estimation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,HIV antigen test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,HIV antigen test,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum ferritin measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum ferritin measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Creatinine measurement, serum",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Creatinine measurement, serum",-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Edinburgh postnatal depression scale,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4164838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Edinburgh postnatal depression scale,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4164838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening for malignant neoplasm of cervix,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062484
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening for malignant neoplasm of cervix,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062484
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Spirometry,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4133840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Spirometry,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4133840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral temperature,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral temperature,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium measurement,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium measurement,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell count,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell size determination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell size determination,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatic function panel,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatic function panel,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Syphilis test, quantitative",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4103678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Syphilis test, quantitative",-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4103678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Bilirubin, total measurement",-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Bilirubin, total measurement",-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine protein measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine protein measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Height centile,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Height centile,-inf to -366,percentage,percentage,87.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse rate,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse rate,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine examination,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphocyte count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphocyte count,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4063579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening procedure,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4063579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ABO blood group,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ABO blood group,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eosinophil count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eosinophil count,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Differential white blood cell count procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Differential white blood cell count procedure,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Basophil count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Basophil count,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood urea measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood urea measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alkaline phosphatase measurement,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alkaline phosphatase measurement,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Packed cell volume measurement,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Packed cell volume measurement,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Glucose measurement, blood",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Glucose measurement, blood",-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse oximetry,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse oximetry,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vital capacity after bronchodilation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44807392
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Vital capacity after bronchodilation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44807392
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sodium measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sodium measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Forced expired volume in 1 second,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4241837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Forced expired volume in 1 second,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4241837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occult blood panel - Stool,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occult blood panel - Stool,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Platelet count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Platelet count,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood glucose level,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37399654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood glucose level,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37399654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,-inf to -366,percentage,percentage,75,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,FEV1/FVC,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3011505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,FEV1/FVC,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3011505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Adult screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Adult screening,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neutrophil count,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neutrophil count,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatitis B e antigen test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatitis B e antigen test,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,FEV1 before bronchodilation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4269010
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,FEV1 before bronchodilation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4269010
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum inorganic phosphate measurement,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum inorganic phosphate measurement,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body height,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body height,-inf to -366,percentage,percentage,87.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine screening for glucose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine screening for glucose,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alanine aminotransferase measurement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alanine aminotransferase measurement,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte sedimentation rate,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte sedimentation rate,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,-365 to -31,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sperm concentration measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sperm concentration measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Respiratory rate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4313591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Respiratory rate,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4313591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood gas measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood gas measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum globulin measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum globulin measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total white blood count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total white blood count,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Heart sounds,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Heart sounds,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Complete blood count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Complete blood count,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,-365 to -31,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Monocyte count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Monocyte count,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral temperature,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral temperature,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum bicarbonate measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum bicarbonate measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell count,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell size determination,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell size determination,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urine protein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urine protein measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Height centile,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Height centile,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse rate,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse rate,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lymphocyte count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lymphocyte count,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Electrolytes measurement, serum",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4066848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Electrolytes measurement, serum",-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4066848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eosinophil count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eosinophil count,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lipids measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lipids measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Heart rate rhythm,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Heart rate rhythm,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Packed cell volume measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Packed cell volume measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Aspartate aminotransferase measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Aspartate aminotransferase measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Peak expiratory flow rate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087260
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Peak expiratory flow rate,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087260
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Platelet count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Platelet count,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Neutrophil count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Neutrophil count,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body height,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body height,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urine screening for glucose,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urine screening for glucose,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte sedimentation rate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte sedimentation rate,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-365 to -31,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-365 to -31,percentage,percentage,22.9166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,-365 to -31,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,-365 to -31,percentage,percentage,22.9166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum fasting glucose measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum fasting glucose measurement,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Chlamydia antibody,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Chlamydia antibody,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,-365 to -31,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,-365 to -31,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sperm concentration measurement,-365 to -31,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sperm concentration measurement,-365 to -31,percentage,percentage,29.1666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 706179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 706179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prothrombin time,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prothrombin time,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum globulin measurement,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum globulin measurement,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid panel,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid panel,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression screening using questions,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44788755
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression screening using questions,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44788755
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-365 to -31,percentage,percentage,14.5833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,PhenX - diabetic retinopathy protocol 140701,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40765533
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,PhenX - diabetic retinopathy protocol 140701,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40765533
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Procedure Endoscopy,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Procedure Endoscopy,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control questionnaire,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40483854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control questionnaire,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40483854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tumor marker measurement,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tumor marker measurement,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density lipoprotein measurement,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density lipoprotein measurement,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total protein measurement,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total protein measurement,-365 to -31,percentage,percentage,14.5833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enzyme/specific protein level measurement,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enzyme/specific protein level measurement,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum total cholesterol measurement,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum total cholesterol measurement,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,-365 to -31,percentage,percentage,14.5833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,-365 to -31,percentage,percentage,14.5833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follicle stimulating hormone measurement,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follicle stimulating hormone measurement,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma folate measurement,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma folate measurement,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Best ever peak flow rate (respiratory),-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Best ever peak flow rate (respiratory),-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinalysis,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinalysis,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FAST - Fast Alcohol Screening Test,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44791753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FAST - Fast Alcohol Screening Test,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44791753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Triiodothyronine, free measurement",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Triiodothyronine, free measurement",-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low density lipoprotein measurement,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low density lipoprotein measurement,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum ferritin measurement,-365 to -31,count,numeric,9,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum ferritin measurement,-365 to -31,percentage,percentage,18.75,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chemical function tests,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chemical function tests,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amylase measurement,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4276028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amylase measurement,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4276028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematology screening test,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4198132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematology screening test,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4198132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,T4 free measurement,-365 to -31,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,T4 free measurement,-365 to -31,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum iron tests,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum iron tests,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062484
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062484
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum vitamin B12 measurement,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum vitamin B12 measurement,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology laboratory test,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology laboratory test,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Last menstrual period -1st day,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Last menstrual period -1st day,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium measurement,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium measurement,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bicarbonate measurement,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bicarbonate measurement,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology test,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology test,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Luteinizing hormone measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Luteinizing hormone measurement,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hemoglobin variant test,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4118981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hemoglobin variant test,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4118981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,-365 to -31,count,numeric,17,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,-365 to -31,percentage,percentage,35.4166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell size determination,-365 to -31,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell size determination,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cerebrospinal fluid index,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136730
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cerebrospinal fluid index,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136730
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",-365 to -31,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein measurement,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of level of substance in blood,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of level of substance in blood,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microalbuminuria measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263307
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microalbuminuria measurement,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263307
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High vaginal swab culture,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High vaginal swab culture,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Partial thromboplastin time ratio,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Partial thromboplastin time ratio,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triglycerides measurement,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triglycerides measurement,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dorsalis pedis pulse rate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4324890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dorsalis pedis pulse rate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4324890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior tibial pulse rate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4180591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior tibial pulse rate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4180591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clotting screening test,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clotting screening test,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-365 to -31,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid stimulating hormone measurement,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ABO blood group,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ABO blood group,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,-365 to -31,count,numeric,17,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,-365 to -31,percentage,percentage,35.4166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Differential white blood cell count procedure,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Differential white blood cell count procedure,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipids measurement,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipids measurement,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,-365 to -31,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,-365 to -31,percentage,percentage,20.8333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estradiol measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4292703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estradiol measurement,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4292703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Folic acid measurement, RBC",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4290096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Folic acid measurement, RBC",-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4290096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-365 to -31,count,numeric,17,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-365 to -31,percentage,percentage,35.4166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total immunoglobulin measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total immunoglobulin measurement,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Glucose measurement, blood",-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Glucose measurement, blood",-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anti-thyroid antibody measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4018606
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anti-thyroid antibody measurement,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4018606
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse oximetry,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse oximetry,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Albumin/creatinine ratio measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4108431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Albumin/creatinine ratio measurement,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4108431
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network score,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44799709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network score,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44799709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,-365 to -31,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspartate aminotransferase measurement,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspartate aminotransferase measurement,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,-365 to -31,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,-365 to -31,percentage,percentage,22.9166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,INR in Blood by Coagulation assay,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3032080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,INR in Blood by Coagulation assay,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3032080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,OB ultrasound panel,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,OB ultrasound panel,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12/folate level,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12/folate level,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B e antigen test,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B e antigen test,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Rheumatoid factor, quantitative",-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Rheumatoid factor, quantitative",-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum inorganic phosphate measurement,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum inorganic phosphate measurement,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-365 to -31,count,numeric,18,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-365 to -31,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screening for glucose,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screening for glucose,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,-365 to -31,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte sedimentation rate,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte sedimentation rate,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body weight,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body weight,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Systolic blood pressure,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Systolic blood pressure,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Prealbumin measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Prealbumin measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Potassium measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Potassium measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sperm concentration measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sperm concentration measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum globulin measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum globulin measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total white blood count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total white blood count,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Heart sounds,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Heart sounds,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,High density lipoprotein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,High density lipoprotein measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total protein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total protein measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum total cholesterol measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum total cholesterol measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Complete blood count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Complete blood count,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diastolic blood pressure,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diastolic blood pressure,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Monocyte count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Monocyte count,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Low density lipoprotein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Low density lipoprotein measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Creatinine measurement, serum",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Creatinine measurement, serum",-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum bicarbonate measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum bicarbonate measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell count,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell size determination,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell size determination,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hepatic function panel,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hepatic function panel,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Bilirubin, total measurement",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Bilirubin, total measurement",-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pulse rate,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pulse rate,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lymphocyte count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lymphocyte count,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Electrolytes measurement, serum",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4066848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Electrolytes measurement, serum",-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4066848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Triglycerides measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Triglycerides measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eosinophil count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eosinophil count,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lipids measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lipids measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood urea measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood urea measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Heart rate rhythm,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Heart rate rhythm,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alkaline phosphatase measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alkaline phosphatase measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Packed cell volume measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Packed cell volume measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sodium measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sodium measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Aspartate aminotransferase measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Aspartate aminotransferase measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Platelet count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Platelet count,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight centile,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight centile,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Neutrophil count,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Neutrophil count,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alanine aminotransferase measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alanine aminotransferase measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte sedimentation rate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte sedimentation rate,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-365 to -31,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Forced vital capacity,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176265
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Forced vital capacity,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176265
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,-365 to -31,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart sounds,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart sounds,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Height centile,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Height centile,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse rate,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse rate,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart rate rhythm,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart rate rhythm,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Forced expired volume in 1 second,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4241837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Forced expired volume in 1 second,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4241837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,-365 to -31,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,FEV1/FVC,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3011505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,FEV1/FVC,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3011505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body height,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body height,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urine protein measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urine protein measurement,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Height centile,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Height centile,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body height,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body height,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urine screening for glucose,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urine screening for glucose,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematology screening test,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4198132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hematology screening test,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4198132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cerebrospinal fluid index,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136730
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cerebrospinal fluid index,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136730
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine protein measurement,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine protein measurement,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Histologic test,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Histologic test,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine screening for glucose,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine screening for glucose,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum fasting glucose measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum fasting glucose measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum globulin measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum globulin measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gamma glutamyl transferase measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gamma glutamyl transferase measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum chloride measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum chloride measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urea and electrolytes,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urea and electrolytes,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urinalysis,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urinalysis,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Anion gap in Blood,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Anion gap in Blood,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lipids measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lipids measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Glomerular filtration rate testing,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Glomerular filtration rate testing,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum inorganic phosphate measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum inorganic phosphate measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],1 to 30,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],1 to 30,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,1 to 30,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,1 to 30,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,1 to 30,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,1 to 30,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for protein,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for protein,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine leukocyte test,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4190448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine leukocyte test,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4190448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for blood,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for blood,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,1 to 30,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,1 to 30,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for nitrite,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4120299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for nitrite,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4120299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,1 to 30,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of ketones in urine using dipstick,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of ketones in urine using dipstick,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening mammography,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4077697
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening mammography,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4077697
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for glucose,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for glucose,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,1 to 30,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,1 to 30,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,1 to 30,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prealbumin measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prealbumin measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum fasting glucose measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum fasting glucose measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Potassium measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Potassium measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum globulin measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum globulin measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gamma glutamyl transferase measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gamma glutamyl transferase measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density lipoprotein measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density lipoprotein measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum total cholesterol measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum total cholesterol measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum chloride measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum chloride measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urea and electrolytes,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urea and electrolytes,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low density lipoprotein measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low density lipoprotein measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Creatinine measurement, serum",1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Creatinine measurement, serum",1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anion gap in Blood,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anion gap in Blood,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatic function panel,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatic function panel,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Bilirubin, total measurement",1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Bilirubin, total measurement",1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Triglycerides measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Triglycerides measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lipids measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lipids measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood urea measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood urea measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alkaline phosphatase measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alkaline phosphatase measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sodium measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sodium measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Glomerular filtration rate testing,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Glomerular filtration rate testing,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum inorganic phosphate measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum inorganic phosphate measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alanine aminotransferase measurement,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alanine aminotransferase measurement,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Peak flow rate (respiratory),31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197461
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Peak flow rate (respiratory),31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197461
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum fasting glucose measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum fasting glucose measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Microscopy, culture and sensitivities",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Microscopy, culture and sensitivities",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood gas measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood gas measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum globulin measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum globulin measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid panel,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid panel,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gamma glutamyl transferase measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gamma glutamyl transferase measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Procedure Endoscopy,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Procedure Endoscopy,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum chloride measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum chloride measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urea and electrolytes,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urea and electrolytes,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,T4 free measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,T4 free measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Anion gap in Blood,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Anion gap in Blood,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse rate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse rate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Colonoscopy Study observation,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Colonoscopy Study observation,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid stimulating hormone measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid stimulating hormone measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lipids measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lipids measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Viral studies,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4191852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Viral studies,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4191852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Glomerular filtration rate testing,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Glomerular filtration rate testing,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,OB ultrasound panel,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,OB ultrasound panel,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum inorganic phosphate measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum inorganic phosphate measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,31 to 365,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,31 to 365,percentage,percentage,16.3265306122449,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of feces,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of feces,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,31 to 365,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,31 to 365,percentage,percentage,22.4489795918367,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum fasting glucose measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum fasting glucose measurement,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,31 to 365,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,31 to 365,percentage,percentage,24.4897959183673,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sperm concentration measurement,31 to 365,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sperm concentration measurement,31 to 365,percentage,percentage,24.4897959183673,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 706179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 706179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control test,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40481511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control test,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40481511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prothrombin time,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prothrombin time,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum globulin measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum globulin measurement,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibrinogen measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094436
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fibrinogen measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094436
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid panel,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid panel,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tumor marker measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tumor marker measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density lipoprotein measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density lipoprotein measurement,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B antigen screening,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37394207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B antigen screening,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37394207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total protein measurement,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total protein measurement,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enzyme/specific protein level measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enzyme/specific protein level measurement,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum total cholesterol measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum total cholesterol measurement,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follicle stimulating hormone measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follicle stimulating hormone measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,31 to 365,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,31 to 365,percentage,percentage,16.3265306122449,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma folate measurement,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma folate measurement,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinalysis,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinalysis,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Triiodothyronine, free measurement",31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Triiodothyronine, free measurement",31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low density lipoprotein measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low density lipoprotein measurement,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum ferritin measurement,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum ferritin measurement,31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",31 to 365,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",31 to 365,percentage,percentage,24.4897959183673,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chemical function tests,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chemical function tests,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amylase measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4276028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amylase measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4276028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,T4 free measurement,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,T4 free measurement,31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum iron tests,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum iron tests,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum vitamin B12 measurement,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum vitamin B12 measurement,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral temperature,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral temperature,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology laboratory test,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology laboratory test,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium measurement,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium measurement,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bicarbonate measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bicarbonate measurement,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Luteinizing hormone measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Luteinizing hormone measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology test,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology test,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell size determination,31 to 365,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell size determination,31 to 365,percentage,percentage,16.3265306122449,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",31 to 365,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",31 to 365,percentage,percentage,20.4081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of level of substance in blood,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of level of substance in blood,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prisma 7 Questionnaire,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prisma 7 Questionnaire,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening procedure,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4063579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening procedure,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4063579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triglycerides measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triglycerides measurement,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clotting screening test,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clotting screening test,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid stimulating hormone measurement,31 to 365,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid stimulating hormone measurement,31 to 365,percentage,percentage,22.4489795918367,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Differential white blood cell count procedure,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Differential white blood cell count procedure,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipids measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipids measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,31 to 365,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,31 to 365,percentage,percentage,22.4489795918367,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum parathyroid hormone measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum parathyroid hormone measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Folic acid measurement, RBC",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4290096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Folic acid measurement, RBC",31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4290096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total immunoglobulin measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total immunoglobulin measurement,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,31 to 365,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,31 to 365,percentage,percentage,22.4489795918367,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Glucose measurement, blood",31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Glucose measurement, blood",31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Electrophoresis measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4218575
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Electrophoresis measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4218575
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smooth muscle antibody measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4179789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smooth muscle antibody measurement,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4179789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse oximetry,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse oximetry,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pack years,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151768
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pack years,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151768
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,31 to 365,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,31 to 365,percentage,percentage,24.4897959183673,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network score,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44799709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network score,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44799709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,31 to 365,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,31 to 365,percentage,percentage,22.4489795918367,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occult blood panel - Stool,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occult blood panel - Stool,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspartate aminotransferase measurement,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspartate aminotransferase measurement,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antimitochondrial antibody titer,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antimitochondrial antibody titer,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,OB ultrasound panel,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,OB ultrasound panel,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12/folate level,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12/folate level,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B e antigen test,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B e antigen test,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Rheumatoid factor, quantitative",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Rheumatoid factor, quantitative",31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum inorganic phosphate measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum inorganic phosphate measurement,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,31 to 365,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,31 to 365,percentage,percentage,26.530612244898,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screening for glucose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screening for glucose,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,31 to 365,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,31 to 365,percentage,percentage,20.4081632653061,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte sedimentation rate,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte sedimentation rate,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Systolic blood pressure,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Systolic blood pressure,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for protein,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for protein,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine leukocyte test,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4190448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine leukocyte test,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4190448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Microscopy, culture and sensitivities",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Microscopy, culture and sensitivities",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for blood,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for blood,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total white blood count,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total white blood count,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine culture,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393946
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine culture,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393946
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Complete blood count,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Complete blood count,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diastolic blood pressure,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diastolic blood pressure,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urea and electrolytes,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urea and electrolytes,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinalysis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinalysis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for pH,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154501
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for pH,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154501
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for nitrite,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4120299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for nitrite,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4120299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Last menstrual period -1st day,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Last menstrual period -1st day,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hepatic function panel,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hepatic function panel,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine protein measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine protein measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,High vaginal swab culture,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,High vaginal swab culture,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Glomerular filtration rate testing,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Glomerular filtration rate testing,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for glucose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for glucose,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Platelet count,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Platelet count,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine screening for glucose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine screening for glucose,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prealbumin measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prealbumin measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum fasting glucose measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum fasting glucose measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum C reactive protein level,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum C reactive protein level,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sperm concentration measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sperm concentration measurement,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Potassium measurement,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Potassium measurement,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum globulin measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum globulin measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid panel,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid panel,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gamma glutamyl transferase measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gamma glutamyl transferase measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Procedure Endoscopy,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Procedure Endoscopy,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3019341
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total white blood count,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total white blood count,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density lipoprotein measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density lipoprotein measurement,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum total cholesterol measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum total cholesterol measurement,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Complete blood count,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Complete blood count,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum chloride measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum chloride measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urea and electrolytes,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urea and electrolytes,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Monocyte count,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Monocyte count,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low density lipoprotein measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low density lipoprotein measurement,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Creatinine measurement, serum",31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Creatinine measurement, serum",31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,T4 free measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,T4 free measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anion gap in Blood,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anion gap in Blood,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium measurement,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell count,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell count,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell size determination,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell size determination,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatic function panel,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatic function panel,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Bilirubin, total measurement",31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Bilirubin, total measurement",31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine protein measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine protein measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Height centile,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Height centile,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse rate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse rate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphocyte count,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphocyte count,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Colonoscopy Study observation,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Colonoscopy Study observation,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Triglycerides measurement,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Triglycerides measurement,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid stimulating hormone measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid stimulating hormone measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eosinophil count,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eosinophil count,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Differential white blood cell count procedure,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Differential white blood cell count procedure,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lipids measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lipids measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Basophil count,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Basophil count,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood urea measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood urea measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alkaline phosphatase measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alkaline phosphatase measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Packed cell volume measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Packed cell volume measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Glucose measurement, blood",31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Glucose measurement, blood",31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sodium measurement,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sodium measurement,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Glomerular filtration rate testing,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Glomerular filtration rate testing,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Platelet count,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Platelet count,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neutrophil count,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neutrophil count,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Rheumatoid factor, quantitative",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Rheumatoid factor, quantitative",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum inorganic phosphate measurement,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum inorganic phosphate measurement,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body height,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body height,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine screening for glucose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine screening for glucose,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alanine aminotransferase measurement,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alanine aminotransferase measurement,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte sedimentation rate,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte sedimentation rate,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body mass index (BMI) [Ratio],366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Forced vital capacity,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176265
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Forced vital capacity,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4176265
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body weight,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Systolic blood pressure,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Peak flow rate (respiratory),366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197461
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Peak flow rate (respiratory),366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197461
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Prealbumin measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum fasting glucose measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum fasting glucose measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum C reactive protein level,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum C reactive protein level,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sperm concentration measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sperm concentration measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Potassium measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Microscopy, culture and sensitivities",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Microscopy, culture and sensitivities",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Respiratory rate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4313591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Respiratory rate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4313591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood gas measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood gas measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 706179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 706179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum globulin measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum globulin measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depression screening using questions,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44788755
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depression screening using questions,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44788755
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gamma glutamyl transferase measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Gamma glutamyl transferase measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total white blood count,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total white blood count,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,High density lipoprotein measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total protein measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum total cholesterol measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Complete blood count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Complete blood count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum chloride measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum chloride measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diastolic blood pressure,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Plasma folate measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Plasma folate measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urea and electrolytes,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urea and electrolytes,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Monocyte count,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Monocyte count,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urinalysis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Urinalysis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Low density lipoprotein measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum ferritin measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum ferritin measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Creatinine measurement, serum",366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,T4 free measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,T4 free measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Right eye Intraocular pressure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 21491756
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Right eye Intraocular pressure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 21491756
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum vitamin B12 measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum vitamin B12 measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urate measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4156643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urate measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4156643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral temperature,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral temperature,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Immunology laboratory test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Immunology laboratory test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Anion gap in Blood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Anion gap in Blood,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Calcium measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum bicarbonate measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum bicarbonate measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell count,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell count,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell size determination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Red blood cell size determination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hepatic function panel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Bilirubin, total measurement",366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Height centile,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Height centile,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Spirometry screening,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Spirometry screening,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse rate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse rate,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lymphocyte count,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lymphocyte count,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Partial thromboplastin time ratio,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Partial thromboplastin time ratio,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Triglycerides measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid stimulating hormone measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Thyroid stimulating hormone measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eosinophil count,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eosinophil count,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Plasma vitamin B12 level,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37398496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Plasma vitamin B12 level,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37398496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Basophil count,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Basophil count,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood urea measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Framingham coronary heart disease 10 year risk score,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Framingham coronary heart disease 10 year risk score,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Histologic test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Histologic test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alkaline phosphatase measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Packed cell volume measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Packed cell volume measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Glucose measurement, blood",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Glucose measurement, blood",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Left eye Intraocular pressure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 21491757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Left eye Intraocular pressure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 21491757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of respiratory function,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4052083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of respiratory function,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4052083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse oximetry,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pulse oximetry,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sodium measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Forced expired volume in 1 second,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4241837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Forced expired volume in 1 second,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4241837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Glomerular filtration rate testing,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Glomerular filtration rate testing,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Occult blood panel - Stool,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Occult blood panel - Stool,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Aspartate aminotransferase measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Aspartate aminotransferase measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Platelet count,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Platelet count,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight centile,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,INR in Blood by Coagulation assay,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3032080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,INR in Blood by Coagulation assay,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3032080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Neutrophil count,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Neutrophil count,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum inorganic phosphate measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Serum inorganic phosphate measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Rheumatoid factor, quantitative",366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Rheumatoid factor, quantitative",366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body height,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Body height,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alanine aminotransferase measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte sedimentation rate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Erythrocyte sedimentation rate,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],366 to inf,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index (BMI) [Ratio],366 to inf,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,366 to inf,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Systolic blood pressure,366 to inf,percentage,percentage,37.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,366 to inf,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body weight,366 to inf,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,366 to inf,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prealbumin measurement,366 to inf,percentage,percentage,31.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum fasting glucose measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum fasting glucose measurement,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum C reactive protein level,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,366 to inf,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Potassium measurement,366 to inf,percentage,percentage,34.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sperm concentration measurement,366 to inf,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sperm concentration measurement,366 to inf,percentage,percentage,34.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Liquid based cervical cytology screening,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4220448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Liquid based cervical cytology screening,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4220448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Microscopy, culture and sensitivities",366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Respiratory rate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4313591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Respiratory rate,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4313591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood gas measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood gas measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for blood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick for blood,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 706179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 706179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum globulin measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum globulin measurement,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid panel,366 to inf,count,numeric,9,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid panel,366 to inf,percentage,percentage,25.7142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gamma glutamyl transferase measurement,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,PhenX - diabetic retinopathy protocol 140701,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40765533
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,PhenX - diabetic retinopathy protocol 140701,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 40765533
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,366 to inf,count,numeric,15,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total white blood count,366 to inf,percentage,percentage,42.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol consumption screening,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol consumption screening,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4062656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tumor marker measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Tumor marker measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HIV screening,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064903
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HIV screening,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4064903
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,366 to inf,count,numeric,15,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,366 to inf,percentage,percentage,42.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heart sounds,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heart sounds,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density lipoprotein measurement,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High density lipoprotein measurement,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B antigen screening,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37394207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B antigen screening,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37394207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total protein measurement,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total protein measurement,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enzyme/specific protein level measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Enzyme/specific protein level measurement,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum total cholesterol measurement,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum total cholesterol measurement,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,366 to inf,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Complete blood count,366 to inf,percentage,percentage,31.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large unstained cell count,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum chloride measurement,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum prolactin measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197603
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum prolactin measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197603
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follicle stimulating hormone measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follicle stimulating hormone measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,366 to inf,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diastolic blood pressure,366 to inf,percentage,percentage,37.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma folate measurement,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma folate measurement,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urea and electrolytes,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monocyte count,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinalysis,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urinalysis,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low density lipoprotein measurement,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low density lipoprotein measurement,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HIV antigen test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HIV antigen test,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4136494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum ferritin measurement,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum ferritin measurement,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",366 to inf,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Creatinine measurement, serum",366 to inf,percentage,percentage,34.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chemical function tests,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chemical function tests,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amylase measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4276028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amylase measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4276028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,T4 free measurement,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,T4 free measurement,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum iron tests,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum iron tests,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Right eye Intraocular pressure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 21491756
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Right eye Intraocular pressure,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 21491756
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum vitamin B12 measurement,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum vitamin B12 measurement,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral temperature,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral temperature,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology laboratory test,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunology laboratory test,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Last menstrual period -1st day,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Last menstrual period -1st day,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium measurement,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calcium measurement,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bicarbonate measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bicarbonate measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Luteinizing hormone measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Luteinizing hormone measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4287388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology test,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology test,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37393701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell count,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell size determination,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Red blood cell size determination,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatic function panel,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Syphilis test, quantitative",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4103678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Syphilis test, quantitative",366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4103678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",366 to inf,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Bilirubin, total measurement",366 to inf,percentage,percentage,34.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stool culture,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4024963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stool culture,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4024963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine protein measurement,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Height centile,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse rate,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of level of substance in blood,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of level of substance in blood,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High vaginal swab culture,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High vaginal swab culture,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lymphocyte count,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triglycerides measurement,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triglycerides measurement,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid stimulating hormone measurement,366 to inf,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Thyroid stimulating hormone measurement,366 to inf,percentage,percentage,34.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eosinophil count,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma viscosity measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plasma viscosity measurement,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Differential white blood cell count procedure,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Differential white blood cell count procedure,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipids measurement,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lipids measurement,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Basophil count,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,366 to inf,count,numeric,9,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood urea measurement,366 to inf,percentage,percentage,25.7142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heart rate rhythm,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Heart rate rhythm,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estradiol measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4292703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estradiol measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4292703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum parathyroid hormone measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum parathyroid hormone measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Folic acid measurement, RBC",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4290096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Folic acid measurement, RBC",366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4290096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screen for chlamydia,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260759
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screen for chlamydia,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260759
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Helicobacter breath test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392839
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Helicobacter breath test,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392839
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total immunoglobulin measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total immunoglobulin measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Histologic test,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,366 to inf,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alkaline phosphatase measurement,366 to inf,percentage,percentage,34.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Packed cell volume measurement,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Glucose measurement, blood",366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Glucose measurement, blood",366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Left eye Intraocular pressure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 21491757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Left eye Intraocular pressure,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 21491757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Creatine kinase measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4265595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Creatine kinase measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4265595
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anti-thyroid antibody measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4018606
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anti-thyroid antibody measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4018606
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bilirubin level,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37398424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum bilirubin level,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37398424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Electrophoresis measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4218575
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Electrophoresis measurement,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4218575
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse oximetry,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pulse oximetry,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,366 to inf,count,numeric,12,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sodium measurement,366 to inf,percentage,percentage,34.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network score,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44799709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network score,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44799709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,366 to inf,count,numeric,11,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Glomerular filtration rate testing,366 to inf,percentage,percentage,31.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occult blood panel - Stool,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occult blood panel - Stool,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,National Early Warning Score - Royal College of Physicians,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44808550
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,National Early Warning Score - Royal College of Physicians,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44808550
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspartate aminotransferase measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspartate aminotransferase measurement,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,366 to inf,count,numeric,15,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Platelet count,366 to inf,percentage,percentage,42.8571428571429,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine dipstick test,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,366 to inf,count,numeric,10,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight centile,366 to inf,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,OB ultrasound panel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,OB ultrasound panel,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Framingham coronary heart disease 10 year risk score,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 42872767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Framingham coronary heart disease 10 year risk score,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 42872767
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bowel cancer screening programme,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44791543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bowel cancer screening programme,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44791543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12/folate level,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12/folate level,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4065035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neutrophil count,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B e antigen test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B e antigen test,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4209123
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemistry battery tests,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Rheumatoid factor, quantitative",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Rheumatoid factor, quantitative",366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum inorganic phosphate measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Serum inorganic phosphate measurement,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body height,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,366 to inf,count,numeric,14,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,366 to inf,percentage,percentage,40,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screening for glucose,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine screening for glucose,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,366 to inf,count,numeric,13,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alanine aminotransferase measurement,366 to inf,percentage,percentage,37.1428571428571,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte sedimentation rate,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Erythrocyte sedimentation rate,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body mass index (BMI) [Ratio],366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body mass index (BMI) [Ratio],366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body weight,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body weight,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Systolic blood pressure,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Systolic blood pressure,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Prealbumin measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Prealbumin measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of Chlamydia antibody,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of Chlamydia antibody,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum C reactive protein level,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum C reactive protein level,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sperm concentration measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sperm concentration measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Potassium measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Potassium measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine leukocyte test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4190448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine leukocyte test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4190448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Microscopy, culture and sensitivities",366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Microscopy, culture and sensitivities",366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum globulin measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum globulin measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Gamma glutamyl transferase measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Gamma glutamyl transferase measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total white blood count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total white blood count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total protein measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total protein measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Complete blood count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Complete blood count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Large unstained cell count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Large unstained cell count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serologic test for rubella,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4321890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serologic test for rubella,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4321890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diastolic blood pressure,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diastolic blood pressure,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Plasma folate measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Plasma folate measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urea and electrolytes,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urea and electrolytes,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Monocyte count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Monocyte count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinalysis,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urinalysis,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum ferritin measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum ferritin measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Creatinine measurement, serum",366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Creatinine measurement, serum",366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mini-mental state examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4169175
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mini-mental state examination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4169175
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for nitrite,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4120299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine dipstick for nitrite,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4120299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum vitamin B12 measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum vitamin B12 measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Immunology laboratory test,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Immunology laboratory test,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Last menstrual period -1st day,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Last menstrual period -1st day,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum bicarbonate measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Serum bicarbonate measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4150494
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell size determination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Red blood cell size determination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hepatic function panel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hepatic function panel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Bilirubin, total measurement",366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Bilirubin, total measurement",366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine protein measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine protein measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Height centile,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Height centile,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pulse rate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pulse rate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,High vaginal swab culture,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,High vaginal swab culture,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lymphocyte count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lymphocyte count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Thyroid stimulating hormone measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Thyroid stimulating hormone measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diagnostic mammogram and ultrasound panel Breast - left Document,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 36203740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eosinophil count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eosinophil count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ABO blood group,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ABO blood group,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Basophil count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Basophil count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood urea measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood urea measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alkaline phosphatase measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alkaline phosphatase measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Viral studies,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4191852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Viral studies,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4191852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Packed cell volume measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Packed cell volume measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood group antibodies identified in Serum or Plasma,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036472
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood group antibodies identified in Serum or Plasma,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036472
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sodium measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sodium measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Aspartate aminotransferase measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Aspartate aminotransferase measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Platelet count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Platelet count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight centile,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight centile,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,OB ultrasound panel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,OB ultrasound panel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3031455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,B12/folate level,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,B12/folate level,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4215703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Neutrophil count,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Neutrophil count,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Unspecified specimen,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 756065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body height,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Body height,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine screening for glucose,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urine screening for glucose,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alanine aminotransferase measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alanine aminotransferase measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte sedimentation rate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Erythrocyte sedimentation rate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index (BMI) [Ratio],366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3038553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body weight,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3025315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Systolic blood pressure,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152194
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prealbumin measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prealbumin measurement,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44813405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum fasting glucose measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum fasting glucose measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4041723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of Chlamydia antibody,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of Chlamydia antibody,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine dipstick for protein,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine dipstick for protein,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum C reactive protein level,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum C reactive protein level,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4048092
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sperm concentration measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sperm concentration measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4057453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Potassium measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Potassium measurement,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density/low density lipoprotein ratio measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353851
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood gas measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood gas measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4042746
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine dipstick for blood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine dipstick for blood,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prothrombin time,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prothrombin time,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4245261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum globulin measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum globulin measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4152984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid panel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid panel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4261836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Depression screening using questions,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44788755
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Depression screening using questions,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44788755
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gamma glutamyl transferase measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Gamma glutamyl transferase measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4289475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total white blood count,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total white blood count,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4212899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of total hemoglobin concentration in plasma specimen,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4015178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart sounds,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart sounds,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4158197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density lipoprotein measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High density lipoprotein measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4076704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total protein measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4119650
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Enzyme/specific protein level measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Enzyme/specific protein level measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum total cholesterol measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum total cholesterol measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4260765
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Complete blood count,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Complete blood count,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4132152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum chloride measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum chloride measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Urine pregnancy test, by visual color comparison methods",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4014769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diastolic blood pressure,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4154790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Plasma folate measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Plasma folate measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4095335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urea and electrolytes,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urea and electrolytes,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4091295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Monocyte count,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Monocyte count,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4194332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urinalysis,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4099313
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low density lipoprotein measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Low density lipoprotein measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4331302
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum ferritin measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum ferritin measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Creatinine measurement, serum",366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Creatinine measurement, serum",366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,T4 free measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,T4 free measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4196969
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum iron tests,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum iron tests,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4155232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3048816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum vitamin B12 measurement,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum vitamin B12 measurement,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral temperature,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral temperature,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3006322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunology laboratory test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunology laboratory test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Last menstrual period -1st day,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Last menstrual period -1st day,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4058439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anion gap in Blood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Anion gap in Blood,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3039000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Calcium measurement,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hemoglobin variant test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4118981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hemoglobin variant test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4118981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell count,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell count,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4030871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell size determination,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Red blood cell size determination,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatic function panel,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hepatic function panel,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4098135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Bilirubin, total measurement",366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Bilirubin, total measurement",366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine protein measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine protein measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4211845
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Height centile,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Height centile,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4086991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse rate,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pulse rate,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4301868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of level of substance in blood,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Measurement of level of substance in blood,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37203929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High vaginal swab culture,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,High vaginal swab culture,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 46285120
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphocyte count,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphocyte count,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4254663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Partial thromboplastin time ratio,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Partial thromboplastin time ratio,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Triglycerides measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Triglycerides measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4032789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dorsalis pedis pulse rate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4324890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dorsalis pedis pulse rate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4324890
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Posterior tibial pulse rate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4180591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Posterior tibial pulse rate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4180591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Clotting screening test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Clotting screening test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4199172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,HbA1c measurement (DCCT aligned),366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4197971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid stimulating hormone measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Thyroid stimulating hormone measurement,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4246879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eosinophil count,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eosinophil count,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4216098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ABO blood group,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ABO blood group,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37397800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Plasma vitamin B12 level,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37398496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Plasma vitamin B12 level,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37398496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Differential white blood cell count procedure,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Differential white blood cell count procedure,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4013251
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lipids measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lipids measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4017202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Basophil count,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Basophil count,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4172647
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood urea measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood urea measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart rate rhythm,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Heart rate rhythm,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3022318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Mean corpuscular hemoglobin determination,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4182871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total immunoglobulin measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total immunoglobulin measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4353511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Histologic test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Histologic test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37018329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alkaline phosphatase measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alkaline phosphatase measurement,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4230636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Plasma total iron binding capacity,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307154
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Plasma total iron binding capacity,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4307154
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Packed cell volume measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Packed cell volume measurement,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4094760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Glucose measurement, blood",366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Glucose measurement, blood",366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4144235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood group antibodies identified in Serum or Plasma,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036472
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood group antibodies identified in Serum or Plasma,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036472
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sodium measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sodium measurement,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4097430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Glomerular filtration rate testing,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Glomerular filtration rate testing,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 44790183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occult blood panel - Stool,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occult blood panel - Stool,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3030153
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine dipstick for glucose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine dipstick for glucose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4151414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Aspartate aminotransferase measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Aspartate aminotransferase measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4263457
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ANA measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4234268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ANA measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4234268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Platelet count,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Platelet count,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4267147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine dipstick test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine dipstick test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 37392734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight centile,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4087496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,INR in Blood by Coagulation assay,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3032080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,INR in Blood by Coagulation assay,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3032080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Glucose tolerance test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4012477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Glucose tolerance test,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4012477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Antibody to gastric parietal cell measurement,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148286
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neutrophil count,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neutrophil count,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4148615
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum inorganic phosphate measurement,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Serum inorganic phosphate measurement,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4153271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Rheumatoid factor, quantitative",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Rheumatoid factor, quantitative",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4009848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body height,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body height,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3036277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte mean corpuscular volume determination,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4016239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine screening for glucose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Urine screening for glucose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4149386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alanine aminotransferase measurement,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alanine aminotransferase measurement,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 4146380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte sedimentation rate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Erythrocyte sedimentation rate,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,measurement &&& event &&& standard &&& 3015183
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smoking cessation education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smoking cessation education,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Electrocardiographic monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4187078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Electrocardiographic monitoring,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4187078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - first dose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - first dose,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administration,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administration,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Contraception care education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Contraception care education,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Electromyography,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Electromyography,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Review of medication,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Review of medication,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dressing of wound,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dressing of wound,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cryotherapy to skin lesion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119980
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cryotherapy to skin lesion,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119980
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Postnatal maternal examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Postnatal maternal examination,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discussion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discussion,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Elective cesarean section,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075182
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Elective cesarean section,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075182
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4293727
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma education,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4293727
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma medication review,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma medication review,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Decompression of median nerve,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Decompression of median nerve,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intramuscular injection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intramuscular injection,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Insertion of intrauterine contraceptive device,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4275113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Insertion of intrauterine contraceptive device,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4275113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - third dose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - third dose,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - second dose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - second dose,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient review,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient review,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Booster vaccination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Booster vaccination,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Removal of intrauterine device,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4238715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Removal of intrauterine device,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4238715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Safe sex education,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4302393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Safe sex education,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4302393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal booking examination,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014148
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal booking examination,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014148
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General examination of patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4036803
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General examination of patient,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4036803
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of etonogestrel implant,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4231935
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of etonogestrel implant,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4231935
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mammography,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4324693
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mammography,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4324693
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Counseling,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4254477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Counseling,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4254477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation education,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation education,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Demonstration of inhaler technique,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42537280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Demonstration of inhaler technique,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42537280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control step 4,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057273
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control step 4,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057273
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hysteroscopy,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4052532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hysteroscopy,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4052532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunization education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062626
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunization education,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062626
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Counseling for termination of pregnancy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4015590
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Counseling for termination of pregnancy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4015590
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control step 2,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma control step 2,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Repeat dispensing at designated pharmacy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4190772
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Repeat dispensing at designated pharmacy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4190772
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of plaster cast,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4078743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of plaster cast,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4078743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recommendation to GP to start patient medication,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4217376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recommendation to GP to start patient medication,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4217376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lower uterine segment cesarean section,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 37312440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lower uterine segment cesarean section,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 37312440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allowing time to listen to worries,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4022551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allowing time to listen to worries,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4022551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,-inf to -366,count,numeric,22,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,-inf to -366,percentage,percentage,52.3809523809524,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception care education,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception care education,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of first inactivated seasonal influenza vaccination,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46286388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of first inactivated seasonal influenza vaccination,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46286388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical examination,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4240345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical examination,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4240345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Maternal postnatal 6 week examination,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Maternal postnatal 6 week examination,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of hormone releasing intrauterine contraceptive device,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 43020953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of hormone releasing intrauterine contraceptive device,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 43020953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication change to branded,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication change to branded,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,-inf to -366,count,numeric,21,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of suture from skin,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of suture from skin,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Normal delivery procedure,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4071507
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Normal delivery procedure,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4071507
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intrauterine device check,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intrauterine device check,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary prevention of ischemic heart disease,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4153322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary prevention of ischemic heart disease,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4153322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postcoital contraceptive procedure,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4059976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postcoital contraceptive procedure,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4059976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dressing of wound,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dressing of wound,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,US scan of bladder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4060629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,US scan of bladder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4060629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Health promotion education,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4301543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Health promotion education,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4301543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review at hospital,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review at hospital,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evacuation of retained product of conception,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4032621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evacuation of retained product of conception,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4032621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Change of medication,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Change of medication,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triage,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4023021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triage,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4023021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise education,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise education,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Local anesthesia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4303995
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Local anesthesia,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4303995
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review of medical notes,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44812068
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review of medical notes,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44812068
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Combined opportunistic and cohort screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4088718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Combined opportunistic and cohort screening,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4088718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic endoscopic examination of colonic pouch and biopsy of colonic pouch using colonoscope,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic endoscopic examination of colonic pouch and biopsy of colonic pouch using colonoscope,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emergency cesarean section,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4167089
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emergency cesarean section,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4167089
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lifestyle education,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lifestyle education,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Education about alcohol consumption,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4090007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Education about alcohol consumption,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4090007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight control education,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4251734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight control education,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4251734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of depot contraception,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of depot contraception,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laparoscopic cholecystectomy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4163971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laparoscopic cholecystectomy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4163971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of respiratory system,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4149530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of respiratory system,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4149530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of hormone releasing intrauterine contraceptive device,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 43020952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of hormone releasing intrauterine contraceptive device,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 43020952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ophthalmoscopy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4201612
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ophthalmoscopy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4201612
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foreign travel education,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foreign travel education,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast self-examination technique education,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast self-examination technique education,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection control procedure,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4298121
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infection control procedure,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4298121
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion about disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion about disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Ear, nose and throat examination",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4013622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Ear, nose and throat examination",-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4013622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pelvic echography,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4086677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pelvic echography,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4086677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of wedge of nail,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4070966
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of wedge of nail,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4070966
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progestogen only oral contraceptive education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4217583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progestogen only oral contraceptive education,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4217583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of genitourinary system,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4153589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of genitourinary system,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4153589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anger management counselling,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791060
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Anger management counselling,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791060
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biopsychosocial assessment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42689701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biopsychosocial assessment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42689701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vegetarian diet,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35622818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Vegetarian diet,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35622818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspiration curettage of uterus for termination of pregnancy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4212941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspiration curettage of uterus for termination of pregnancy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4212941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prenatal examination and care of mother,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prenatal examination and care of mother,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of midstream urine specimen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4330074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of midstream urine specimen,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4330074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Varicose vein operation,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Varicose vein operation,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of breast,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4188188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of breast,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4188188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Coping strategy counseling,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4055249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Coping strategy counseling,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4055249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cauterization of skin lesion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4114640
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cauterization of skin lesion,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4114640
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syringing ear to remove wax,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syringing ear to remove wax,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evaluation procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Evaluation procedure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obstetric examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4038747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obstetric examination,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4038747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet education,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet education,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endocervical chlamydia swab,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4190805
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endocervical chlamydia swab,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4190805
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal 38 week examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal 38 week examination,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014152
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health assessment,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4193397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health assessment,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4193397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intramuscular injection of vitamin B12,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4204021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intramuscular injection of vitamin B12,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4204021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression medication review,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4212868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression medication review,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4212868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of skin closure material from skin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4146401
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of skin closure material from skin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4146401
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Elective cesarean section,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075182
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Elective cesarean section,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075182
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ultrasonography,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4037672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ultrasonography,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4037672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Activities of daily living assessment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4126495
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Activities of daily living assessment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4126495
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4293727
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma education,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4293727
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnancy counselling,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pregnancy counselling,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792235
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Termination of pregnancy,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297250
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Termination of pregnancy,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297250
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of papilloma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4125348
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of papilloma,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4125348
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominoplasty,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4071518
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abdominoplasty,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4071518
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma medication review,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma medication review,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computed tomography,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4300757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computed tomography,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4300757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neurological examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4225119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Neurological examination,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4225119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Well woman health examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4094041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Well woman health examination,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4094041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion about procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion about procedure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of sebaceous cyst,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4114806
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of sebaceous cyst,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4114806
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nursing procedure,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4321906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nursing procedure,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4321906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bilateral endoscopic occlusion of fallopian tubes,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4070938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bilateral endoscopic occlusion of fallopian tubes,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4070938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Colposcopy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4189586
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Colposcopy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4189586
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review with patient,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44809952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review with patient,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44809952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of intrauterine contraceptive device,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4275113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of intrauterine contraceptive device,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4275113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intramuscular injection,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intramuscular injection,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal 28 week examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal 28 week examination,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Audiogram,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4139936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Audiogram,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4139936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - third dose,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - third dose,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collection of blood specimen for laboratory,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collection of blood specimen for laboratory,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infertility study,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4227745
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infertility study,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4227745
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large loop excision of transformation zone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074288
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large loop excision of transformation zone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074288
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of lesion of skin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4147588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of lesion of skin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4147588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice to aim for 30 minutes of moderate activity on 5 days or more each week,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791534
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice to aim for 30 minutes of moderate activity on 5 days or more each week,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791534
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pertussis vaccination in pregnancy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46284879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pertussis vaccination in pregnancy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46284879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult health examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4145333
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult health examination,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4145333
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total thyroidectomy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total thyroidectomy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient review,-inf to -366,count,numeric,22,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient review,-inf to -366,percentage,percentage,52.3809523809524,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4063125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical cytology education,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4063125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drainage of abscess,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4040923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drainage of abscess,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4040923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Optimization of drug dosage,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4191838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Optimization of drug dosage,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4191838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total abdominal hysterectomy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total abdominal hysterectomy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health review,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4294885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health review,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4294885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Booster vaccination,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Booster vaccination,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Brief intervention for smoking cessation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 36674999
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Brief intervention for smoking cessation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 36674999
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic laparoscopy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4296594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic laparoscopy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4296594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of etonogestrel implant,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 40483594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of etonogestrel implant,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 40483594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recommendation to,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recommendation to,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of intrauterine device,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4238715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of intrauterine device,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4238715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Local anesthesia, by infiltration",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Local anesthesia, by infiltration",-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Smoking cessation education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Smoking cessation education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Immunization education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062626
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Immunization education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062626
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - first dose,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - first dose,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Provision of penile sheath,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Provision of penile sheath,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: general behavior,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4016204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: general behavior,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4016204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administration,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administration,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Electromyography,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Electromyography,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Review of medication,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Review of medication,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dressing of wound,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dressing of wound,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cardiovascular examination and evaluation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cardiovascular examination and evaluation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: genitalia,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4015447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: genitalia,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4015447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: vision,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014858
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: vision,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014858
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Recommend travel vaccinations,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4064796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Recommend travel vaccinations,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4064796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Foreign travel education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Foreign travel education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Active or passive immunization,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4132855
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Active or passive immunization,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4132855
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pelvic echography,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4086677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pelvic echography,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4086677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Transurethral external sphincterotomy of male bladder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4309591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Transurethral external sphincterotomy of male bladder,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4309591
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: hips,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4016622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: hips,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4016622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: language development,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: language development,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Requires protection against malaria,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Requires protection against malaria,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: herniae,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4015446
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: herniae,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4015446
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Aspiration of cataract by phacoemulsification,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4223363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Aspiration of cataract by phacoemulsification,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4223363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Syringing ear to remove wax,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Syringing ear to remove wax,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: hearing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4016620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: hearing,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4016620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Specialized medical examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4194672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Specialized medical examination,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4194672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Aspiration of bursa,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4072033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Aspiration of bursa,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4072033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Discussion,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Discussion,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: fine motor development,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: fine motor development,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diagnostic urethroscopy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4303575
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diagnostic urethroscopy,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4303575
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - third dose,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - third dose,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: general/head,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4147944
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: general/head,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4147944
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - second dose,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - second dose,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: squint,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4016619
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: squint,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4016619
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: motor tone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child examination: motor tone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urodynamic studies,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099391
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urodynamic studies,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099391
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient review,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient review,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical cytology education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4063125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical cytology education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4063125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Booster vaccination,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Booster vaccination,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Antenatal booking examination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014148
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Antenatal booking examination,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014148
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 3,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 3,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Smoking cessation education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Smoking cessation education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Demonstration of inhaler technique,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42537280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Demonstration of inhaler technique,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42537280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Primary immunisation - first dose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Primary immunisation - first dose,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 1,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 1,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Indirect laryngoscopy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4284837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Indirect laryngoscopy,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4284837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contraception care education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contraception care education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review of medication,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review of medication,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal delivery procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4071507
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Normal delivery procedure,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4071507
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dressing of wound,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dressing of wound,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Tooth extraction,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4208393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Tooth extraction,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4208393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review at hospital,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review at hospital,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review of medical notes,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44812068
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review of medical notes,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44812068
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cryotherapy to skin lesion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119980
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cryotherapy to skin lesion,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119980
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Standard chest X-ray,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4056836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Standard chest X-ray,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4056836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Operation on larynx,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4300372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Operation on larynx,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4300372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Surgical removal of third molar tooth,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4103175
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Surgical removal of third molar tooth,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4103175
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prenatal examination and care of mother,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prenatal examination and care of mother,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4254480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4254480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Opening of chest,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Opening of chest,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet education,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet education,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Elective cesarean section,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075182
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Elective cesarean section,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075182
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diagnostic endoscopic examination on colon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068278
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diagnostic endoscopic examination on colon,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068278
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Excision of neurofibroma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42537942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Excision of neurofibroma,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42537942
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Computed tomography,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4300757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Computed tomography,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4300757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma medication review,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma medication review,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review with patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44809952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review with patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44809952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Collection of blood specimen for laboratory,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Collection of blood specimen for laboratory,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ultrasonography of abdomen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4261497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ultrasonography of abdomen,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4261497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diagnostic fiberoptic endoscopic examination of upper gastrointestinal tract,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4139148
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diagnostic fiberoptic endoscopic examination of upper gastrointestinal tract,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4139148
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Evacuation of hematoma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4042179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Evacuation of hematoma,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4042179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient review,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient review,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Optimization of drug dosage,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4191838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Optimization of drug dosage,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4191838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Booster vaccination,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Booster vaccination,-inf to -366,percentage,percentage,75,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Laser surgery,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4261829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Laser surgery,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4261829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Active immunization,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4144375
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Active immunization,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4144375
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smoking cessation education,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smoking cessation education,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Review of medication,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Review of medication,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dressing of wound,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dressing of wound,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cardiovascular examination and evaluation,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cardiovascular examination and evaluation,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of respiratory system,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4149530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of respiratory system,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4149530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Ear, nose and throat examination",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4013622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Ear, nose and throat examination",-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4013622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Elective cesarean section,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075182
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Elective cesarean section,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075182
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Osteotomy of bone of foot,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Osteotomy of bone of foot,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma medication review,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma medication review,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Recommendation to mobilize part,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4079378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Recommendation to mobilize part,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4079378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Excision of bunion,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Excision of bunion,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Fitting procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4047347
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Fitting procedure,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4047347
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intramuscular injection,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intramuscular injection,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient review,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient review,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Counseling,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4254477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Counseling,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4254477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation education,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation education,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Radiography of foot,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Radiography of foot,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,-365 to -31,count,numeric,9,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,-365 to -31,percentage,percentage,18.75,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,-365 to -31,count,numeric,11,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,-365 to -31,percentage,percentage,22.9166666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of first inactivated seasonal influenza vaccination,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46286388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of first inactivated seasonal influenza vaccination,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46286388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,-365 to -31,percentage,percentage,14.5833333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Change of medication,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Change of medication,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total replacement of hip,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4203771
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total replacement of hip,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4203771
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise education,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise education,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of depot contraception,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of depot contraception,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Elective lower segment cesarean section,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Elective lower segment cesarean section,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foreign travel education,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foreign travel education,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syringing ear to remove wax,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syringing ear to remove wax,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet education,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet education,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health assessment,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4193397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health assessment,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4193397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Curettage and cauterization of skin wart,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4169838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Curettage and cauterization of skin wart,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4169838
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ultrasound scan - obstetric,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4152021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ultrasound scan - obstetric,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4152021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collection of blood specimen for laboratory,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collection of blood specimen for laboratory,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laser iridotomy,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4154104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laser iridotomy,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4154104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient review,-365 to -31,count,numeric,11,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient review,-365 to -31,percentage,percentage,22.9166666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Booster vaccination,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Booster vaccination,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of intrauterine device,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4238715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of intrauterine device,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4238715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Post hospital discharge medication reconciliation with medical notes,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Post hospital discharge medication reconciliation with medical notes,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Review of medication,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Review of medication,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dressing of wound,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dressing of wound,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Change of medication,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Change of medication,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cardiovascular examination and evaluation,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cardiovascular examination and evaluation,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Osteotomy of bone of foot,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Osteotomy of bone of foot,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074271
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Recommendation to mobilize part,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4079378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Recommendation to mobilize part,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4079378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Excision of bunion,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Excision of bunion,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fitting procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4047347
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fitting procedure,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4047347
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient review,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient review,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 3,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 3,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Smoking cessation education,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Smoking cessation education,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 2,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 2,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080964
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review of medication,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review of medication,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Local anesthesia,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4303995
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Local anesthesia,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4303995
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Wide local excision of breast lesion,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4129190
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Wide local excision of breast lesion,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4129190
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Radiation oncology AND/OR radiotherapy,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4029715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Radiation oncology AND/OR radiotherapy,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4029715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review without patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4192287
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review without patient,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4192287
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nursing procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4321906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nursing procedure,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4321906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient review,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient review,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Recommendation to,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Recommendation to,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - first dose,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - first dose,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Arthrodesis,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4024267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Arthrodesis,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4024267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Excision of bunion,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Excision of bunion,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - third dose,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - third dose,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endoscopic endometrial polypectomy,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172203
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endoscopic endometrial polypectomy,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172203
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical polypectomy,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4138737
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical polypectomy,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4138737
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Arthrodesis,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4024267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Arthrodesis,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4024267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Excision of bunion,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Excision of bunion,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nursing procedure,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4321906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nursing procedure,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4321906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Application of dressing,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Application of dressing,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laparoscopic hysterectomy,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4127887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laparoscopic hysterectomy,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4127887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,1 to 30,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,1 to 30,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleeve resection of stomach,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4227605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleeve resection of stomach,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4227605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of depot contraception,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of depot contraception,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laparoscopy assisted vaginal hysterectomy with bilateral salpingo-oophorectomy,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 40480864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laparoscopy assisted vaginal hysterectomy with bilateral salpingo-oophorectomy,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 40480864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administration,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administration,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Normal delivery procedure,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4071507
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Normal delivery procedure,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4071507
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Application of dressing,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Application of dressing,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smoking cessation education,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smoking cessation education,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - first dose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - first dose,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Review of medication,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Review of medication,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Removal of suture from skin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Removal of suture from skin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dressing of wound,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dressing of wound,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Change of medication,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Change of medication,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Endoscopic procedure,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Endoscopic procedure,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blepharoplasty,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blepharoplasty,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Foreign travel education,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Foreign travel education,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Application of dressing for burn,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4233678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Application of dressing for burn,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4233678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Syringing ear to remove wax,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Syringing ear to remove wax,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discussion,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discussion,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma medication review,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma medication review,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Nerve conduction study,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4198105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Nerve conduction study,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4198105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intramuscular injection,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intramuscular injection,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Application of dressing,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Application of dressing,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Booster vaccination,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Booster vaccination,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of etonogestrel implant,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4231935
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of etonogestrel implant,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4231935
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Counseling,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4254477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Counseling,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4254477
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation education,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation education,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessment of Year of Care goal importance,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44808809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessment of Year of Care goal importance,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44808809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hysteroscopy,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4052532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hysteroscopy,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4052532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,31 to 365,count,numeric,9,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,31 to 365,percentage,percentage,18.3673469387755,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,31 to 365,count,numeric,10,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,31 to 365,percentage,percentage,20.4081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception care education,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception care education,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of first inactivated seasonal influenza vaccination,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46286388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of first inactivated seasonal influenza vaccination,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46286388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical examination,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4240345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical examination,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4240345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of patient goals,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44805569
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of patient goals,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44805569
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postcoital contraceptive procedure,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4059976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postcoital contraceptive procedure,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4059976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Arthroscopic meniscectomy,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119997
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Arthroscopic meniscectomy,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119997
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleeve resection of stomach,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4227605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sleeve resection of stomach,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4227605
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triage,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4023021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triage,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4023021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Colposcopic biopsy of cervix,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Colposcopic biopsy of cervix,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Education about human papillomavirus,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44808916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Education about human papillomavirus,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44808916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of depot contraception,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of depot contraception,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast self-examination technique education,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast self-examination technique education,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pelvic echography,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4086677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pelvic echography,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4086677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Identifying personal goals,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 37017325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Identifying personal goals,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 37017325
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Standard chest X-ray,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4056836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Standard chest X-ray,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4056836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prenatal examination and care of mother,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prenatal examination and care of mother,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessment of Year of Care action confidence,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44808810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessment of Year of Care action confidence,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44808810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health assessment,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4193397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health assessment,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4193397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic arthroscopy of knee joint,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4076189
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic arthroscopy of knee joint,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4076189
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141760
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of intrauterine contraceptive device,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4275113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of intrauterine contraceptive device,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4275113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - third dose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - third dose,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collection of blood specimen for laboratory,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collection of blood specimen for laboratory,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large loop excision of transformation zone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074288
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Large loop excision of transformation zone,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4074288
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endometrial ablation,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endometrial ablation,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient review,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient review,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of etonogestrel implant,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 40483594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of etonogestrel implant,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 40483594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion about clinical red flag warning sign,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 37016904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussion about clinical red flag warning sign,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 37016904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer care review,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 36714678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer care review,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 36714678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Review of medication,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Review of medication,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Removal of suture from skin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Removal of suture from skin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Change of medication,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Change of medication,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blepharoplasty,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blepharoplasty,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Postnatal maternal examination,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Postnatal maternal examination,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Examination of midstream urine specimen,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4330074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Examination of midstream urine specimen,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4330074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Syringing ear to remove wax,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Syringing ear to remove wax,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Audiogram,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4139936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Audiogram,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4139936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urodynamic studies,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099391
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Urodynamic studies,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4099391
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain relief,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082404
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain relief,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082404
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Smoking cessation education,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Smoking cessation education,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Primary immunisation - first dose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Primary immunisation - first dose,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review of medication,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review of medication,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Endoscopic procedure,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Endoscopic procedure,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise education,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise education,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lifestyle education,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lifestyle education,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Child examination: bowel control,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014863
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Child examination: bowel control,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4014863
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast self-examination technique education,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast self-examination technique education,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet education,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet education,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review without patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4192287
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review without patient,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4192287
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Application of dressing,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Application of dressing,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient review,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient review,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General examination of patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4036803
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General examination of patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4036803
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Issue of chronic obstructive pulmonary disease rescue pack,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803979
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Issue of chronic obstructive pulmonary disease rescue pack,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803979
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incision and drainage of wound,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073688
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incision and drainage of wound,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073688
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administration of medication under patient specific direction,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44813052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administration of medication under patient specific direction,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44813052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cardiomemo electrocardiographic monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4137237
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cardiomemo electrocardiographic monitoring,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4137237
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smoking cessation education,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Smoking cessation education,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Electrocardiographic monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4187078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Electrocardiographic monitoring,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4187078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administration of vaccine under patient specific direction,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44806912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administration of vaccine under patient specific direction,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44806912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - first dose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - first dose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of digestive system,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4150941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of digestive system,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4150941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administration,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Review of medication,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Review of medication,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dressing of wound,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dressing of wound,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lifestyle education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lifestyle education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of respiratory system,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4149530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of respiratory system,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4149530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication reconciliation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication reconciliation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Biopsychosocial assessment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42689701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Biopsychosocial assessment,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42689701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dispensing review of use of medicines,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dispensing review of use of medicines,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4188188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of breast,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4188188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of abdomen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075966
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Examination of abdomen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075966
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol abuse prevention education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4248984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol abuse prevention education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4248984
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Nebulizer therapy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4206920
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Nebulizer therapy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4206920
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discussion,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discussion,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4073156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"History and physical examination, administrative",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4183687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"History and physical examination, administrative",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4183687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma medication review,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma medication review,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intramuscular injection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Intramuscular injection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Collection of blood specimen for laboratory,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Collection of blood specimen for laboratory,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - second dose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Primary immunisation - second dose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient review,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient review,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Booster vaccination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Booster vaccination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Post hospital discharge medication reconciliation with medical notes,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Post hospital discharge medication reconciliation with medical notes,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injection of carpal tunnel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Injection of carpal tunnel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Developing a treatment plan,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4022110
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Developing a treatment plan,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4022110
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of etonogestrel implant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4231935
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of etonogestrel implant,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4231935
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation education,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation education,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hysteroscopy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4052532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hysteroscopy,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4052532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunization education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062626
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunization education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062626
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,366 to inf,count,numeric,9,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - first dose,366 to inf,percentage,percentage,25.7142857142857,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psychological well-being education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4293716
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psychological well-being education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4293716
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Repeat dispensing at designated pharmacy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4190772
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Repeat dispensing at designated pharmacy,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4190772
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug therapy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4216752
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug therapy,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4216752
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of penile sheath,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of penile sheath,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Transesophageal echocardiography,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4019824
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Transesophageal echocardiography,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4019824
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,366 to inf,count,numeric,11,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration,366 to inf,percentage,percentage,31.4285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception care education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception care education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of subcutaneous contraceptive,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4059978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of subcutaneous contraceptive,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4059978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of first inactivated seasonal influenza vaccination,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46286388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administration of first inactivated seasonal influenza vaccination,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46286388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of care plan,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4174236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of care plan,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4174236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4240345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical examination,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4240345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Maternal postnatal 6 week examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Maternal postnatal 6 week examination,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of hormone releasing intrauterine contraceptive device,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 43020953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of hormone releasing intrauterine contraceptive device,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 43020953
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,366 to inf,count,numeric,10,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Review of medication,366 to inf,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intrauterine device check,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intrauterine device check,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dressing of wound,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dressing of wound,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Change of medication,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Change of medication,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4080985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiovascular examination and evaluation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiovascular examination and evaluation,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stress counseling,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4151764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stress counseling,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4151764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triage,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4023021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Triage,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4023021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low fat diet education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low fat diet education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of fibroadenoma of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4289738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of fibroadenoma of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4289738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review of medical notes,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44812068
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review of medical notes,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44812068
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Education about human papillomavirus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44808916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Education about human papillomavirus,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44808916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Problem solving therapy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4269047
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Problem solving therapy,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4269047
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of hormone releasing intrauterine contraceptive device,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 43020952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of hormone releasing intrauterine contraceptive device,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 43020952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foreign travel education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Foreign travel education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast self-examination technique education,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast self-examination technique education,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hysteroscopy and endometrial biopsy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4146171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hysteroscopy and endometrial biopsy,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4146171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice to return if problem persists or deteriorates,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 45770392
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice to return if problem persists or deteriorates,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 45770392
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication reconciliation,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4326177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pelvic echography,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4086677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pelvic echography,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4086677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal maternal examination,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Post hospital discharge medication reconciliation with patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Post hospital discharge medication reconciliation with patient,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Incision and curettage of chalazion,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4309602
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Incision and curettage of chalazion,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4309602
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biopsy of lesion of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42872632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biopsy of lesion of skin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42872632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient medication education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4216164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient medication education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4216164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drainage of breast lesion,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4064246
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drainage of breast lesion,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4064246
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plain radiography,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4056681
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plain radiography,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4056681
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prenatal examination and care of mother,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prenatal examination and care of mother,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4188188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4188188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syringing ear to remove wax,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syringing ear to remove wax,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4068191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health assessment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4193397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health assessment,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4193397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endocervical chlamydia swab,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4190805
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Endocervical chlamydia swab,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4190805
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessment of fluid loss from wound,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Assessment of fluid loss from wound,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021177
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Check of subcutaneous contraceptive,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4061685
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Check of subcutaneous contraceptive,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4061685
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiovascular education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiovascular education,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4179991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bone density scan,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4195803
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bone density scan,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4195803
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"History and physical examination, administrative",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4183687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"History and physical examination, administrative",366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4183687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical polypectomy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4138737
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical polypectomy,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4138737
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma medication review,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma medication review,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4214676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Well woman health examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4094041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Well woman health examination,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4094041
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psychoeducation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 45765576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psychoeducation,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 45765576
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plain chest X-ray,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4163872
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Plain chest X-ray,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4163872
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review with patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44809952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review with patient,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44809952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intramuscular injection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intramuscular injection,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4295880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspiration of lesion of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4302670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Aspiration of lesion of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4302670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collection of blood specimen for laboratory,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Collection of blood specimen for laboratory,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4218408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of lesion of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4147588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excision of lesion of skin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4147588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contact tracing,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contact tracing,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Application of dressing,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Application of dressing,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Primary immunisation - second dose,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient review,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient review,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health review,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4294885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health review,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4294885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Booster vaccination,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Booster vaccination,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic laparoscopy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4296594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diagnostic laparoscopy,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4296594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of etonogestrel implant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 40483594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Removal of etonogestrel implant,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 40483594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recommendation to,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recommendation to,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Post hospital discharge medication reconciliation with medical notes,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Post hospital discharge medication reconciliation with medical notes,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44803622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Smoking cessation education,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Smoking cessation education,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total cystectomy and urethrectomy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4117050
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Total cystectomy and urethrectomy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4117050
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Immunization education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062626
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Immunization education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062626
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - first dose,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - first dose,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Provision of penile sheath,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Provision of penile sheath,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administration,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Removal of suture,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4147691
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Removal of suture,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4147691
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Maternal postnatal 6 week examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Maternal postnatal 6 week examination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Review of medication,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Review of medication,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cardiovascular examination and evaluation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cardiovascular examination and evaluation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4181638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Taking aspirin education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4201027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Taking aspirin education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4201027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Foreign travel education,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Foreign travel education,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4062629
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Breast self-examination technique education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Breast self-examination technique education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4170036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Prenatal examination and care of mother,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Prenatal examination and care of mother,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Obstetric examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4038747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Obstetric examination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4038747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Activities of daily living assessment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4126495
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Activities of daily living assessment,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4126495
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Surgical procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4301351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Surgical procedure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4301351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Curettage of products of conception from uterus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42873021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Curettage of products of conception from uterus,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 42873021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Insertion of intrauterine contraceptive device,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4275113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Insertion of intrauterine contraceptive device,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4275113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - third dose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - third dose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44791906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Application of dressing,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Application of dressing,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4305581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - second dose,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Primary immunisation - second dose,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient review,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient review,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Booster vaccination,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Booster vaccination,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4230536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Removal of intrauterine device,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4238715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Removal of intrauterine device,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4238715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration of medication under patient specific direction,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44813052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration of medication under patient specific direction,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44813052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 3,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma control step 3,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4082252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cardiomemo electrocardiographic monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4137237
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cardiomemo electrocardiographic monitoring,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4137237
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Smoking cessation education,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Smoking cessation education,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021160
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Electrocardiographic monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4187078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Electrocardiographic monitoring,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4187078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration of vaccine under patient specific direction,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44806912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration of vaccine under patient specific direction,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44806912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Primary immunisation - first dose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Primary immunisation - first dose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Flexible check cystoscopy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4023425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Flexible check cystoscopy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4023425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Digital retinal screening,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4308371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Digital retinal screening,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4308371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Examination of reflexes,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4063469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Examination of reflexes,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4063469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4166266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contraception care education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contraception care education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4237486
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Physical examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4240345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Physical examination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4240345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Maternal postnatal 6 week examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Maternal postnatal 6 week examination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4297233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review of medication,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Review of medication,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4057411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Removal of suture from skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Removal of suture from skin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4119985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4124904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lifestyle education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lifestyle education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4196581
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection of medroxyprogesterone acetate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight control education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4251734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight control education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4251734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration of depot contraception,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administration of depot contraception,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 46271417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunisation course to maintain protection against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2),366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 608585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Punch biopsy of skin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4227733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Punch biopsy of skin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4227733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ophthalmoscopy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4201612
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ophthalmoscopy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4201612
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4241075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Ear, nose and throat examination",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4013622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Ear, nose and throat examination",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4013622
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Repair of hernia of anterior abdominal wall,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4031973
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Repair of hernia of anterior abdominal wall,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4031973
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Long-term drug therapy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141759
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Long-term drug therapy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4141759
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prenatal examination and care of mother,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prenatal examination and care of mother,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4112701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Examination of abdomen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075966
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Examination of abdomen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4075966
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Obstetric examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4038747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Obstetric examination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4038747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet education,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet education,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4041982
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Rectal examination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4257820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Rectal examination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4257820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Skin fluorescence test by Wood's light,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4175291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Skin fluorescence test by Wood's light,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4175291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain control,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Pain control,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4021823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Examination of cranial nerve,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4171928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Examination of cranial nerve,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4171928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 2313815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nursing procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4321906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nursing procedure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4321906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Primary immunisation - second dose,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Primary immunisation - second dose,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44792016
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Emergency appendectomy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4018012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Emergency appendectomy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4018012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient review,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient review,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 35621985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Recommendation to,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Recommendation to,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 4172321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Chlamydia screening counselling,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44790474
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Chlamydia screening counselling,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 44790474
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cancer care review,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 36714678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cancer care review,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,procedure_occurrence &&& event &&& standard &&& 36714678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Life assurance report status,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4205691
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Life assurance report status,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4205691
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in neurology clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088538
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in neurology clinic,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088538
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - 3rd recall,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - 3rd recall,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cigarette smoker,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cigarette smoker,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma monitoring call second letter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma monitoring call second letter,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,IUD checked - no problems,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,IUD checked - no problems,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Health education offered,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Health education offered,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lloyd George and problem summary,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lloyd George and problem summary,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by deputizing doctor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by deputizing doctor,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Consultation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Consultation,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy or intolerance criticality,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy or intolerance criticality,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,FH: Ischemic heart disease at greater than 60 years,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,FH: Ischemic heart disease at greater than 60 years,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review done,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review done,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient Health Questionnaire Nine Item score,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient Health Questionnaire Nine Item score,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Contraception,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Contraception,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral contraceptive claim,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral contraceptive claim,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from specialist,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from specialist,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in orthopedic clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in orthopedic clinic,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend - no reason,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend - no reason,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Progestogen only oral contraceptive,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Progestogen only oral contraceptive,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral contraception,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral contraception,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review due date,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review due date,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Private referral,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082071
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Private referral,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082071
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incoming mail processing,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incoming mail processing,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy to drug,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy to drug,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter received,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,IUD check,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061406
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,IUD check,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061406
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No history of clinical finding in subject,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40481925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No history of clinical finding in subject,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40481925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma limiting activities,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma limiting activities,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient encounter procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient encounter procedure,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by Accident and Emergency doctor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by Accident and Emergency doctor,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-inf to -366,percentage,percentage,83.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,X-ray report received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,X-ray report received,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discharged from outpatients,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081762
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discharged from outpatients,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081762
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma annual review,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma annual review,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dog bite,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 433116
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Dog bite,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 433116
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inhaler technique - good,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inhaler technique - good,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General finding of height,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General finding of height,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given advice,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given advice,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No respiratory symptoms,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059914
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No respiratory symptoms,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059914
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to antenatal clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to antenatal clinic,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Refer to appliance officer,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4092774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Refer to appliance officer,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4092774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Computer summary updated,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Computer summary updated,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral for further care,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral for further care,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Telephone encounter,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Telephone encounter,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sample sent to laboratory for test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sample sent to laboratory for test,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient discharge,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient discharge,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to podiatrist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to podiatrist,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy to substance,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4169307
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy to substance,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4169307
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Out of hours visit - not night visit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083574
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Out of hours visit - not night visit,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083574
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Adverse reaction to drug,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Adverse reaction to drug,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given choice of treatment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152698
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given choice of treatment,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152698
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Bladder drill,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4102236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Bladder drill,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4102236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Notes summary on computer,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Notes summary on computer,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in EMG clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in EMG clinic,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Had a chat to patient,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Had a chat to patient,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma monitoring call first letter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma monitoring call first letter,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inpatient discharge summary received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inpatient discharge summary received,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Family history of clinical finding,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Family history of clinical finding,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Advice given,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Advice given,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Born by cesarean section,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4192676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Born by cesarean section,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4192676
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized anxiety disorder 7 item score,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40483769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized anxiety disorder 7 item score,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40483769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd call,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd call,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bite of nonvenomous arthropod,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bite of nonvenomous arthropod,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No current problems or disability,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051099
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No current problems or disability,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051099
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care: obstetric risk,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care: obstetric risk,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computer record status,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computer record status,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145388
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma review using Royal College of Physicians three questions,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805526
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma review using Royal College of Physicians three questions,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805526
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history with explicit context,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4210989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history with explicit context,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4210989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation via video conference,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36717718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation via video conference,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36717718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration form sent to family practitioner committee,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration form sent to family practitioner committee,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History of event,-inf to -366,count,numeric,16,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History of event,-inf to -366,percentage,percentage,38.0952380952381,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Well woman monitoring check done,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090364
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Well woman monitoring check done,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090364
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal heart feature,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal heart feature,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sampling of cervix for Papanicolaou smear done,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35624550
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sampling of cervix for Papanicolaou smear done,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35624550
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraceptive claim,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44801197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraceptive claim,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44801197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone triage encounter,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone triage encounter,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - call deleted,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085176
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - call deleted,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085176
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Personal Independence Payment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Personal Independence Payment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monitoring of respiration,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monitoring of respiration,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to outside agency,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to outside agency,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma sometimes restricts exercise,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma sometimes restricts exercise,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of body mass index,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of body mass index,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol intake within recommended sensible limits,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol intake within recommended sensible limits,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,-inf to -366,count,numeric,20,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,-inf to -366,percentage,percentage,47.6190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication given,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication given,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,IUD checked - problems,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059965
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,IUD checked - problems,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059965
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer to weight management program,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4246959
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer to weight management program,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4246959
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Marital problems,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4278980
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Marital problems,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4278980
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient Health Questionnaire Nine Item score,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient Health Questionnaire Nine Item score,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent - influenza immunization,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent - influenza immunization,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination invitation short message service text message sent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813057
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination invitation short message service text message sent,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813057
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of ischemic heart disease,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4182335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of ischemic heart disease,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4182335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Solicitors report requested,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196727
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Solicitors report requested,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196727
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Short message service text message received from patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Short message service text message received from patient,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No known allergy,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No known allergy,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration status,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086444
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration status,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086444
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraception,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraception,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,GP out of hours service administration,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,GP out of hours service administration,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in primary care center,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088401
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in primary care center,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088401
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend asthma clinic,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend asthma clinic,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic disease initial assessment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic disease initial assessment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laboratory test requested,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013385
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laboratory test requested,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013385
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in general surgery clinic,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in general surgery clinic,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to general surgical service,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to general surgical service,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Deferred antibiotic therapy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Deferred antibiotic therapy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussed with healthcare professional,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussed with healthcare professional,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Presentation of fetus,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Presentation of fetus,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Employment and support allowance,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807390
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Employment and support allowance,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807390
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Using inhaled steroids - high dose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015824
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Using inhaled steroids - high dose,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015824
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non - drinker,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non - drinker,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for seasonal influenza vaccination,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for seasonal influenza vaccination,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical report received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical report received,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Main spoken language,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152283
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Main spoken language,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152283
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination invitation letter sent,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination invitation letter sent,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No smear - no cervix,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064370
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No smear - no cervix,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064370
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Implied consent for core Summary Care Record dataset upload,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Implied consent for core Summary Care Record dataset upload,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma management,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma management,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wants to lose weight,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062986
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wants to lose weight,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062986
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to counselor,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to counselor,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of cardiovascular disease in first degree male relative less than 55 years of age,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of cardiovascular disease in first degree male relative less than 55 years of age,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235809
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient informed - test result,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient informed - test result,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer to hospital OPD,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer to hospital OPD,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nurse telephone triage,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nurse telephone triage,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique observed,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique observed,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low fat diet,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Low fat diet,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-inf to -366,count,numeric,26,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-inf to -366,percentage,percentage,61.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment date,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment date,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gastroenterology service,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084685
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gastroenterology service,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084685
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Greenstick fracture,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40481829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Greenstick fracture,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40481829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visit out of hours,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visit out of hours,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by practice phlebotomist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by practice phlebotomist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12 injections - at surgery,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12 injections - at surgery,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,-inf to -366,count,numeric,17,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,-inf to -366,percentage,percentage,40.4761904761905,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Number of asthma exacerbations in past year,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40545672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Number of asthma exacerbations in past year,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40545672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,MED5 status,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,MED5 status,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for ultrasound investigation,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for ultrasound investigation,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from physiotherapy service,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from physiotherapy service,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to primary care mental health team,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to primary care mental health team,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uses hormone releasing intrauterine device contraception,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40492989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Uses hormone releasing intrauterine device contraception,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40492989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hospital admission,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hospital admission,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by respiratory physician,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by respiratory physician,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal ultrasound scan status,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal ultrasound scan status,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription by supplementary prescriber,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription by supplementary prescriber,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monitoring of patient,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082264
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Monitoring of patient,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082264
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear due,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear due,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left with household member,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left with household member,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visual acuity - left eye,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visual acuity - left eye,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussed with consultant,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussed with consultant,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet good,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet good,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obtaining consent,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4186543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obtaining consent,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4186543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for minor surgery,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4213781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for minor surgery,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4213781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient allocated named accountable general practitioner,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient allocated named accountable general practitioner,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care midwifery led,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care midwifery led,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care from consultant,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care from consultant,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Registered child surveillance,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086947
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Registered child surveillance,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086947
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication increased,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication increased,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral statuses,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral statuses,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up arranged,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up arranged,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred to rheumatologist,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred to rheumatologist,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amount of time off work,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Amount of time off work,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Motor vehicle traffic accident,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Motor vehicle traffic accident,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total notes on computer,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total notes on computer,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bereavement,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4252735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bereavement,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4252735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screening - not attended,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152044
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screening - not attended,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152044
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative wound management generated from secondary care done by practice,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44810730
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postoperative wound management generated from secondary care done by practice,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44810730
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol screen - alcohol use disorder identification test consumption questions completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol screen - alcohol use disorder identification test consumption questions completed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent for operation given,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent for operation given,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Requires a pneumococcal vaccination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Requires a pneumococcal vaccination,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Verbal advice about long acting reversible contraception,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Verbal advice about long acting reversible contraception,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax sent to:,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax sent to:,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma restricts exercise,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015951
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma restricts exercise,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015951
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient screening done,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37016873
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient screening done,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37016873
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient referral to dietitian,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4304362
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient referral to dietitian,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4304362
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Under care of child and adolescent psychiatrist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4124085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Under care of child and adolescent psychiatrist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4124085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Initial respiratory assessment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016926
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Initial respiratory assessment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016926
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal movement feature,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal movement feature,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to psychologist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203866
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to psychologist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203866
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Presence of chaperone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200117
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Presence of chaperone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200117
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital outpatient department,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital outpatient department,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Student,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4277918
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Student,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4277918
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation advice declined,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802474
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Smoking cessation advice declined,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802474
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Glaucoma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Glaucoma,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for microbiological test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for microbiological test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Using inhaled steroids - normal dose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Using inhaled steroids - normal dose,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigarette smoker,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigarette smoker,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call second letter,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call second letter,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend hospital appointment,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend hospital appointment,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by community psychiatric nurse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4125701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by community psychiatric nurse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4125701
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Blood disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Blood disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient-initiated diet,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient-initiated diet,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 1st recall,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085960
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 1st recall,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085960
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to breast surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to breast surgeon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of cardiac disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4173498
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of cardiac disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4173498
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in GP's surgery,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in GP's surgery,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to orthopedic service,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080082
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to orthopedic service,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080082
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by psychiatrist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by psychiatrist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pneumococcal vaccination declined,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pneumococcal vaccination declined,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal blood group screening done,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal blood group screening done,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non-urgent gynecological admission,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non-urgent gynecological admission,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Health education offered,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Health education offered,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - no answer when rang back,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - no answer when rang back,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to patient,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to patient,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination / signs,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination / signs,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiovascular disease risk assessment second letter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiovascular disease risk assessment second letter,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in fracture clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in fracture clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergy or intolerance criticality,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergy or intolerance criticality,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol screen - fast alcohol screening test completed,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791450
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol screen - fast alcohol screening test completed,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791450
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excepted from asthma quality indicators - patient unsuitable,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813771
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excepted from asthma quality indicators - patient unsuitable,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813771
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by hospital-based midwife,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136644
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by hospital-based midwife,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136644
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice about management of depression,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4212469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice about management of depression,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4212469
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergy to food,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4188027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergy to food,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4188027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laboratory test result not back yet,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laboratory test result not back yet,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug compliance good,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056965
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug compliance good,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056965
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of stroke,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4169009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of stroke,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4169009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adverse reaction to substance,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441488
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adverse reaction to substance,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441488
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Folic acid supplement therapeutic role,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37206900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Folic acid supplement therapeutic role,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37206900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast screening non-attender,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089357
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breast screening non-attender,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089357
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Atopy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4050944
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Atopy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4050944
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in early pregnancy assessment unit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42536434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in early pregnancy assessment unit,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42536434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Message given to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791206
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Message given to patient,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791206
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal care from general practitioner,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal care from general practitioner,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progestogen only oral contraceptive,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progestogen only oral contraceptive,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol units consumed per week,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol units consumed per week,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,-inf to -366,count,numeric,21,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nasal discharge present,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149990
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nasal discharge present,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149990
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression interim review,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4189144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression interim review,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4189144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected UTI (urinary tract infection),-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected UTI (urinary tract infection),-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Repeat prescription monitoring,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Repeat prescription monitoring,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in vascular clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in vascular clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Planned telephone contact,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Planned telephone contact,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Incoming mail processing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Incoming mail processing,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for communication by short message service text messaging,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for communication by short message service text messaging,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergy to drug,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Allergy to drug,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 2nd recall,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 2nd recall,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088733
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in own home,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in own home,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet [Type],-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet [Type],-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Needs influenza immunization,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 432526
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Needs influenza immunization,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 432526
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No FH: Ischemic heart disease,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145791
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No FH: Ischemic heart disease,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145791
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in maxillofacial unit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790882
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in maxillofacial unit,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790882
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Has a sore throat,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Has a sore throat,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Steroid treatment card issued,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Steroid treatment card issued,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804266
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Referral to ear, nose and throat service",-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079634
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Referral to ear, nose and throat service",-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079634
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient record status,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146319
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient record status,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146319
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent for key information summary upload,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent for key information summary upload,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by Accident and Emergency doctor,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by Accident and Emergency doctor,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-inf to -366,count,numeric,39,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-inf to -366,percentage,percentage,92.8571428571429,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative form statuses,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative form statuses,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred to urologist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080190
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred to urologist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080190
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084913
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084913
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to community psychiatric nurse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to community psychiatric nurse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,24 hr blood pressure monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,24 hr blood pressure monitoring,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-inf to -366,count,numeric,39,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-inf to -366,percentage,percentage,92.8571428571429,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to colorectal surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141846
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to colorectal surgeon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141846
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Hypertension,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4050816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Hypertension,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4050816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of cancer,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of cancer,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred to plastic surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred to plastic surgeon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient on waiting list,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient on waiting list,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma annual review,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma annual review,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emergency hospital admission,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emergency hospital admission,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration data verified,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration data verified,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient clinic letter received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient clinic letter received,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by gynecologist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139729
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by gynecologist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139729
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Third party encounter,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Third party encounter,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to nurse,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to nurse,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to breast clinic,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to breast clinic,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,-inf to -366,count,numeric,14,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultant unit booking,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultant unit booking,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060252
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiovascular disease risk assessment invitation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiovascular disease risk assessment invitation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in physiotherapy department,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in physiotherapy department,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Employment milestones,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Employment milestones,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood test requested,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4188815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood test requested,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4188815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 1st call,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 1st call,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression enhanced services administration,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression enhanced services administration,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive repeat,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061665
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive repeat,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061665
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Main spoken language English,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Main spoken language English,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood sample taken,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood sample taken,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal syphilis screen-blood sent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015137
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal syphilis screen-blood sent,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015137
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for further care,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for further care,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Accidental fall,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Accidental fall,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dietary history,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036783
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dietary history,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036783
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up respiratory assessment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up respiratory assessment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter to patient,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter to patient,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Feeding pattern,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4266616
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Feeding pattern,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4266616
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Statin declined,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Statin declined,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Thyroid disorder,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053375
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Thyroid disorder,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053375
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical therapy procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4238738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical therapy procedure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4238738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to intermediate care,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to intermediate care,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Morning after pill method of contraception,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012115
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Morning after pill method of contraception,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012115
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No FH: Glaucoma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051558
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No FH: Glaucoma,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051558
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient deregistration - health record sent to Health Authority,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791099
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient deregistration - health record sent to Health Authority,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791099
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to general surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to general surgeon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to podiatrist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to podiatrist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in antenatal clinic,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in antenatal clinic,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital casualty,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital casualty,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care: social risk,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060244
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care: social risk,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060244
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,IUD fitting awaited,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,IUD fitting awaited,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical management plan agreed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical management plan agreed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Personal Independence Payment claim form completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Personal Independence Payment claim form completed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Med3 certificate issued to patient,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Med3 certificate issued to patient,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in ENT clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in ENT clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breastfeeding started,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Breastfeeding started,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Light drinker - 1-2u/day,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052022
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Light drinker - 1-2u/day,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052022
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notes summary on computer,-inf to -366,count,numeric,29,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notes summary on computer,-inf to -366,percentage,percentage,69.0476190476191,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient consultation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient consultation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Had a chat to patient,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Had a chat to patient,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call first letter,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call first letter,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient medical record envelope received from family practitioner committee,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788476
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient medical record envelope received from family practitioner committee,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788476
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for laboratory tests,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for laboratory tests,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given,-inf to -366,count,numeric,26,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given,-inf to -366,percentage,percentage,61.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mirena coil check,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791470
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mirena coil check,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791470
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral letter status,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral letter status,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mid stream urine sent to laboratory,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4055275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mid stream urine sent to laboratory,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4055275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occasional drinker,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occasional drinker,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Indirect encounter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Indirect encounter,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088561
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone in house,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052628
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone in house,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052628
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in family planning clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in family planning clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HAD scale: anxiety score,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4296656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HAD scale: anxiety score,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4296656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiac disease monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cardiac disease monitoring,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in dermatology clinic,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in dermatology clinic,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Date records held from,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Date records held from,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge by physiotherapist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4142007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge by physiotherapist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4142007
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check invitation first letter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check invitation first letter,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine sample sent to Lab,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012970
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine sample sent to Lab,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012970
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Copy of clinical record given to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807619
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Copy of clinical record given to patient,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807619
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dorsalis pedis pulse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4225511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dorsalis pedis pulse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4225511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 2nd call,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085173
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 2nd call,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085173
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Papule,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4105835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Papule,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4105835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intradermal nevus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4010103
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intradermal nevus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4010103
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,IUD checked - no problems,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,IUD checked - no problems,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hospital prescription,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4215546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hospital prescription,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4215546
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occupation,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occupation,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history of stroke and/or transient ischemic attack,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history of stroke and/or transient ischemic attack,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection given,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Injection given,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to obstetrics service,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084693
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to obstetrics service,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084693
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix declined,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42537279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix declined,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42537279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bronchodilators used a maximum of once daily,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bronchodilators used a maximum of once daily,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring by nurse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring by nurse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history diabetes,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history diabetes,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lloyd George and problem summary,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lloyd George and problem summary,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination given by other healthcare provider,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46284829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination given by other healthcare provider,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46284829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression management program,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression management program,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal/postnatal care,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4170305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal/postnatal care,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4170305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Interpreter not needed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Interpreter not needed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from outside agency,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from outside agency,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent pneumococcal immunization,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4065032
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent pneumococcal immunization,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4065032
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to community treatment room,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to community treatment room,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Problems at work,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Problems at work,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination declined,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination declined,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Message from patient,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Message from patient,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Ischemic heart disease at greater than 60 years,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Ischemic heart disease at greater than 60 years,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by rheumatologist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136623
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by rheumatologist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136623
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Rubella screening - blood sent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Rubella screening - blood sent,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in colposcopy clinic,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085644
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in colposcopy clinic,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085644
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done - injection,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148745
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done - injection,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148745
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excepted from asthma quality indicators - informed dissent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excepted from asthma quality indicators - informed dissent,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunization invitation - not attended,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064390
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunization invitation - not attended,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064390
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive started,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060122
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive started,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060122
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to smoking cessation advisor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4217594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to smoking cessation advisor,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4217594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microbiology report received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Microbiology report received,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Left military service,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148421
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Left military service,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148421
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Test result by letter to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012975
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Test result by letter to patient,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012975
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult immunization - first call,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult immunization - first call,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086113
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,-inf to -366,count,numeric,16,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,-inf to -366,percentage,percentage,38.0952380952381,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception,-inf to -366,count,numeric,16,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception,-inf to -366,percentage,percentage,38.0952380952381,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Treatment indicated,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789054
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Treatment indicated,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789054
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected victim of child abuse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected victim of child abuse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037139
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Under care of midwife,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Under care of midwife,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139098
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of osteoporosis,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of osteoporosis,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter invite to screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter invite to screening,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FP7B male patient clinical notes card to follow from Family Practitioner Committee,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FP7B male patient clinical notes card to follow from Family Practitioner Committee,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Language spoken,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Language spoken,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma follow-up,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma follow-up,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Keep well programme,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Keep well programme,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Late for appointment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Late for appointment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,-inf to -366,count,numeric,20,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,-inf to -366,percentage,percentage,47.6190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Communication from:,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Communication from:,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from Accident and Emergency service,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144346
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from Accident and Emergency service,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144346
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine sample obtained,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209108
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urine sample obtained,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209108
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up psychiatric assessment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015826
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up psychiatric assessment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015826
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by podiatrist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083436
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by podiatrist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083436
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excessive thirst,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 432454
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excessive thirst,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 432454
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Absence,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Absence,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption of skin present,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 3655162
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eruption of skin present,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 3655162
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring check done,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring check done,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent - tetanus immunization,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4065027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent - tetanus immunization,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4065027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient signed registration form,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient signed registration form,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight increasing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight increasing,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No breathlessness,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No breathlessness,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ethnicity / related nationality data,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ethnicity / related nationality data,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient referral,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient referral,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug treatment stopped - medical advice,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug treatment stopped - medical advice,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by optometrist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085787
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by optometrist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085787
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma limiting activities,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma limiting activities,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to mammography clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to mammography clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estimated date of delivery,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estimated date of delivery,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High vaginal swab taken,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056284
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,High vaginal swab taken,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056284
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient encounter procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient encounter procedure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to orthopaedic triage service,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809126
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to orthopaedic triage service,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809126
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emergency contraception,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 433400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emergency contraception,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 433400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred to vascular surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084694
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred to vascular surgeon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084694
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from hospital,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from hospital,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excepted from depression quality indicators - informed dissent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803644
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excepted from depression quality indicators - informed dissent,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803644
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Apgar at 1 minute,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Apgar at 1 minute,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infant feeding method,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Infant feeding method,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014439
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Myocardial infarction,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Myocardial infarction,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment canceled by patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment canceled by patient,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraceptive history,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraceptive history,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient record sent to solicitor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4193691
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient record sent to solicitor,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4193691
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by physician,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4125679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by physician,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4125679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abnormal weight loss,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abnormal weight loss,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No FH: Hypertension,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No FH: Hypertension,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intrauterine contraceptive device claim,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intrauterine contraceptive device claim,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - good,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - good,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,-inf to -366,count,numeric,28,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,-inf to -366,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive prescribed,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37312222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive prescribed,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37312222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice,-inf to -366,count,numeric,22,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice,-inf to -366,percentage,percentage,52.3809523809524,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraception -no problem,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraception -no problem,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Attends stop smoking monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Attends stop smoking monitoring,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086132
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to musculoskeletal clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to musculoskeletal clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disease suspected,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disease suspected,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma severely restricts exercise,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma severely restricts exercise,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of neoplasm,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of neoplasm,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical genetics,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4215121
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical genetics,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4215121
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - poor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - poor,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to antenatal clinic,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to antenatal clinic,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Up-to-date with immunizations,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Up-to-date with immunizations,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computer summary updated,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computer summary updated,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Night cough present,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Night cough present,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registered GMS1,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registered GMS1,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred by general practitioner,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44787814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referred by general practitioner,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44787814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lloyd George record received,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lloyd George record received,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call third letter,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call third letter,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Expedite appointment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Expedite appointment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to hospital,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to hospital,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in breast clinic,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in breast clinic,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear non-responder,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear non-responder,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to respiratory nurse specialist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4135667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to respiratory nurse specialist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4135667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psychological therapy started,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804552
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Psychological therapy started,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804552
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intake of fruit and vegetables at least 5 portions daily,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44795893
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Intake of fruit and vegetables at least 5 portions daily,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44795893
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient discharge,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient discharge,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear defaulter,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear defaulter,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,English as a second language,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059787
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,English as a second language,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059787
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health monitoring first letter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4212198
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health monitoring first letter,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4212198
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to midwife,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to midwife,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,-inf to -366,count,numeric,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,-inf to -366,percentage,percentage,59.5238095238095,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery booking place,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4076939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Delivery booking place,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4076939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up consultation,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094043
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up consultation,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094043
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral letter sent by email,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45773636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral letter sent by email,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45773636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adverse reaction to drug,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adverse reaction to drug,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical reports sent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical reports sent,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083277
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,DNA - Did not attend mental health appointment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,DNA - Did not attend mental health appointment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in baby clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196556
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in baby clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196556
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by midwife,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088552
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by midwife,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088552
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Light cigarette smoker (1-9 cigarettes per day),-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Light cigarette smoker (1-9 cigarettes per day),-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903659
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Midwife attends,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Midwife attends,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's next of kin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's next of kin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment status,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202344
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment status,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202344
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination declined,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination declined,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inpatient discharge summary received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inpatient discharge summary received,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of clinical finding,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of clinical finding,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Throat swab,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4119519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Throat swab,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4119519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to fertility clinic,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086283
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to fertility clinic,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086283
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by surgeon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given about breast screening programme,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given about breast screening programme,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by physiotherapist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by physiotherapist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription sent to pharmacy,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription sent to pharmacy,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Child health surveillance,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Child health surveillance,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left on answer machine,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left on answer machine,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd recall,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd recall,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunization status,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4126323
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Immunization status,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4126323
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No nasal symptoms,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No nasal symptoms,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gastroenterology clinic,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083423
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gastroenterology clinic,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083423
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in Health Center,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in Health Center,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to physiotherapist,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to physiotherapist,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history of,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history of,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression enhanced service completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression enhanced service completed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about treatment given,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about treatment given,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,-inf to -366,count,numeric,33,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,-inf to -366,percentage,percentage,78.5714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Report procedure,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Report procedure,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,On depression register,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131518
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,On depression register,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131518
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12 deficiency monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12 deficiency monitoring,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent status for immunizations,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent status for immunizations,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laboratory test result abnormal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Laboratory test result abnormal,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient screening verbal invitation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient screening verbal invitation,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription given no examination of patient,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription given no examination of patient,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FP106 immediate necessary treatment claim paid,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FP106 immediate necessary treatment claim paid,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception from other agency,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803127
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception from other agency,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803127
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in plastic surgery clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in plastic surgery clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Night cough absent,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Night cough absent,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to radiology service,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to radiology service,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to practice nurse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to practice nurse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of asthma,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051241
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of asthma,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051241
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from inpatient care,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from inpatient care,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in dietician clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in dietician clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gynecology service,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gynecology service,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trivial drinker - <1u/day,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trivial drinker - <1u/day,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full-time employment,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053118
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full-time employment,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053118
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Attended new patient screening,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Attended new patient screening,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refusal by patient to provide information about ethnic group,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35607960
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refusal by patient to provide information about ethnic group,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35607960
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal visit,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postnatal visit,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,-inf to -366,count,numeric,33,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,-inf to -366,percentage,percentage,78.5714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Biochemist,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Financial problem,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Financial problem,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by co-operative doctor,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by co-operative doctor,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to respiratory physician,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127758
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to respiratory physician,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127758
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to surgeon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dictated on tape:letter to,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dictated on tape:letter to,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4268284
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4268284
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Solicitors report sent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Solicitors report sent,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call telephone invite,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call telephone invite,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090837
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Type of abdominal pain,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Type of abdominal pain,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stress at work,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4175371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stress at work,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4175371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informing patient of named accountable general practitioner,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informing patient of named accountable general practitioner,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4173786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4173786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No benefits received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052762
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No benefits received,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052762
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non-urgent obstetric admission,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non-urgent obstetric admission,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - no reason,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - no reason,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception using injectable contraceptive medication,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception using injectable contraceptive medication,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear screening third letter,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear screening third letter,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient breast aware,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4190905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient breast aware,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4190905
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to consultant,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789485
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to consultant,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789485
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self-referral to accident and emergency department,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self-referral to accident and emergency department,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in emergency clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in emergency clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication discontinued,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4164526
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication discontinued,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4164526
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,-inf to -366,count,numeric,17,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,-inf to -366,percentage,percentage,40.4761904761905,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by triage nurse,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152728
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by triage nurse,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152728
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Birth outcome,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4264823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Birth outcome,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4264823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screening - up-to-date,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064366
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screening - up-to-date,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064366
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,IUD contraception,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4207158
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,IUD contraception,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4207158
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Passive smoker,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Passive smoker,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient questionnaire completed,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient questionnaire completed,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription not collected,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription not collected,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in psychiatry clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in psychiatry clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,AFP - blood sent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,AFP - blood sent,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor injury enhanced service completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor injury enhanced service completed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788299
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy review,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormone replacement therapy review,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urgent referral,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Urgent referral,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Electronic record notes summary verified,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803042
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Electronic record notes summary verified,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803042
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,X-ray report received,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,X-ray report received,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Possible pregnancy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40310686
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Possible pregnancy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40310686
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from follow-up,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from follow-up,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Born in Afghanistan,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Born in Afghanistan,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of subcutaneous contraceptive implant by other healthcare provider,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813058
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Insertion of subcutaneous contraceptive implant by other healthcare provider,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813058
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in rheumatology clinic,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in rheumatology clinic,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Going to travel abroad,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Going to travel abroad,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to psychiatry service,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084686
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to psychiatry service,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084686
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of diabetes mellitus,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of diabetes mellitus,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Resp. system examined - NAD,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Resp. system examined - NAD,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813741
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check completed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813741
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in ophthalmology clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in ophthalmology clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eating habit,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eating habit,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Reassurance given,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Reassurance given,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigar smoker,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigar smoker,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Apgar at 5 minutes,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Apgar at 5 minutes,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Preparation of medical certificate,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4304360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Preparation of medical certificate,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4304360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done by pharmacist,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done by pharmacist,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Ischemic heart disease at less than 60 years,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Ischemic heart disease at less than 60 years,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to maxillofacial surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4247381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to maxillofacial surgeon,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4247381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in out of hours centre,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in out of hours centre,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax received,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Electronic general practitioner medical record received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Electronic general practitioner medical record received,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812654
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for X-ray,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for X-ray,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for colposcopy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for colposcopy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Length of gestation at birth,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4260747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Length of gestation at birth,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4260747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in radiology department,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in radiology department,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Test result to patient by telephone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Test result to patient by telephone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Epilepsy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Epilepsy,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Korotkoff sounds,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4311672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Korotkoff sounds,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4311672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Birth detail,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Birth detail,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up in outpatient clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084839
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up in outpatient clinic,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084839
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,E-mail sent to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,E-mail sent to patient,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to community mental health team,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791443
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to community mental health team,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791443
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Long acting reversible contraception leaflet given,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Long acting reversible contraception leaflet given,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,-inf to -366,count,numeric,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,-inf to -366,percentage,percentage,59.5238095238095,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exposure to Rubella virus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40479430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exposure to Rubella virus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40479430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Hay fever,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Hay fever,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sample sent to laboratory for test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sample sent to laboratory for test,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,DLA 370 Disability living allowance completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788320
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,DLA 370 Disability living allowance completed,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788320
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior tibial pulse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4222862
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior tibial pulse,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4222862
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visual acuity - right eye,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visual acuity - right eye,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Verbal invite to screening,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Verbal invite to screening,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sheath contraception,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sheath contraception,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,MED5 issued to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788146
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,MED5 issued to patient,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788146
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mini-mental state examination score,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40491929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mini-mental state examination score,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40491929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrence of problem,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrence of problem,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family tension,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4019961
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family tension,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4019961
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to dermatology service,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to dermatology service,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to social worker,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to social worker,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient record requested by solicitor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4236289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient record requested by solicitor,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4236289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Treatment plan given,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Treatment plan given,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Well adult monitoring telephone invite,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Well adult monitoring telephone invite,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Frequency of defecation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012504
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Frequency of defecation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012504
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child health surveillance,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child health surveillance,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in neurology clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088538
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in neurology clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088538
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cigarette smoker,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cigarette smoker,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in dermatology clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in dermatology clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Respiratory disease monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Respiratory disease monitoring,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Spouse deceased,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42538166
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Spouse deceased,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42538166
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Listed for admission to hospital,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084992
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Listed for admission to hospital,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084992
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Size of blood pressure cuff,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Size of blood pressure cuff,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,History of event,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,History of event,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Podiatry service,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Podiatry service,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149143
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient-initiated diet,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient-initiated diet,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in GP's surgery,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in GP's surgery,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,FP106 immediate necessary treatment claim paid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,FP106 immediate necessary treatment claim paid,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Time symptom lasts,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037328
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Time symptom lasts,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037328
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Health education offered,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Health education offered,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone triage encounter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone triage encounter,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Life assurance preliminary report sent off,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Life assurance preliminary report sent off,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Travel abroad on vacation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Travel abroad on vacation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consultation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consultation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Trivial drinker - <1u/day,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Trivial drinker - <1u/day,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,FH: Ischemic heart disease at greater than 60 years,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,FH: Ischemic heart disease at greater than 60 years,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148409
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergy or intolerance criticality,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergy or intolerance criticality,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza vaccination declined,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza vaccination declined,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review done,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review done,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication given,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication given,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Repeated prescription,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Repeated prescription,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight finding,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight finding,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraceptive claim,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraceptive claim,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Contraception,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Contraception,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No consent - influenza immunization,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No consent - influenza immunization,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in gynecology clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in gynecology clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Life assurance preliminary report completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083884
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Life assurance preliminary report completed,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083884
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Life assurance report requested,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Life assurance report requested,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Speech and language therapy surveillance,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4174536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Speech and language therapy surveillance,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4174536
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in orthopedic clinic,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in orthopedic clinic,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No known allergy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No known allergy,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Discharged from hospital,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Discharged from hospital,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Did not attend - no reason,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Did not attend - no reason,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Life assurance preliminary report fee paid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083154
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Life assurance preliminary report fee paid,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083154
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review due date,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review due date,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraception,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraception,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alcohol units consumed per week,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alcohol units consumed per week,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Never used tobacco or its derivatives,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Never used tobacco or its derivatives,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Non-urgent hospital admission,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Non-urgent hospital admission,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084669
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Communication from:,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Communication from:,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Family illness,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4142972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Family illness,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4142972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Repeat prescription monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Repeat prescription monitoring,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Failed encounter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Failed encounter,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Incoming mail processing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Incoming mail processing,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Excepted from COPD quality indicators - informed dissent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803712
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Excepted from COPD quality indicators - informed dissent,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803712
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Absence,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Absence,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergy to drug,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergy to drug,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diet [Type],-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Diet [Type],-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No FH: Ischemic heart disease,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145791
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No FH: Ischemic heart disease,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145791
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Minor surgery done,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Minor surgery done,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,New patient questionnaire completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,New patient questionnaire completed,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Has a sore throat,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Has a sore throat,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Exercise,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Exercise,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sickness/invalidity benefit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sickness/invalidity benefit,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Appointment date,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Appointment date,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pill check,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pill check,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Domiciliary visit requested,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Domiciliary visit requested,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Third party encounter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Third party encounter,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alcoholic beverage intake,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Alcoholic beverage intake,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,General finding of height,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,General finding of height,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eating habit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Eating habit,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Refer to appliance officer,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4092774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Refer to appliance officer,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4092774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral for further care,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral for further care,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Accidental fall,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Accidental fall,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dietary history,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036783
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Dietary history,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4036783
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter encounter to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter encounter to patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in urology clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in urology clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight monitoring,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication requested,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication requested,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone encounter,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone encounter,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical cancer screening offered,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cervical cancer screening offered,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Wheelchair applied for,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4047213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Wheelchair applied for,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4047213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of gait,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4179298
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of gait,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4179298
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sample sent to laboratory for test,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Sample sent to laboratory for test,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergy to substance,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4169307
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Allergy to substance,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4169307
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication increased,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication increased,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in hospital casualty,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in hospital casualty,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administrative procedure,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administrative procedure,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to general practitioner,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to general practitioner,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Out of hours visit - not night visit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083574
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Out of hours visit - not night visit,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083574
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Adverse reaction to drug,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Adverse reaction to drug,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Home visit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Home visit,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child health care,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145320
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Child health care,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145320
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Bladder drill,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4102236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Bladder drill,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4102236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Incontinence care,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Incontinence care,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Notes summary on computer,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Notes summary on computer,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in EMG clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in EMG clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Had a chat to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Had a chat to patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient's next of kin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient's next of kin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Family history of clinical finding,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Family history of clinical finding,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Advice given,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Advice given,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Housebound,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Housebound,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunisation offered,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunisation offered,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital outpatient department,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital outpatient department,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in gastroenterology clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083423
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in gastroenterology clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083423
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in oral surgery clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in oral surgery clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consent given for pandemic influenza vaccination,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consent given for pandemic influenza vaccination,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history with explicit context,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4210989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history with explicit context,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4210989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice about treatment given,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice about treatment given,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lloyd George culled and tagged,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791176
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lloyd George culled and tagged,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791176
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call second letter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call second letter,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,History of event,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,History of event,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Benign neurofibroma,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 603163
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Benign neurofibroma,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 603163
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consultant letter from:,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789449
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consultant letter from:,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789449
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient-initiated diet,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient-initiated diet,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Father deceased,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Father deceased,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fit for work,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053230
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fit for work,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053230
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in GP's surgery,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in GP's surgery,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occupation,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occupation,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,FH: Bowel cancer,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4166438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,FH: Bowel cancer,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4166438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Health education offered,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Health education offered,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough absent,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough absent,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone triage encounter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone triage encounter,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to outside agency,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to outside agency,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in general medical clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083421
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in general medical clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083421
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review done,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review done,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message from patient,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message from patient,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergy or intolerance criticality,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergy or intolerance criticality,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Postnatal visit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Postnatal visit,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Repeated prescription,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Repeated prescription,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,-inf to -366,percentage,percentage,75,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referred to thoracic surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referred to thoracic surgeon,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Usual warning given,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082549
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Usual warning given,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082549
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive started,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060122
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive started,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060122
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to surgeon,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergy to dust mite protein,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4048169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergy to dust mite protein,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4048169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive claim,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive claim,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphadenopathy absent,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4168211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lymphadenopathy absent,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4168211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from specialist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from specialist,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message given to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791206
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message given to patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791206
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to audiologist,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to audiologist,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in orthopedic clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in orthopedic clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma follow-up,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma follow-up,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No known allergy,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No known allergy,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend - no reason,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend - no reason,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Discharged from hospital,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Discharged from hospital,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight decreasing,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight decreasing,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review due date,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review due date,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Never used tobacco or its derivatives,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Never used tobacco or its derivatives,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to consultant,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789485
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to consultant,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789485
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Repeat prescription monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Repeat prescription monitoring,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062329
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Self-referral to accident and emergency department,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Self-referral to accident and emergency department,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consent given for communication by short message service text messaging,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consent given for communication by short message service text messaging,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Incoming mail processing,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Incoming mail processing,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in general surgery clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in general surgery clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergy to drug,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Allergy to drug,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Extensive notes on computer,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083731
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Extensive notes on computer,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083731
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet [Type],-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet [Type],-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient referral,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient referral,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Non - drinker,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Non - drinker,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medical report received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medical report received,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Passive smoker,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Passive smoker,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,New patient questionnaire completed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,New patient questionnaire completed,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086943
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prescription not collected,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prescription not collected,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma management,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma management,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient informed - test result,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient informed - test result,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter encounter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter encounter,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique observed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique observed,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by Accident and Emergency doctor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by Accident and Emergency doctor,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,-inf to -366,percentage,percentage,75,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consent given for communication by email,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45767571
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consent given for communication by email,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45767571
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-inf to -366,percentage,percentage,75,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to gastroenterology service,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084685
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to gastroenterology service,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084685
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Appointment canceled by patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Appointment canceled by patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of cancer,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of cancer,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171594
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Resp. system examined - NAD,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Resp. system examined - NAD,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma annual review,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma annual review,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by nurse,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by nurse,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136636
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Emergency hospital admission,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Emergency hospital admission,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunisation claim,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunisation claim,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803167
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - moderate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4305735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - moderate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4305735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Penicillin adverse reaction,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 433658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Penicillin adverse reaction,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 433658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - good,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - good,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General finding of height,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General finding of height,-inf to -366,percentage,percentage,87.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eating habit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eating habit,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient given advice,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient given advice,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neurofibromatosis,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219205
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neurofibromatosis,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219205
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Employment milestones,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Employment milestones,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Registration transferred to practice pooled list,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Registration transferred to practice pooled list,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Main spoken language English,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Main spoken language English,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by cardiothoracic surgeon,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136627
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by cardiothoracic surgeon,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136627
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough present,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough present,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter encounter to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter encounter to patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Korotkoff sounds,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4311672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Korotkoff sounds,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4311672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lloyd George record received,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lloyd George record received,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call third letter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call third letter,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication requested,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication requested,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medical report received from hospital,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medical report received from hospital,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Appointment made by telephone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083569
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Appointment made by telephone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083569
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient discharge,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient discharge,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital casualty,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital casualty,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Social drinker,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4102142
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Social drinker,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4102142
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lloyd George culled and summarised,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788391
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Lloyd George culled and summarised,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788391
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administrative procedure,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administrative procedure,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Follow-up arranged,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Follow-up arranged,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in cardiac clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in cardiac clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Amount of time off work,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Amount of time off work,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total notes on computer,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Total notes on computer,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Follow-up consultation,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094043
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Follow-up consultation,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094043
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Clinical management plan agreed,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Clinical management plan agreed,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Adverse reaction to drug,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Adverse reaction to drug,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Med3 certificate issued to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Med3 certificate issued to patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788151
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in ENT clinic,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in ENT clinic,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Church of England,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Church of England,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148978
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Home visit,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Home visit,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza immunisation for those in the 65 years and over and other at risk groups enhanced services administration,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788285
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza immunisation for those in the 65 years and over and other at risk groups enhanced services administration,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788285
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Notes summary on computer,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Notes summary on computer,-inf to -366,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No smear - not sexually active,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No smear - not sexually active,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Had a chat to patient,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Had a chat to patient,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call first letter,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call first letter,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Out of hours consultation at surgery,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Out of hours consultation at surgery,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fax sent to:,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fax sent to:,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of clinical finding,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of clinical finding,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice given,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice given,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient temporarily left,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient temporarily left,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cigarette smoker,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cigarette smoker,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,-365 to -31,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Occupation,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Occupation,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Consultation,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Consultation,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy or intolerance criticality,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy or intolerance criticality,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review done,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review done,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient registered by FPC,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148742
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient registered by FPC,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148742
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from specialist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from specialist,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in orthopedic clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in orthopedic clinic,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma follow-up,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma follow-up,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend - no reason,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend - no reason,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review due date,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review due date,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incoming mail processing,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incoming mail processing,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by ophthalmologist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by ophthalmologist,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No FH: Ischemic heart disease,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145791
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No FH: Ischemic heart disease,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145791
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-365 to -31,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Overweight,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Overweight,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-365 to -31,percentage,percentage,62.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma monitoring,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma monitoring,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General finding of height,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General finding of height,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given advice,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given advice,-365 to -31,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in physiotherapy department,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in physiotherapy department,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Computer summary updated,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Computer summary updated,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lloyd George record received,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lloyd George record received,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Telephone encounter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Telephone encounter,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood test due,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood test due,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Light drinker - 1-2u/day,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052022
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Light drinker - 1-2u/day,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052022
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,New patient consultation,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,New patient consultation,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Had a chat to patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Had a chat to patient,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Treatment plan given,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Treatment plan given,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Family history of clinical finding,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Family history of clinical finding,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Advice given,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Advice given,-365 to -31,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appropriate triage decision,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45770403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appropriate triage decision,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45770403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occasional drinker,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occasional drinker,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd call,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd call,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Unemployed,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4251171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Unemployed,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4251171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Subject requests referral,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40480414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Subject requests referral,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40480414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Risk assessment status,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4236300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Risk assessment status,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4236300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to physiotherapist,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to physiotherapist,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history of,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history of,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigarette smoker,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigarette smoker,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient call procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient call procedure,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Date records held from,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Date records held from,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Listed for admission to hospital,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084992
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Listed for admission to hospital,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084992
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Main spoken language Yoruba,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Main spoken language Yoruba,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154085
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend hospital appointment,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend hospital appointment,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History of event,-365 to -31,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History of event,-365 to -31,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dorsalis pedis pulse,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4225511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Dorsalis pedis pulse,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4225511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Report procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Report procedure,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 2nd call,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085173
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 2nd call,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085173
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient-initiated diet,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient-initiated diet,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house physio,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088714
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house physio,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088714
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 1st recall,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085960
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 1st recall,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085960
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,-365 to -31,count,numeric,10,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,-365 to -31,percentage,percentage,20.8333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of chaperone refused,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35622065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of chaperone refused,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35622065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral needed,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086779
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral needed,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086779
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - no answer when rang back,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - no answer when rang back,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for guided self-help for anxiety,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for guided self-help for anxiety,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to patient,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination / signs,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination / signs,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Interpreter not needed,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Interpreter not needed,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from outside agency,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from outside agency,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in dietician clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in dietician clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gynecology service,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gynecology service,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trivial drinker - <1u/day,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trivial drinker - <1u/day,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol intake within recommended sensible limits,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol intake within recommended sensible limits,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Message from patient,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Message from patient,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication given,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication given,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,-365 to -31,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,-365 to -31,percentage,percentage,22.9166666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Touch sensation, function",-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4265871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Touch sensation, function",-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4265871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wound care,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Wound care,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excepted from asthma quality indicators - informed dissent,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Excepted from asthma quality indicators - informed dissent,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4268284
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma trigger,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4268284
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination invitation short message service text message sent,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813057
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination invitation short message service text message sent,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813057
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for NMR scanning,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for NMR scanning,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetic annual review,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016050
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetic annual review,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016050
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Language spoken,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Language spoken,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in orthopedic clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in orthopedic clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug prescription,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug prescription,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Short message service text message received from patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Short message service text message received from patient,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No known allergy,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No known allergy,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - no reason,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - no reason,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progestogen only oral contraceptive,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progestogen only oral contraceptive,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear screening third letter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear screening third letter,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit - no reply,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit - no reply,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088709
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol units consumed per week,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol units consumed per week,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to consultant,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789485
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to consultant,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789485
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression interim review,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4189144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression interim review,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4189144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up status,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up status,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,GP out of hours service administration,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,GP out of hours service administration,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected UTI (urinary tract infection),-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected UTI (urinary tract infection),-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self-referral to accident and emergency department,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self-referral to accident and emergency department,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alert received from telehealth monitoring system,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alert received from telehealth monitoring system,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Myocardial infarction at less than 60,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4170147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Myocardial infarction at less than 60,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4170147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic disease initial assessment,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic disease initial assessment,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for communication by short message service text messaging,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for communication by short message service text messaging,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Absence,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Absence,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by ophthalmologist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by ophthalmologist,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet [Type],-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet [Type],-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non - drinker,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non - drinker,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetic foot at risk,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4163116
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetic foot at risk,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4163116
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical report received,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical report received,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Implied consent for core Summary Care Record dataset upload,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Implied consent for core Summary Care Record dataset upload,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estimated date of delivery,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estimated date of delivery,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient encounter procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient encounter procedure,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,360 degree sweep of cervix performed,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,360 degree sweep of cervix performed,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient informed - test result,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient informed - test result,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussed with patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4191842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discussed with patient,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4191842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-365 to -31,count,numeric,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-365 to -31,percentage,percentage,52.0833333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative form statuses,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative form statuses,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790130
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-365 to -31,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-365 to -31,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-365 to -31,count,numeric,14,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-365 to -31,percentage,percentage,29.1666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in rheumatology clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in rheumatology clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Going to travel abroad,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Going to travel abroad,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment canceled by patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment canceled by patient,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089038
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of diabetes mellitus,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of diabetes mellitus,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by practice phlebotomist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by practice phlebotomist,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma annual review,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma annual review,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Not a carer,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Not a carer,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802941
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration data verified,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration data verified,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,MSU sent for C/S,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059230
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,MSU sent for C/S,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059230
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Third party encounter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Third party encounter,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to nurse,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to nurse,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - good,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - good,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in ophthalmology clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in ophthalmology clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise on prescription,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150697
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise on prescription,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150697
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eating habit,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eating habit,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for ultrasound investigation,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for ultrasound investigation,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice,-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from physiotherapy service,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from physiotherapy service,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Preparation of medical certificate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4304360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Preparation of medical certificate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4304360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraception -no problem,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraception -no problem,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in minor injuries department,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44787907
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in minor injuries department,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44787907
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to sleep clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4205656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to sleep clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4205656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone consultation,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302396
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone consultation,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302396
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disease suspected,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disease suspected,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for X-ray,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for X-ray,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet average,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet average,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to antenatal clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to antenatal clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 1st call,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 1st call,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ultrasound scan requested,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4292193
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ultrasound scan requested,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4292193
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected arrhythmia,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44808625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected arrhythmia,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44808625
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computer summary updated,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computer summary updated,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood sample taken,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood sample taken,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for further care,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for further care,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Declined consent for short message service text messaging,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802338
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Declined consent for short message service text messaging,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802338
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription by supplementary prescriber,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription by supplementary prescriber,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peak flow meter at home,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017185
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peak flow meter at home,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017185
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lloyd George record received,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Lloyd George record received,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call third letter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call third letter,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient failed to respond to appointment opt-in letter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient failed to respond to appointment opt-in letter,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication decreased,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication decreased,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical therapy procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4238738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Physical therapy procedure,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4238738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Expedite appointment,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Expedite appointment,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089197
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in breast clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in breast clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear non-responder,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear non-responder,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,-365 to -31,count,numeric,16,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,-365 to -31,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient allocated named accountable general practitioner,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient allocated named accountable general practitioner,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient discharge,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient discharge,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Under care of cardiologist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Under care of cardiologist,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to podiatrist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to podiatrist,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear defaulter,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear defaulter,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital casualty,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital casualty,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to cardiologist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to cardiologist,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in antenatal clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in antenatal clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication increased,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication increased,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of neoplasm of lung,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4182336
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of neoplasm of lung,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4182336
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior tibial pulse,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4222862
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Posterior tibial pulse,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4222862
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,-365 to -31,count,numeric,13,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,-365 to -31,percentage,percentage,27.0833333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in cardiac clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in cardiac clinic,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total notes on computer,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Total notes on computer,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by midwife,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088552
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by midwife,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088552
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Long term condition summary sent to patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Long term condition summary sent to patient,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent for operation given,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent for operation given,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notes summary on computer,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notes summary on computer,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Previous treatment continue,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Previous treatment continue,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gynecologist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gynecologist,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetic retinopathy of eye not detected,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36715429
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetic retinopathy of eye not detected,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36715429
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Had a chat to patient,-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Had a chat to patient,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's next of kin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient's next of kin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Treatment plan given,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Treatment plan given,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for cervical smear given,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for cervical smear given,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by own GP,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139717
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by own GP,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139717
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment status,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202344
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment status,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202344
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination declined,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination declined,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of clinical finding,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of clinical finding,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax sent to:,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax sent to:,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given,-365 to -31,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given,-365 to -31,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral letter status,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral letter status,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetes: practice program,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetes: practice program,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Occasional drinker,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Occasional drinker,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Size of blood pressure cuff,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Size of blood pressure cuff,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,History of event,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,History of event,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consultation,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consultation,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review done,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review done,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in orthopedic clinic,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in orthopedic clinic,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review due date,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review due date,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Never used tobacco or its derivatives,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Never used tobacco or its derivatives,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by ophthalmologist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by ophthalmologist,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Overweight,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Overweight,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-365 to -31,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in physiotherapy department,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in physiotherapy department,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,E-mail sent to patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,E-mail sent to patient,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication requested,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication requested,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone encounter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone encounter,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood test due,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood test due,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Follow-up arranged,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Follow-up arranged,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per week,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per week,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in dermatology clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in dermatology clinic,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Informed consent for procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Informed consent for procedure,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Bronchodilators used a maximum of once daily,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Bronchodilators used a maximum of once daily,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Health education offered,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Health education offered,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in clinic,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone triage encounter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone triage encounter,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma sometimes restricts exercise,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma sometimes restricts exercise,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message from patient,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message from patient,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,-365 to -31,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from specialist,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from specialist,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in orthopedic clinic,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in orthopedic clinic,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No smear - benign hysterectomy,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No smear - benign hysterectomy,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review due date,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review due date,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Never used tobacco or its derivatives,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Never used tobacco or its derivatives,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Suspected UTI (urinary tract infection),-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Suspected UTI (urinary tract infection),-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Minor surgery done,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Minor surgery done,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma management,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma management,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to counselor,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to counselor,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Minor surgery information leaflet given,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Minor surgery information leaflet given,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient encounter procedure,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient encounter procedure,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique observed,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique observed,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,-365 to -31,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma annual review,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma annual review,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by physician,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4125679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by physician,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4125679
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Emergency hospital admission for asthma,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Emergency hospital admission for asthma,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084667
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - good,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - good,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General finding of height,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General finding of height,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient given advice,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient given advice,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Reassurance given,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Reassurance given,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Item held as scanned document,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Item held as scanned document,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Employment milestones,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Employment milestones,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough present,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough present,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital casualty,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital casualty,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Had a chat to patient,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Had a chat to patient,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call first letter,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call first letter,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Treatment plan given,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Treatment plan given,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice given,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice given,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Minor surgery done - excision,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Minor surgery done - excision,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Family history with explicit context,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4210989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Family history with explicit context,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4210989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from consultant,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from consultant,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Choice and booking enhanced services administration,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Choice and booking enhanced services administration,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General finding of height,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General finding of height,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lloyd George record received,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lloyd George record received,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in hospital casualty,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in hospital casualty,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appropriate triage decision,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45770403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appropriate triage decision,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45770403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd call,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd call,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 2nd call,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085173
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 2nd call,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085173
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,-30 to -1,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,-30 to -1,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription given no examination of patient,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription given no examination of patient,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144135
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Test result by letter to patient,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012975
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Test result by letter to patient,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012975
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alert received from telehealth monitoring system,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alert received from telehealth monitoring system,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-30 to -1,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,-30 to -1,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for ultrasound investigation,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for ultrasound investigation,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient allocated named accountable general practitioner,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient allocated named accountable general practitioner,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Previous treatment continue,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Previous treatment continue,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144136
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient medical record envelope received from family practitioner committee,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788476
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient medical record envelope received from family practitioner committee,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788476
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza vaccination invitation letter sent,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza vaccination invitation letter sent,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Occasional drinker,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Occasional drinker,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Employment report status,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Employment report status,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Trivial drinker - <1u/day,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Trivial drinker - <1u/day,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination declined,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination declined,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Poor hypertension control,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016922
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Poor hypertension control,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016922
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No consent - influenza immunization,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No consent - influenza immunization,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from specialist,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from specialist,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Drug treatment stopped - medical advice,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Drug treatment stopped - medical advice,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,1 to 30,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient on waiting list,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient on waiting list,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sample sent to laboratory for test,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sample sent to laboratory for test,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mid stream urine sent to laboratory,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4055275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mid stream urine sent to laboratory,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4055275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd call,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd call,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent for seasonal influenza vaccination,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44810385
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent for seasonal influenza vaccination,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44810385
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Listed for admission to hospital,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084992
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Listed for admission to hospital,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084992
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,1 to 30,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,1 to 30,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,1 to 30,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,1 to 30,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of body mass index,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of body mass index,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,1 to 30,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,1 to 30,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Short message service text message received from patient,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Short message service text message received from patient,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alert received from telehealth monitoring system,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alert received from telehealth monitoring system,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by podiatrist,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083436
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by podiatrist,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083436
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,1 to 30,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,1 to 30,percentage,percentage,16.3265306122449,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,X-ray report received,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,X-ray report received,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in endocrine clinic,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085649
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in endocrine clinic,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085649
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,1 to 30,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for colposcopy,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for colposcopy,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079639
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to antenatal clinic,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to antenatal clinic,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,1 to 30,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Long acting reversible contraception leaflet given,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Long acting reversible contraception leaflet given,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in antenatal clinic,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in antenatal clinic,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,1 to 30,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sheath contraception,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Sheath contraception,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call first letter,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call first letter,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination declined,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination declined,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inpatient discharge summary received,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inpatient discharge summary received,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax sent to:,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax sent to:,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by surgeon,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by surgeon,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139734
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Postnatal visit,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Postnatal visit,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Birth outcome,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4264823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Birth outcome,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4264823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Drug treatment stopped - medical advice,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Drug treatment stopped - medical advice,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Apgar at 1 minute,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Apgar at 1 minute,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient on waiting list,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient on waiting list,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Apgar at 5 minutes,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Apgar at 5 minutes,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Duration of labor,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4122728
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Duration of labor,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4122728
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Duration of second stage of labor,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Duration of second stage of labor,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Duration of third stage of labor,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Duration of third stage of labor,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Birth detail,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Birth detail,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occasional drinker,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occasional drinker,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,History of event,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,History of event,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient-initiated diet,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient-initiated diet,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination declined,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination declined,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Poor hypertension control,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016922
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Poor hypertension control,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016922
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No consent - influenza immunization,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No consent - influenza immunization,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alcohol units consumed per week,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alcohol units consumed per week,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet [Type],1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet [Type],1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eating habit,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eating habit,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sample sent to laboratory for test,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sample sent to laboratory for test,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in cardiac clinic,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in cardiac clinic,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - 3rd recall,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - 3rd recall,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cigarette smoker,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cigarette smoker,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication commenced,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication commenced,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lloyd George and problem summary,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Lloyd George and problem summary,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy or intolerance criticality,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy or intolerance criticality,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review done,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review done,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Report status,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203886
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Report status,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203886
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from specialist,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from specialist,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Language spoken,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Language spoken,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma follow-up,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma follow-up,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend - no reason,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend - no reason,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discharged from hospital,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discharged from hospital,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review due date,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review due date,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incoming mail processing,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incoming mail processing,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in general surgery clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in general surgery clinic,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy to drug,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy to drug,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Drug treatment stopped - medical advice,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Drug treatment stopped - medical advice,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Non - drinker,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Non - drinker,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by Accident and Emergency doctor,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by Accident and Emergency doctor,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,31 to 365,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,X-ray report received,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,X-ray report received,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given advice,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given advice,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hospital admission,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hospital admission,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Full consent for immunization,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Full consent for immunization,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Main spoken language English,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Main spoken language English,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Visual acuity - left eye,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Visual acuity - left eye,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Good hypertension control,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Good hypertension control,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient discharge,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient discharge,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in hospital casualty,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in hospital casualty,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Visual acuity - right eye,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Visual acuity - right eye,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to general practitioner,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to general practitioner,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total notes on computer,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total notes on computer,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Adverse reaction to drug,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Adverse reaction to drug,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Notes summary on computer,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Notes summary on computer,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Had a chat to patient,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Had a chat to patient,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inpatient discharge summary received,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inpatient discharge summary received,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Advice given,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Advice given,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal movement feature,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal movement feature,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized anxiety disorder 7 item score,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40483769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Generalized anxiety disorder 7 item score,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40483769
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occasional drinker,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occasional drinker,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in neurology clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088538
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in neurology clinic,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088538
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left on answer machine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left on answer machine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self-referral,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4138517
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self-referral,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4138517
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd recall,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear - 3rd recall,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma review using Royal College of Physicians three questions,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805526
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma review using Royal College of Physicians three questions,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805526
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigarette smoker,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigarette smoker,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call second letter,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call second letter,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gynaecology,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gynaecology,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803815
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,31 to 365,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,31 to 365,percentage,percentage,16.3265306122449,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend hospital appointment,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend hospital appointment,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History of event,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History of event,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given telephone advice out of hours,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given telephone advice out of hours,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Report procedure,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Report procedure,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house physio,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088714
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house physio,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088714
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Social care,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Social care,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal heart feature,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal heart feature,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,31 to 365,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,31 to 365,percentage,percentage,22.4489795918367,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of chaperone refused,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35622065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of chaperone refused,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35622065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occupation,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occupation,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by pharmacist,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by pharmacist,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone triage encounter,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone triage encounter,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - no answer when rang back,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - no answer when rang back,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Procedure not done,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4168192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Procedure not done,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4168192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to patient,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination / signs,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination / signs,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of body mass index,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding of body mass index,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol intake within recommended sensible limits,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol intake within recommended sensible limits,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Message from patient,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Message from patient,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in walk in centre,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791560
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in walk in centre,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791560
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Partner had vasectomy,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 3654349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Partner had vasectomy,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 3654349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in oncology clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in oncology clinic,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done - injection,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148745
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done - injection,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148745
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient not examined,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037142
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient not examined,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037142
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Type of abdominal pain,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Type of abdominal pain,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent - influenza immunization,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No consent - influenza immunization,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - reason given,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - reason given,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4173786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4173786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma follow-up,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma follow-up,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notification status,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notification status,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204795
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient themselves providing care,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4073186
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient themselves providing care,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4073186
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - no reason,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - no reason,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear screening third letter,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear screening third letter,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol units consumed per week,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol units consumed per week,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,eConsultation via online application,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42690710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,eConsultation via online application,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42690710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Communication from:,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Communication from:,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up status,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Follow-up status,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected UTI (urinary tract infection),31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected UTI (urinary tract infection),31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to pharmacist,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to pharmacist,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alert received from telehealth monitoring system,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alert received from telehealth monitoring system,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Planned telephone contact,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Planned telephone contact,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for CAT scanning,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085010
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for CAT scanning,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085010
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend asthma clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend asthma clinic,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Agreeing on patient actions in care plan,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Agreeing on patient actions in care plan,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic disease initial assessment,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chronic disease initial assessment,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,31 to 365,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,31 to 365,percentage,percentage,18.3673469387755,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for communication by short message service text messaging,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for communication by short message service text messaging,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Incoming mail processing,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Incoming mail processing,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Phlebotomy domiciliary visit requested,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Phlebotomy domiciliary visit requested,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by smoking cessation advisor,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by smoking cessation advisor,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295004
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Presentation of fetus,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Presentation of fetus,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Birth outcome,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4264823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Birth outcome,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4264823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Verbal consent for examination,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4218800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Verbal consent for examination,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4218800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Using inhaled steroids - high dose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015824
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Using inhaled steroids - high dose,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015824
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical report received,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical report received,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma limiting activities,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma limiting activities,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma management,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma management,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Requires vaccination,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37109774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Requires vaccination,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37109774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emergency contraception,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 433400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Emergency contraception,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 433400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique observed,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique observed,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,31 to 365,count,numeric,25,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,31 to 365,percentage,percentage,51.0204081632653,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,X-ray report received,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,X-ray report received,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Apgar at 1 minute,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Apgar at 1 minute,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014304
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Overweight,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Overweight,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 437525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,31 to 365,count,numeric,10,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,31 to 365,percentage,percentage,20.4081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in rheumatology clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in rheumatology clinic,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089021
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in endocrine clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085649
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in endocrine clinic,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085649
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by practice phlebotomist,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by practice phlebotomist,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma annual review,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma annual review,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12 injections - at surgery,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12 injections - at surgery,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration data verified,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient registration data verified,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient clinic letter received,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient clinic letter received,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - moderate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4305735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - moderate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4305735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by gynecologist,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139729
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by gynecologist,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4139729
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Third party encounter,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Third party encounter,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - good,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - good,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to nurse,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to nurse,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4094169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit request by patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit request by patient,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise on prescription,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150697
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise on prescription,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150697
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Apgar at 5 minutes,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Apgar at 5 minutes,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraception -no problem,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraception -no problem,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059962
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hospital admission,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hospital admission,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Email encounter from third party,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37019076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Email encounter from third party,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37019076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Not for resuscitation,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4119499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Not for resuscitation,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4119499
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in out of hours centre,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in out of hours centre,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone consultation,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302396
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone consultation,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302396
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for X-ray,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for X-ray,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Length of gestation at birth,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4260747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Length of gestation at birth,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4260747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood sample taken,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Blood sample taken,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Declined consent for short message service text messaging,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802338
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Declined consent for short message service text messaging,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802338
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription by supplementary prescriber,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription by supplementary prescriber,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Statin declined,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Statin declined,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health information leaflet given,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789203
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mental health information leaflet given,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789203
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Birth detail,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Birth detail,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient deregistration,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient deregistration,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication monitoring,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4216473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication monitoring,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4216473
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,31 to 365,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,31 to 365,percentage,percentage,16.3265306122449,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from service,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from service,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear non-responder,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear non-responder,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet good,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet good,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,31 to 365,count,numeric,18,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,31 to 365,percentage,percentage,36.734693877551,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient discharge,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient discharge,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care from consultant,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care from consultant,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Under care of palliative care specialist nurse,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44808854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Under care of palliative care specialist nurse,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44808854
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination not indicated,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination not indicated,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806822
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear defaulter,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear defaulter,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital casualty,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital casualty,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by palliative care service,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40480924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by palliative care service,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40480924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,31 to 365,count,numeric,12,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,31 to 365,percentage,percentage,24.4897959183673,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrence of problem,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Recurrence of problem,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical management plan agreed,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical management plan agreed,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gynecological history,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gynecological history,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for spirometry,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4187350
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for spirometry,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4187350
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormonal replacement therapy stopped,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4063112
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hormonal replacement therapy stopped,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4063112
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to dermatology service,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to dermatology service,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Long term condition summary sent to patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Long term condition summary sent to patient,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notes summary on computer,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notes summary on computer,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient examined,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient examined,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Had a chat to patient,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Had a chat to patient,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call first letter,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring call first letter,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Treatment plan given,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Treatment plan given,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination declined,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination declined,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment status,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202344
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment status,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202344
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma restricts exercise,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015951
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma restricts exercise,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015951
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient has no paper record,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45770369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient has no paper record,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 45770369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given,31 to 365,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given,31 to 365,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Failed encounter - message left on answer machine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Failed encounter - message left on answer machine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Size of blood pressure cuff,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Size of blood pressure cuff,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient given telephone advice out of hours,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient given telephone advice out of hours,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,History of event,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,History of event,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication commenced,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication commenced,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone triage encounter,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone triage encounter,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lloyd George and problem summary,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lloyd George and problem summary,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consultation,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consultation,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review done,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review done,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Postnatal visit,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Postnatal visit,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by co-operative doctor,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by co-operative doctor,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraceptive claim,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraceptive claim,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Report status,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203886
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Report status,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203886
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in orthopedic clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in orthopedic clinic,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Discharged from hospital,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Discharged from hospital,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraception,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraception,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review due date,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review due date,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Never used tobacco or its derivatives,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Never used tobacco or its derivatives,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Suspected UTI (urinary tract infection),31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Suspected UTI (urinary tract infection),31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Planned telephone contact,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Planned telephone contact,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Drug treatment stopped - medical advice,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Drug treatment stopped - medical advice,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Non - drinker,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Non - drinker,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Minor surgery done,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Minor surgery done,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Procedure refused,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Procedure refused,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Estimated date of delivery,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Estimated date of delivery,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma management,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma management,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient informed - test result,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient informed - test result,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Referral to ear, nose and throat service",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079634
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Referral to ear, nose and throat service",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079634
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Inhaler technique observed,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Inhaler technique observed,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,31 to 365,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Choice and booking enhanced services administration,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Choice and booking enhanced services administration,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma annual review,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma annual review,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Reassurance given,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Reassurance given,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to district nurse,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to district nurse,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Main spoken language English,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Main spoken language English,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151757
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Night cough present,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Night cough present,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by receptionist,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by receptionist,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Visual acuity - left eye,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Visual acuity - left eye,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter encounter from patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter encounter from patient,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Investigation indicated,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Investigation indicated,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,E-mail sent to patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,E-mail sent to patient,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication requested,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication requested,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone encounter,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone encounter,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in hospital casualty,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in hospital casualty,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Visual acuity - right eye,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Visual acuity - right eye,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Follow-up arranged,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Follow-up arranged,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administrative procedure,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administrative procedure,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to general practitioner,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to general practitioner,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Clinical management plan agreed,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Clinical management plan agreed,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in ENT clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in ENT clinic,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Had a chat to patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Had a chat to patient,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per week,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per week,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Conversation content,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022244
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Conversation content,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022244
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,History of event,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,History of event,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient-initiated diet,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient-initiated diet,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to breast surgeon,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to breast surgeon,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in GP's surgery,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in GP's surgery,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Health education offered,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Health education offered,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone triage encounter,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone triage encounter,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough absent,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough absent,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to urologist,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to urologist,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma sometimes restricts exercise,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma sometimes restricts exercise,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message from patient,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message from patient,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review done,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review done,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in oncology clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in oncology clinic,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,31 to 365,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to surgeon,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to surgeon,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive claim,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive claim,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contraception,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contraception,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from specialist,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from specialist,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from consultant,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from consultant,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend - no reason,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend - no reason,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Discharged from hospital,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Discharged from hospital,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review due date,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review due date,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Never used tobacco or its derivatives,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Never used tobacco or its derivatives,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Suspected UTI (urinary tract infection),31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Suspected UTI (urinary tract infection),31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in general surgery clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in general surgery clinic,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet [Type],31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet [Type],31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Peak expiratory flow rate monitoring,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Peak expiratory flow rate monitoring,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter received,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter received,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Non - drinker,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Non - drinker,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma management,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma management,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient encounter procedure,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient encounter procedure,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique observed,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique observed,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,31 to 365,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referred to urologist,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080190
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referred to urologist,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080190
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,31 to 365,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Choice and booking enhanced services administration,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Choice and booking enhanced services administration,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of diabetes mellitus,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of diabetes mellitus,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051114
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Resp. system examined - NAD,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Resp. system examined - NAD,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma annual review,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma annual review,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Visit out of hours,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Visit out of hours,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by hepatobiliary surgeon,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4125692
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by hepatobiliary surgeon,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4125692
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Number of asthma exacerbations in past year,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40545672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Number of asthma exacerbations in past year,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40545672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - good,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - good,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General finding of height,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General finding of height,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alcoholic beverage intake,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alcoholic beverage intake,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient given advice,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient given advice,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eating habit,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eating habit,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hospital admission,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hospital admission,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood sample taken,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood sample taken,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough present,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Night cough present,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Disorder excluded,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Disorder excluded,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in urology clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in urology clinic,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Good hypertension control,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Good hypertension control,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication requested,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication requested,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in breast clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in breast clinic,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sample sent to laboratory for test,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sample sent to laboratory for test,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient discharge,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient discharge,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital casualty,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital casualty,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to general practitioner,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to general practitioner,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to neurology service,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to neurology service,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in ENT clinic,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in ENT clinic,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089019
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Had a chat to patient,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Had a chat to patient,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of clinical finding,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of clinical finding,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice given,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice given,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient recall procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient recall procedure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202169
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Right and left,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197258
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Right and left,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197258
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Occasional drinker,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Occasional drinker,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - 3rd recall,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear - 3rd recall,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Drug compliance poor,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4292063
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Drug compliance poor,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4292063
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma limits activities 1 to 2 times per month,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805091
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma limits activities 1 to 2 times per month,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805091
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No consent for seasonal influenza vaccination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44810385
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No consent for seasonal influenza vaccination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44810385
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cigarette smoker,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cigarette smoker,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Size of blood pressure cuff,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend hospital appointment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend hospital appointment,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight loss advised,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077806
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight loss advised,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077806
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,History of event,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient-initiated diet,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,B12 deficiency monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,B12 deficiency monitoring,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Target systolic blood pressure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153323
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Target systolic blood pressure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153323
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,SMS (short message service) text message sent to patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,SMS (short message service) text message sent to patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to breast surgeon,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to breast surgeon,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Consent status for immunizations,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Consent status for immunizations,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087257
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,BP screening - second call,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088872
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,BP screening - second call,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088872
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Provision of chaperone refused,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35622065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Provision of chaperone refused,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35622065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination consent given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4065031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination consent given,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4065031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from outside agency,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from outside agency,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to gynecology service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to gynecology service,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in general medical clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083421
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in general medical clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083421
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy or intolerance criticality,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy or intolerance criticality,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42528776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review done,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review done,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination declined,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Repeated prescription,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Repeated prescription,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Weight finding,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient Health Questionnaire Nine Item score,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient Health Questionnaire Nine Item score,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Contraception,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Contraception,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral contraceptive claim,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Oral contraceptive claim,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No consent - influenza immunization,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No consent - influenza immunization,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in gynecology clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in gynecology clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Informing patient of named accountable general practitioner,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Informing patient of named accountable general practitioner,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma follow-up,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma follow-up,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from consultant,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter from consultant,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discharged from hospital,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Discharged from hospital,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend - no reason,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend - no reason,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review due date,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication review due date,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol units consumed per week,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Never used tobacco or its derivatives,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depression interim review,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4189144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depression interim review,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4189144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Failed encounter,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Failed encounter,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incoming mail processing,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Incoming mail processing,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seasonal influenza vaccination given by pharmacist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46284832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seasonal influenza vaccination given by pharmacist,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46284832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in general surgery clinic,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in general surgery clinic,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Deferred antibiotic therapy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Deferred antibiotic therapy,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy to drug,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Allergy to drug,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 439224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by ophthalmologist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by ophthalmologist,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Diet [Type],366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No breathlessness,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No breathlessness,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060227
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Non - drinker,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Non - drinker,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Procedure refused,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Procedure refused,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination invitation letter sent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Influenza vaccination invitation letter sent,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma limiting activities,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma limiting activities,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015948
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma management,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma management,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Exercise,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter encounter,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Letter encounter,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hospital discharge letter received,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812244
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hospital discharge letter received,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812244
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,No matching concept,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,X-ray report received,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,X-ray report received,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pill check,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Pill check,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,BP screening - first call,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,BP screening - first call,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Target diastolic blood pressure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Target diastolic blood pressure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Choice and booking enhanced services administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Choice and booking enhanced services administration,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to mental health team,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4193009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to mental health team,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4193009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient on waiting list,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient on waiting list,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by practice phlebotomist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by practice phlebotomist,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088559
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,NHS Health Check completed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813741
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,NHS Health Check completed,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813741
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Emergency hospital admission,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Emergency hospital admission,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Stress fracture,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4050742
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Stress fracture,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4050742
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Asthma monitoring,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inhaler technique - good,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Inhaler technique - good,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in ophthalmology clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in ophthalmology clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcoholic beverage intake,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General finding of height,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,General finding of height,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given advice,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient given advice,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Eating habit,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend hypertension clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4307032
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Did not attend hypertension clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4307032
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Spirometry test declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4217689
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Spirometry test declined,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4217689
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in out of hours centre,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in out of hours centre,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Disease suspected,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Disease suspected,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to orthopedic surgeon,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral to orthopedic surgeon,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depression monitoring second letter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Depression monitoring second letter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Full consent for immunization,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Full consent for immunization,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by respiratory physician,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by respiratory physician,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,DNA (did not attend) breast screening clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791243
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,DNA (did not attend) breast screening clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791243
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral for further care,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Referral for further care,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood sample taken,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Blood sample taken,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Accidental fall,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Accidental fall,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435991
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by receptionist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen by receptionist,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Visual acuity - left eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Visual acuity - left eye,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication satisfactory,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication satisfactory,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Good hypertension control,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Good hypertension control,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication requested,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Medication requested,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in breast clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in breast clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Telephone encounter,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Telephone encounter,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hypertension monitoring telephone invite,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Hypertension monitoring telephone invite,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sample sent to laboratory for test,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Sample sent to laboratory for test,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient allocated named accountable general practitioner,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient allocated named accountable general practitioner,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient discharge,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Patient discharge,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear defaulter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Cervical smear defaulter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in hospital casualty,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seen in hospital casualty,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Visual acuity - right eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Visual acuity - right eye,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administrative procedure,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Administrative procedure,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total notes on computer,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Total notes on computer,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Adverse reaction to drug,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Adverse reaction to drug,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 441207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Family tension,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4019961
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Family tension,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4019961
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol screen - alcohol use disorder identification test consumption questions completed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Alcohol screen - alcohol use disorder identification test consumption questions completed,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Had a chat to patient,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Had a chat to patient,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Out of hours consultation at surgery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Out of hours consultation at surgery,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Treatment plan given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Treatment plan given,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seasonal influenza vaccination declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Seasonal influenza vaccination declined,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Fit frequency,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017306
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Fit frequency,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017306
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Advice given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,Advice given,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mid stream urine sent to laboratory,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4055275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Mid stream urine sent to laboratory,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4055275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occasional drinker,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occasional drinker,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone in house,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052628
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone in house,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052628
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per week,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma causes daytime symptoms 1 to 2 times per week,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155464
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done - incision,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done - incision,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check invitation first letter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check invitation first letter,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802033
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No suicidal thoughts,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No suicidal thoughts,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4046664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History of event,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History of event,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening - second recall,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Adult screening - second recall,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house physio,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088714
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house physio,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088714
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal heart feature,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal heart feature,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screened - no result yet,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screened - no result yet,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient has moved away,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient has moved away,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086800
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of chaperone refused,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35622065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of chaperone refused,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35622065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occupation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Occupation,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,GOS18 form status,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,GOS18 form status,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788188
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Health promotion,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4063525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Health promotion,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4063525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done by medicines management technician,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done by medicines management technician,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral needed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086779
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral needed,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086779
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring by nurse,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma monitoring by nurse,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293732
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone triage encounter,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone triage encounter,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history diabetes,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history diabetes,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051106
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination given by other healthcare provider,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46284829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination given by other healthcare provider,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46284829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gonorrhoea screening declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Gonorrhoea screening declined,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to outside agency,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter sent to outside agency,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index 25-29 - overweight,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index 25-29 - overweight,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Interpreter not needed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Interpreter not needed,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol intake within recommended sensible limits,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol intake within recommended sensible limits,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza vaccination declined,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication given,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HIV screening declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36712804
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,HIV screening declined,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36712804
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Repeated prescription,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Repeated prescription,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house dermatology,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house dermatology,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Encounter by computer link,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Encounter by computer link,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of copy of letter from specialist to patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4233571
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Provision of copy of letter from specialist to patient,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4233571
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive claim,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraception,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from specialist,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - reason given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - reason given,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085790
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of osteoporosis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of osteoporosis,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Employed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4076340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Employed,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4076340
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter invite to screening,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter invite to screening,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088719
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter from consultant,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No known allergy,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No known allergy,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend blood test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend blood test,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790171
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,366 to inf,count,numeric,9,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review due date,366 to inf,percentage,percentage,25.7142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by clinical nurse specialist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by clinical nurse specialist,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,eConsultation via online application,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42690710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,eConsultation via online application,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42690710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to pharmacist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to pharmacist,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in primary care center,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088401
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in primary care center,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088401
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in general surgery clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in general surgery clinic,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to general surgical service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to general surgical service,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Absence,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Absence,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Extensive notes on computer,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083731
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Extensive notes on computer,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083731
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Presentation of fetus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Presentation of fetus,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery enhanced services administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery enhanced services administration,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter received,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient referral,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient referral,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH myocardial infarction male first degree age known,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH myocardial infarction male first degree age known,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non - drinker,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Non - drinker,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for seasonal influenza vaccination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for seasonal influenza vaccination,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical report received,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical report received,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by optometrist,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085787
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by optometrist,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085787
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening offered,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685901
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening offered,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685901
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estimated date of delivery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Estimated date of delivery,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza immunization advised,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza immunization advised,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171433
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma management,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma management,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to counselor,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to counselor,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204658
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient encounter procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient encounter procedure,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient informed - test result,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient informed - test result,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nurse telephone triage,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Nurse telephone triage,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791496
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hospital discharge letter received,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812244
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hospital discharge letter received,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812244
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Myocardial infarction,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Myocardial infarction,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145793
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abnormal weight loss,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Abnormal weight loss,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12 injections - at surgery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,B12 injections - at surgery,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about long acting reversible contraception,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Palliative care,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Palliative care,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice about management of anxiety,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice about management of anxiety,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,MED5 status,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,MED5 status,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802239
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - good,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Inhaler technique - good,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screen-no result yet,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064912
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General finding of height,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for ultrasound investigation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for ultrasound investigation,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085009
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice,366 to inf,count,numeric,8,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient given advice,366 to inf,percentage,percentage,22.8571428571429,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from physiotherapy service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharge from physiotherapy service,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,COVID-19 excluded by laboratory test,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 703430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,COVID-19 excluded by laboratory test,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 703430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home exercise program,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home exercise program,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to musculoskeletal clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to musculoskeletal clinic,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription types,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4190564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription types,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4190564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disease suspected,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Disease suspected,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Measles, mumps and rubella vaccination invitation",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805495
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,"Measles, mumps and rubella vaccination invitation",366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805495
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to antenatal clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to antenatal clinic,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to ophthalmology service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084691
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to ophthalmology service,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084691
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computer summary updated,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Computer summary updated,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4211664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syphilis screening declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Syphilis screening declined,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B immunization declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4256920
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B immunization declined,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4256920
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Integrated care priorities for end of life,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809749
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Integrated care priorities for end of life,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809749
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription by supplementary prescriber,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Prescription by supplementary prescriber,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788090
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear due,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear due,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062487
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left with household member,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left with household member,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visual acuity - left eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visual acuity - left eye,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter from patient,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in urology clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in urology clinic,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083414
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight monitoring,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear non-responder,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear non-responder,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in breast clinic,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in breast clinic,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet good,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet good,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147718
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obtaining consent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4186543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Obtaining consent,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4186543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient allocated named accountable general practitioner,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient allocated named accountable general practitioner,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient discharge,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient discharge,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care from consultant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care from consultant,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear defaulter,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear defaulter,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History taken on subject,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40479416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,History taken on subject,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40479416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by palliative care service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40480924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by palliative care service,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40480924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house physiotherapy first appointment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790988
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,In-house physiotherapy first appointment,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790988
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Specialised sexual health enhanced service completed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Specialised sexual health enhanced service completed,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,366 to inf,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Administrative procedure,366 to inf,percentage,percentage,31.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Housing problem,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022661
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Housing problem,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022661
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informal referral - signposted to other agency,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4137051
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informal referral - signposted to other agency,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4137051
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,DNA - Did not attend mental health appointment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,DNA - Did not attend mental health appointment,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269184
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screening - not attended,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152044
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screening - not attended,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152044
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Phlebotomy generated from secondary care done by practice,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Phlebotomy generated from secondary care done by practice,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetic retinopathy of eye not detected,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36715429
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diabetic retinopathy of eye not detected,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36715429
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B screening declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Hepatitis B screening declined,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment status,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202344
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Appointment status,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202344
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax sent to:,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fax sent to:,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of clinical finding,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of clinical finding,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given about breast screening programme,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given about breast screening programme,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44804249
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal movement feature,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Fetal movement feature,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by physiotherapist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by physiotherapist,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Procedure started,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4216179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Procedure started,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4216179
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chlamydia test offered,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Chlamydia test offered,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789376
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self-referral,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4138517
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Self-referral,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4138517
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left on answer machine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter - message left on answer machine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to physiotherapist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to physiotherapist,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history of,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No family history of,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4051104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for echocardiography,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4305721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for echocardiography,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4305721
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigarette smoker,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cigarette smoker,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient call procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient call procedure,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202168
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about treatment given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice about treatment given,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062624
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Informed consent for procedure,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082261
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,366 to inf,count,numeric,13,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Size of blood pressure cuff,366 to inf,percentage,percentage,37.1428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend hospital appointment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend hospital appointment,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postpartum care,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4047392
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Postpartum care,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4047392
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Report procedure,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Report procedure,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient-initiated diet,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient-initiated diet,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraceptive check administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792379
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Contraceptive check administration,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44792379
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to breast surgeon,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to breast surgeon,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SMS (short message service) text message sent to patient,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication commenced,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in GP's surgery,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in GP's surgery,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bereavement support,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4191840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Bereavement support,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4191840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to radiology service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to radiology service,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination / signs,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Examination / signs,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Motor vehicle accident,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Motor vehicle accident,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435134
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gynecology service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to gynecology service,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trivial drinker - <1u/day,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Trivial drinker - <1u/day,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Partner had vasectomy,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 3654349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Partner had vasectomy,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 3654349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,366 to inf,count,numeric,10,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight finding,366 to inf,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check invitation second letter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check invitation second letter,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by co-operative doctor,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by co-operative doctor,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for minor surgery procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for minor surgery procedure,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789355
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by health support worker,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4188318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by health support worker,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4188318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in gynecology clinic,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stress at work,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4175371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Stress at work,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4175371
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4173786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Antenatal care,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4173786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Myocardial infarct in 1st degree male relative <55 years,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269022
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Myocardial infarct in 1st degree male relative <55 years,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269022
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Discharged from hospital,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - no reason,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend - no reason,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive check - first call,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Oral contraceptive check - first call,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progestogen only oral contraceptive,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Progestogen only oral contraceptive,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061668
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol units consumed per week,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcohol units consumed per week,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 35609491
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,366 to inf,count,numeric,11,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Never used tobacco or its derivatives,366 to inf,percentage,percentage,31.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General practitioner out of hours handover form completed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,General practitioner out of hours handover form completed,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788589
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression interim review,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4189144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Depression interim review,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4189144
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected UTI (urinary tract infection),366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Suspected UTI (urinary tract infection),366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: neoplasm of cervix,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: neoplasm of cervix,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4053374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Planned telephone contact,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Planned telephone contact,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in emergency clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in emergency clinic,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Healthy diet,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022846
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Healthy diet,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022846
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,366 to inf,count,numeric,12,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Failed encounter,366 to inf,percentage,percentage,34.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for communication by short message service text messaging,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent given for communication by short message service text messaging,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Incoming mail processing,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Incoming mail processing,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination given by pharmacist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46284832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seasonal influenza vaccination given by pharmacist,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46284832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Phlebotomy domiciliary visit requested,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Phlebotomy domiciliary visit requested,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent for Primary Care Trust to review patients records,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consent for Primary Care Trust to review patients records,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790971
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by ophthalmologist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen by ophthalmologist,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in own home,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in own home,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical social worker involved,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079612
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medical social worker involved,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079612
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screening - up-to-date,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064366
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cancer cervix screening - up-to-date,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064366
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet [Type],366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Diet [Type],366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No history of clinical finding in subject,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40481925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No history of clinical finding in subject,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40481925
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in psychiatry clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in psychiatry clinic,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Exercise,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,366 to inf,count,numeric,21,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,No matching concept,366 to inf,percentage,percentage,60,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,X-ray report received,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,X-ray report received,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789447
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084913
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Did not attend,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084913
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Pill check,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,366 to inf,count,numeric,16,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,366 to inf,percentage,percentage,45.7142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Choice and booking enhanced services administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Choice and booking enhanced services administration,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma annual review,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Asthma annual review,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation for minor injury,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44787904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Consultation for minor injury,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44787904
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check completed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813741
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check completed,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813741
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear overdue,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4307034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Cervical smear overdue,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4307034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient clinic letter received,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Outpatient clinic letter received,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Third party encounter,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Third party encounter,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083438
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of neoplasm of breast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4210263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of neoplasm of breast,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4210263
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient self-report,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to breast clinic,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral to breast clinic,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit request by patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit request by patient,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Alcoholic beverage intake,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eating habit,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Eating habit,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Reassurance given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Reassurance given,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done by pharmacist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication review done by pharmacist,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Increased body mass index,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171825
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Increased body mass index,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171825
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug treatment still needed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4255383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Drug treatment still needed,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4255383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Ischemic heart disease at less than 60 years,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FH: Ischemic heart disease at less than 60 years,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in physiotherapy department,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in physiotherapy department,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in out of hours centre,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in out of hours centre,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Full consent for immunization,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for X-ray,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Refer for X-ray,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check indicated,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,NHS Health Check indicated,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Attended extended hours clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802717
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Attended extended hours clinic,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802717
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ultrasound scan requested,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4292193
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Ultrasound scan requested,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4292193
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in radiology department,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in radiology department,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza immunization advised in surgery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Influenza immunization advised in surgery,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for further care,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral for further care,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter to patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Letter encounter to patient,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089037
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Specialised sexual health enhanced services administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Specialised sexual health enhanced services administration,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Opportunistic verification of patient mobile telephone number,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Opportunistic verification of patient mobile telephone number,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,366 to inf,count,numeric,10,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Medication requested,366 to inf,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FP1001 sent to family practitioner committee,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,FP1001 sent to family practitioner committee,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44812642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,366 to inf,count,numeric,17,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Telephone encounter,366 to inf,percentage,percentage,48.5714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in antenatal clinic,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in antenatal clinic,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital casualty,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Seen in hospital casualty,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of neoplasm of lung,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4182336
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family history of neoplasm of lung,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4182336
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visual acuity - right eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Visual acuity - right eye,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Normal body mass index,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4261660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Normal body mass index,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4261660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical management plan agreed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Clinical management plan agreed,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination invitation SMS (short message service) text message sent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37310267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination invitation SMS (short message service) text message sent,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37310267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family tension,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4019961
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Family tension,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4019961
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index 30+ - obesity,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Body mass index 30+ - obesity,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Home visit,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient examined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Patient examined,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notes summary on computer,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Notes summary on computer,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient consultation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,New patient consultation,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight symptom,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Weight symptom,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Had a chat to patient,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Had a chat to patient,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menstrual data,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150646
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Menstrual data,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4150646
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given,366 to inf,count,numeric,15,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Advice given,366 to inf,percentage,percentage,42.8571428571429,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done - excision,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Minor surgery done - excision,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral letter status,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Referral letter status,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fetal movement feature,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fetal movement feature,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Failed encounter - message left on answer machine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Failed encounter - message left on answer machine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Antenatal care: obstetric risk,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Antenatal care: obstetric risk,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cigarette smoker,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cigarette smoker,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Size of blood pressure cuff,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Size of blood pressure cuff,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Did not attend hospital appointment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Did not attend hospital appointment,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient given telephone advice out of hours,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient given telephone advice out of hours,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,History of event,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,History of event,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fetal heart feature,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fetal heart feature,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,SMS (short message service) text message sent to patient,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,SMS (short message service) text message sent to patient,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient awaiting investigation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient awaiting investigation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090386
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to orthopedic service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080082
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to orthopedic service,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080082
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in pediatric clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in pediatric clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Time symptom lasts,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037328
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Time symptom lasts,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4037328
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Screening for malignant neoplasm of cervix done,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 606819
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone triage encounter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone triage encounter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lloyd George and problem summary,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Lloyd George and problem summary,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Procedure not done,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4168192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Procedure not done,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4168192
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Antenatal/postnatal care,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4170305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Antenatal/postnatal care,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4170305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consultation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consultation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient given telephone advice during surgery hours,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4190892
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient given telephone advice during surgery hours,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4190892
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to gynecology service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to gynecology service,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080083
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of body mass index,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding of body mass index,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review done,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review done,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in oncology clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in oncology clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight finding,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Weight finding,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Postnatal visit,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Postnatal visit,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,IUD checked - problems,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059965
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,IUD checked - problems,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059965
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Excepted from asthma quality indicators - patient unsuitable,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813771
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Excepted from asthma quality indicators - patient unsuitable,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44813771
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by co-operative doctor,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by co-operative doctor,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to stroke clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to stroke clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136455
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Type of abdominal pain,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Type of abdominal pain,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4090435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraceptive claim,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraceptive claim,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Contraception,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Contraception,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in gynecology clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in gynecology clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Care provision regime,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4024618
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Care provision regime,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4024618
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter from specialist,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter from specialist,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Informing patient of named accountable general practitioner,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Informing patient of named accountable general practitioner,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in orthopedic clinic,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in orthopedic clinic,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085648
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Language spoken,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Language spoken,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4052785
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Invitation by telephone for influenza vaccination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42537564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Invitation by telephone for influenza vaccination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 42537564
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter from consultant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter from consultant,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Short message service text message received from patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Short message service text message received from patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791532
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No known allergy,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No known allergy,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37396387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Discharged from hospital,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Discharged from hospital,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Did not attend - no reason,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Did not attend - no reason,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraception,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Oral contraception,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4241216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by trauma surgeon,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by trauma surgeon,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140781
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review due date,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication review due date,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Never used tobacco or its derivatives,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Never used tobacco or its derivatives,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Suspected UTI (urinary tract infection),366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Suspected UTI (urinary tract infection),366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4198427
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Communication from:,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Communication from:,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Failed encounter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Failed encounter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085789
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consent given for communication by short message service text messaging,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Consent given for communication by short message service text messaging,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44783180
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Absence,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Absence,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302931
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Presentation of fetus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Presentation of fetus,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Nausea present,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Nausea present,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Non - drinker,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Non - drinker,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Death administrative procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145391
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Death administrative procedure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145391
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Prescription not collected,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Prescription not collected,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Estimated date of delivery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Estimated date of delivery,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Suspected cerebrovascular disease,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789577
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Suspected cerebrovascular disease,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789577
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient informed - test result,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient informed - test result,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012816
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter encounter,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter encounter,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,No matching concept,366 to inf,percentage,percentage,77.7777777777778,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Death,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4306655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Death,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4306655
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by urgent care team,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802566
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen by urgent care team,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802566
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pill check,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Pill check,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4127440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Choice and booking enhanced services administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Choice and booking enhanced services administration,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to stop-smoking clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to stop-smoking clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4199818
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Abnormal weight loss,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Abnormal weight loss,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 435928
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Advice about long acting reversible contraception,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Advice about long acting reversible contraception,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Neoplasm, metastatic",366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4032806
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"Neoplasm, metastatic",366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4032806
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,General finding of height,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,General finding of height,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient given advice,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient given advice,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cause of death,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Cause of death,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083743
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to district nurse,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to district nurse,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hospital admission,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Hospital admission,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 8715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to maxillofacial surgeon,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4247381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to maxillofacial surgeon,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4247381
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Disease suspected,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Disease suspected,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Full consent for immunization,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Full consent for immunization,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to antenatal clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to antenatal clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in radiology department,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in radiology department,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083289
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood sample taken,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Blood sample taken,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral for further care,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral for further care,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza immunization advised in surgery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Influenza immunization advised in surgery,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4145331
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Declined consent for short message service text messaging,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802338
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Declined consent for short message service text messaging,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44802338
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter encounter from patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Letter encounter from patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148753
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Korotkoff sounds,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4311672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Korotkoff sounds,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4311672
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Investigation indicated,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Investigation indicated,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient deregistration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient deregistration,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Reporting of significant event,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Reporting of significant event,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44805885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Practice leaflet sent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Practice leaflet sent,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082885
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication requested,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Medication requested,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in breast clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in breast clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone encounter,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Telephone encounter,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Morning after pill method of contraception,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012115
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Morning after pill method of contraception,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4012115
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to general surgeon,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Referral to general surgeon,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4204666
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient discharge,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient discharge,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient allocated named accountable general practitioner,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Patient allocated named accountable general practitioner,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Antenatal care from consultant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Antenatal care from consultant,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in hospital casualty,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Seen in hospital casualty,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Follow-up arranged,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Follow-up arranged,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administrative procedure,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Administrative procedure,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Clinical management plan agreed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Clinical management plan agreed,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination invitation SMS (short message service) text message sent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37310267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination invitation SMS (short message service) text message sent,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37310267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Home visit,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Home visit,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4259432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Had a chat to patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Had a chat to patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma monitoring call first letter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Asthma monitoring call first letter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Treatment plan given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Treatment plan given,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4196133
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fax sent to:,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Fax sent to:,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788214
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Advice given,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Advice given,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Minor surgery done - excision,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Minor surgery done - excision,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4087107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral letter status,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral letter status,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136748
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunisation offered,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Immunisation offered,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685899
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fetal movement feature,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fetal movement feature,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269424
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Follow-up (wait and see),366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147571
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Follow-up (wait and see),366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147571
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occasional drinker,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occasional drinker,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4027342
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in neurology clinic,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088538
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in neurology clinic,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088538
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in elderly assessment clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088539
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in elderly assessment clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088539
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Retired,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Retired,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No consent for seasonal influenza vaccination,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44810385
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No consent for seasonal influenza vaccination,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44810385
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cigarette smoker,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cigarette smoker,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903657
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Bronchodilators used more than once daily,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017181
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Bronchodilators used more than once daily,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017181
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in dermatology clinic,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in dermatology clinic,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Size of blood pressure cuff,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36716458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call second letter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call second letter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to general medical service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to general medical service,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080074
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend hospital appointment,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend hospital appointment,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4194582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,History of event,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,History of event,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 1340204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dorsalis pedis pulse,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4225511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Dorsalis pedis pulse,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4225511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Report procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Report procedure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203889
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient-initiated diet,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient-initiated diet,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4058149
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,B12 deficiency monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,B12 deficiency monitoring,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061923
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fetal heart feature,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Fetal heart feature,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4269426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,SMS (short message service) text message sent to patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,SMS (short message service) text message sent to patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791497
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Member of military family,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Member of military family,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44809072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in GP's surgery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in GP's surgery,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,BP screening - second call,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088872
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,BP screening - second call,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088872
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occupation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Occupation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination invitation first letter sent,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789365
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Injection given,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4077387
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Health education offered,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Health education offered,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4146339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in plastic surgery clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in plastic surgery clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone triage encounter,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone triage encounter,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4293864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Antenatal/postnatal care,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4170305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Antenatal/postnatal care,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4170305
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from outside agency,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from outside agency,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to outside agency,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter sent to outside agency,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consultation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Consultation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014829
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of body mass index,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding of body mass index,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4103471
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma sometimes restricts exercise,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma sometimes restricts exercise,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017191
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review done,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review done,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4200295
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message from patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message from patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44790782
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination declined,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4154097
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication given,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082383
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Repeated prescription,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Repeated prescription,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082397
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight finding,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4030015
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Minor surgery done - injection,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148745
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Minor surgery done - injection,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148745
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Excepted from asthma quality indicators - informed dissent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Excepted from asthma quality indicators - informed dissent,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive started,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060122
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive started,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060122
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to surgeon,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to surgeon,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084690
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient Health Questionnaire Nine Item score,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient Health Questionnaire Nine Item score,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36714983
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive claim,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive claim,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44796551
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No consent - influenza immunization,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No consent - influenza immunization,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062509
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from specialist,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from specialist,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4151573
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Informing patient of named accountable general practitioner,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Informing patient of named accountable general practitioner,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44811924
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message given to patient,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791206
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Message given to patient,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791206
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diabetic annual review,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016050
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diabetic annual review,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4016050
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from consultant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter from consultant,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4078131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend - no reason,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend - no reason,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148754
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contraception using injectable contraceptive medication,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Contraception using injectable contraceptive medication,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4147938
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review due date,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Medication review due date,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44807096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Never used tobacco or its derivatives,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Never used tobacco or its derivatives,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Communication from:,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Communication from:,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,GP out of hours service administration,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,GP out of hours service administration,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4295028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Self-referral to accident and emergency department,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Self-referral to accident and emergency department,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44803027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke [PhenX]",366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 40766579
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Incoming mail processing,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Incoming mail processing,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4155519
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in general surgery clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in general surgery clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088542
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to general surgical service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to general surgical service,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to diabetes structured education program,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4213783
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to diabetes structured education program,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4213783
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by ophthalmologist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by ophthalmologist,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Presentation of fetus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Presentation of fetus,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4152200
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Birth outcome,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4264823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Birth outcome,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4264823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet [Type],366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Diet [Type],366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 21493945
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter received,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter received,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44789360
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Drug treatment stopped - medical advice,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Drug treatment stopped - medical advice,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4057412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in cardiothoracic surgery clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4323196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in cardiothoracic surgery clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4323196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Non - drinker,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Non - drinker,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in musculoskeletal clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4323493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in musculoskeletal clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4323493
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination invitation letter sent,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Influenza vaccination invitation letter sent,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4153159
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prescription not collected,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Prescription not collected,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4056968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Estimated date of delivery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Estimated date of delivery,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4059478
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma management,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma management,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4235703
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient encounter procedure,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient encounter procedure,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Exercise,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4116678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter encounter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Letter encounter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4203434
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique observed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique observed,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017020
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No matching concept,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 0
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Finding relating to alcohol drinking behavior,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4042860
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,BP screening - first call,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,BP screening - first call,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088871
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by dietitian,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen by dietitian,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088553
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Findings of tobacco or its derivatives use or exposure,366 to inf,percentage,percentage,66.6666666666667,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903652
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast cancer screening declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36712833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Breast cancer screening declined,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36712833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Discharge by dietitian,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Discharge by dietitian,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Resp. system examined - NAD,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Resp. system examined - NAD,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4149531
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient on waiting list,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient on waiting list,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4148887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma annual review,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma annual review,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4214588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice about long acting reversible contraception,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice about long acting reversible contraception,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Emergency hospital admission,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Emergency hospital admission,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,B12 injections - at surgery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,B12 injections - at surgery,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061927
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - moderate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4305735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inhaler technique - moderate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4305735
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient self-report,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient self-report,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 32865
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to breast clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to breast clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4197459
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in ophthalmology clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in ophthalmology clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089018
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alcoholic beverage intake,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Alcoholic beverage intake,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 619635
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General finding of height,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,General finding of height,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4093972
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive prescribed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37312222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Oral contraceptive prescribed,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37312222
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Screening for malignant neoplasm of cervix not wanted,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4062642
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eating habit,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Eating habit,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4021055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient given advice,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient given advice,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082541
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Reassurance given,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Reassurance given,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4079764
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Discharge from physiotherapy service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Discharge from physiotherapy service,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4140505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend hypertension clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4307032
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Did not attend hypertension clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4307032
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neurofibromatosis,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219205
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Neurofibromatosis,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219205
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Currently doesn't use tobacco or its derivatives,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 903651
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to musculoskeletal clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to musculoskeletal clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4136052
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Item held as scanned document,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Item held as scanned document,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44791125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in out of hours centre,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in out of hours centre,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788588
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Disease suspected,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Disease suspected,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4219847
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Full consent for immunization,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Full consent for immunization,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4064389
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of neoplasm,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of neoplasm,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4144262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Refer for X-ray,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Refer for X-ray,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to antenatal clinic,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to antenatal clinic,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081292
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Length of gestation at birth,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4260747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Length of gestation at birth,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4260747
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood sample taken,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Blood sample taken,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4209107
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No disease of retina of eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 3655145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,No disease of retina of eye,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 3655145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Visual acuity - left eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Visual acuity - left eye,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4299713
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advised to attend for retinal screening,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4255398
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advised to attend for retinal screening,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4255398
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call third letter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call third letter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4085318
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Birth detail,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Birth detail,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4014291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Good hypertension control,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Good hypertension control,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4017170
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight monitoring,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Weight monitoring,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4141416
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cardiovascular disease risk assessment telephone invitation,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cardiovascular disease risk assessment telephone invitation,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44793585
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cervical smear non-responder,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cervical smear non-responder,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4171432
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Telephone encounter,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4089036
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Obtaining consent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4186543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Obtaining consent,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4186543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hypertension monitoring telephone invite,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Hypertension monitoring telephone invite,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4088881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cervical cancer screening offered,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Cervical cancer screening offered,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 36685900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sample sent to laboratory for test,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Sample sent to laboratory for test,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4013828
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient discharge,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient discharge,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4240723
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient allocated named accountable general practitioner,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient allocated named accountable general practitioner,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 46285147
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to podiatrist,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to podiatrist,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4202178
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Antenatal care from consultant,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Antenatal care from consultant,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4061437
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nutrition,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4298503
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Nutrition,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4298503
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital casualty,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seen in hospital casualty,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4083411
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Visual acuity - right eye,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Visual acuity - right eye,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4302660
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Posterior tibial pulse,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4222862
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Posterior tibial pulse,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4222862
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Follow-up arranged,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Follow-up arranged,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084835
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Delivery booking place,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4076939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Delivery booking place,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4076939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administrative procedure,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Administrative procedure,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4033224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to general practitioner,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to general practitioner,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Housing problem,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022661
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Housing problem,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4022661
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to neurology service,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to neurology service,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4084349
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Clinical management plan agreed,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Clinical management plan agreed,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4131382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination invitation SMS (short message service) text message sent,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37310267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination invitation SMS (short message service) text message sent,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 37310267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to dermatology service,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Referral to dermatology service,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4080076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index 30+ - obesity,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Body mass index 30+ - obesity,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4060985
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Notes summary on computer,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Notes summary on computer,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4081598
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Had a chat to patient,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Had a chat to patient,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4082880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call first letter,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma monitoring call first letter,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4086119
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Out of hours consultation at surgery,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Out of hours consultation at surgery,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seasonal influenza vaccination declined,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Seasonal influenza vaccination declined,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44806820
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma restricts exercise,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015951
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Asthma restricts exercise,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4015951
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of clinical finding,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Family history of clinical finding,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167217
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inpatient discharge summary received,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Inpatient discharge summary received,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 44788372
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient referral to dietitian,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4304362
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Patient referral to dietitian,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4304362
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice given,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Advice given,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,observation &&& event &&& standard &&& 4167554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"estrogens, conjugated (USP)",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,"estrogens, conjugated (USP)",-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,magnesium sulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19093848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,magnesium sulfate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19093848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,gramicidin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 963742
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,gramicidin,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 963742
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,dihydrocodeine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,dihydrocodeine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cholecalciferol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cholecalciferol,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,sertraline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,sertraline,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prednisolone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prednisolone,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clavulanate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clavulanate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clobetasone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clobetasone,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,estradiol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,estradiol,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lidocaine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lidocaine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,diclofenac,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,diclofenac,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,floxacillin,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,floxacillin,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amoxicillin,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amoxicillin,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,beclomethasone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,beclomethasone,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clobetasol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clobetasol,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,flumethasone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,flumethasone,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,erythromycin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,erythromycin,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,tramadol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103314
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,tramadol,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103314
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prochlorperazine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prochlorperazine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,pizotyline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19047076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,pizotyline,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19047076
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,penicillin V,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,penicillin V,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amitriptyline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amitriptyline,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,albuterol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,albuterol,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amlodipine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amlodipine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,metronidazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,metronidazole,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,loratadine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,loratadine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,isopropyl myristate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,isopropyl myristate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,codeine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,codeine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nystatin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nystatin,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ofloxacin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ofloxacin,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nicotine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nicotine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,mineral oil,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,mineral oil,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fusidate,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fusidate,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,triamcinolone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,triamcinolone,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,acetaminophen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,acetaminophen,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,betamethasone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,betamethasone,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,norethindrone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,norethindrone,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clioquinol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 980867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clioquinol,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 980867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,phenol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,phenol,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,temazepam,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,temazepam,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,levonorgestrel,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,levonorgestrel,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fluoxetine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fluoxetine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,glycerin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,glycerin,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,hydrocortisone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,hydrocortisone,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,piroxicam,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1146810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,piroxicam,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1146810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,neomycin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,neomycin,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clindamycin,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clindamycin,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chloramphenicol,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chloramphenicol,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,etonogestrel,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1519936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,etonogestrel,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1519936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chloroform,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chloroform,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012199
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,oxytetracycline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,oxytetracycline,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,-inf to -366,count,numeric,16,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,-inf to -366,percentage,percentage,38.0952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluconazole,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1754994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluconazole,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1754994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbimazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19040606
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbimazole,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19040606
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetic acid,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929549
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetic acid,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929549
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clotrimazole,-inf to -366,count,numeric,15,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clotrimazole,-inf to -366,percentage,percentage,35.7142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzydamine,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19019620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzydamine,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19019620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,adenosine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1309204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,adenosine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1309204
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous sulfate,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous sulfate,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amphotericin B,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1717240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amphotericin B,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1717240
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,morphine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1110410
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,morphine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1110410
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alpha tocopherol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19056802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alpha tocopherol,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19056802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cefaclor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cefaclor,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,solifenacin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,solifenacin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bacitracin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915175
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bacitracin,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915175
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desloratadine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103006
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desloratadine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103006
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citrate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citrate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gramicidin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 963742
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gramicidin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 963742
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peruvian balsam,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peruvian balsam,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Magnesium glycerophosphate,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 36879003
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Magnesium glycerophosphate,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 36879003
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium citrate,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 977968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium citrate,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 977968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium bicarbonate,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939506
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium bicarbonate,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939506
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,drospirenone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1512674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,drospirenone,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1512674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dihydrocodeine,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dihydrocodeine,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dexamethasone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dexamethasone,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,naproxen,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,naproxen,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzalkonium,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzalkonium,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prednisolone,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prednisolone,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasone,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasone,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium bicarbonate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium bicarbonate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prilocaine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 951279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prilocaine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 951279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calendula officinalis extract,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Calendula officinalis extract,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lidocaine,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lidocaine,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mucopolysaccharide polysulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mucopolysaccharide polysulfate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011028
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diclofenac,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diclofenac,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,permethrin,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,permethrin,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,floxacillin,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,floxacillin,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zolpidem,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 744740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zolpidem,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 744740
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lansoprazole,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lansoprazole,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,-inf to -366,count,numeric,23,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,-inf to -366,percentage,percentage,54.7619047619048,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,-inf to -366,count,numeric,14,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,-inf to -366,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholestyramine resin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholestyramine resin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ketoconazole,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985708
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ketoconazole,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985708
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,methyl salicylate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 909440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,methyl salicylate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 909440
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lymecycline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lymecycline,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,flumethasone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,flumethasone,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium sulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium sulfate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027475
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzyl benzoate,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19036946
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzyl benzoate,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19036946
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,doxycycline,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,doxycycline,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,erythromycin,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,erythromycin,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pantoprazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 948078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pantoprazole,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 948078
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,terfenadine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1150836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,terfenadine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1150836
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,biotin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,biotin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tramadol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103314
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tramadol,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103314
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diethylamine salicylate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19029278
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diethylamine salicylate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19029278
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mometasone,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mometasone,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cimetidine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cimetidine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lactate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lactate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011035
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pyridoxine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pyridoxine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,silver sulfadiazine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,silver sulfadiazine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,duloxetine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 715259
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,duloxetine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 715259
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbocysteine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19041843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbocysteine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19041843
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bismuth oxide,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037706
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bismuth oxide,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037706
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cobalt sulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cobalt sulfate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012207
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,meloxicam,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1150345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,meloxicam,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1150345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,orlistat,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 741530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,orlistat,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 741530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium chloride,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium chloride,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ibuprofen,-inf to -366,count,numeric,17,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ibuprofen,-inf to -366,percentage,percentage,40.4761904761905,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phenoxyethanol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19058343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phenoxyethanol,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19058343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbomer homopolymer type c,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42898572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbomer homopolymer type c,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42898572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc acetate,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc acetate,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,rizatriptan,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,rizatriptan,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metoclopramide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 906780
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metoclopramide,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 906780
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,adapalene,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 981774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,adapalene,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 981774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc oxide,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 911064
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc oxide,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 911064
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethyl linoleate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19059630
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethyl linoleate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19059630
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,minocycline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1708880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,minocycline,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1708880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzoyl peroxide,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzoyl peroxide,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citric acid,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 950435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citric acid,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 950435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium ironedetate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19001131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium ironedetate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19001131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,escitalopram,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 715939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,escitalopram,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 715939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,miconazole,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,miconazole,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cromolyn,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cromolyn,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dicyclomine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 924724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dicyclomine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 924724
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lactulose,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lactulose,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,copper sulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19057346
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,copper sulfate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19057346
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,domperidone,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,domperidone,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Capsicum oleoresin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055492
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Capsicum oleoresin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055492
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lauromacrogols,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19101454
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lauromacrogols,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19101454
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ofloxacin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ofloxacin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923081
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium hydroxyquinoline sulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium hydroxyquinoline sulfate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorpheniramine,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorpheniramine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mupirocin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 951511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mupirocin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 951511
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cyclizine,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 909358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cyclizine,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 909358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ranitidine,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961047
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ranitidine,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961047
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alfacalcidol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alfacalcidol,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014202
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nicotine,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nicotine,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polymyxin B,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 948582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polymyxin B,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 948582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propranolol,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propranolol,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbaryl,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136040
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbaryl,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136040
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,felbinac,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,felbinac,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salmeterol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salmeterol,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,rutin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19063981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,rutin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19063981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sulfamethoxazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1836430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sulfamethoxazole,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1836430
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,azelastine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 934075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,azelastine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 934075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nedocromil,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1114620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nedocromil,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1114620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,-inf to -366,count,numeric,19,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,-inf to -366,percentage,percentage,45.2380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,budesonide,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939259
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,budesonide,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939259
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous gluconate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous gluconate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clioquinol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 980867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clioquinol,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 980867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,povidone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 950056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,povidone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 950056
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,temazepam,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,temazepam,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,xylometazoline,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 943852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,xylometazoline,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 943852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cysteine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010955
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cysteine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010955
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,crotamiton,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 969276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,crotamiton,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 969276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glycerin,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glycerin,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mebendazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1794280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mebendazole,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1794280
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin B12,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin B12,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbamide peroxide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 958999
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbamide peroxide,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 958999
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,terbutaline,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1236744
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,terbutaline,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1236744
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,peppermint oil,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19086712
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,peppermint oil,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19086712
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pholcodine,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pholcodine,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydrocortisone,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydrocortisone,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lysine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092377
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lysine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092377
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,piroxicam,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1146810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,piroxicam,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1146810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acyclovir,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acyclovir,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,neomycin,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,neomycin,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glucose,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1560524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glucose,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1560524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,framycetin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19056694
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,framycetin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19056694
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,heparinoids,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19113045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,heparinoids,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19113045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mebeverine,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mebeverine,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium hydroxide,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 992956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium hydroxide,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 992956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,azithromycin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1734104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,azithromycin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1734104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,paraffin,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,paraffin,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ephedrine,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1143374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ephedrine,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1143374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,epinephrine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1343916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,epinephrine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1343916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,buspirone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 733301
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,buspirone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 733301
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,imipramine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 778268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,imipramine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 778268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clonidine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1398937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clonidine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1398937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium sulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19093848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium sulfate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19093848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aluminum chloride,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aluminum chloride,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorobutanol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorobutanol,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092412
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sucrose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sucrose,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gentamicin,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45892419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gentamicin,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45892419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tranexamic acid,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tranexamic acid,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tacrolimus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 950637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tacrolimus,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 950637
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,brompheniramine,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1130863
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,brompheniramine,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1130863
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polyethylene glycol 3350,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 986417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polyethylene glycol 3350,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 986417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trazodone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 703547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trazodone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 703547
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,peanut oil,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033278
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,peanut oil,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033278
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lanolin,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lanolin,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clavulanate,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clavulanate,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,threonine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19000537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,threonine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19000537
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cephalexin,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cephalexin,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,enoxaparin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1301025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,enoxaparin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1301025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,inositol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1379525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,inositol,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1379525
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium ascorbate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1319219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium ascorbate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1319219
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,camphor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 938205
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,camphor,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 938205
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxyzine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 777221
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxyzine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 777221
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,karaya gum,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19084915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,karaya gum,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19084915
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,urea,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 906914
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,urea,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 906914
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,choline,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1195334
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,choline,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1195334
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propylthiouracil,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1554072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propylthiouracil,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1554072
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,labetalol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1386957
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,labetalol,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1386957
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,povidone-iodine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,povidone-iodine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mefenamate,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1197736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mefenamate,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1197736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,theophylline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1237049
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,theophylline,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1237049
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gabapentin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797399
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gabapentin,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797399
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prochlorperazine,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prochlorperazine,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bismuth subgallate,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 937725
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bismuth subgallate,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 937725
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium molybdate(VI),-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium molybdate(VI),-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,-inf to -366,count,numeric,16,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,-inf to -366,percentage,percentage,38.0952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bentonite,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19016467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bentonite,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19016467
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,venlafaxine,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 743670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,venlafaxine,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 743670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,-inf to -366,count,numeric,17,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,-inf to -366,percentage,percentage,40.4761904761905,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pregabalin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 734354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pregabalin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 734354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calamine,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 902616
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calamine,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 902616
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polawax polysorbate,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43532069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polawax polysorbate,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43532069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,paroxetine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 722031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,paroxetine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 722031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ampicillin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1717327
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ampicillin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1717327
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,psyllium,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,psyllium,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,promethazine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,promethazine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,varenicline,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 780442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,varenicline,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 780442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pseudoephedrine,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pseudoephedrine,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cephradine,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cephradine,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zopiclone,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zopiclone,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,menthol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 901656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,menthol,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 901656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium carbonate,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium carbonate,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,manganese sulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008897
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,manganese sulfate,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008897
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metronidazole,-inf to -366,count,numeric,11,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metronidazole,-inf to -366,percentage,percentage,26.1904761904762,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iron,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iron,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ulipristal,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40225722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ulipristal,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40225722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cefotetan,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1774932
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cefotetan,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1774932
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,malathion,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 993979
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,malathion,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 993979
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestrel,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521592
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestrel,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521592
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,isopropyl myristate,-inf to -366,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,isopropyl myristate,-inf to -366,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hepatitis A virus,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 44814322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hepatitis A virus,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 44814322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nystatin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nystatin,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitrofurantoin,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitrofurantoin,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium chloride,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium chloride,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clarithromycin,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clarithromycin,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,-inf to -366,count,numeric,10,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,-inf to -366,percentage,percentage,23.8095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mirtazapine,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 725131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mirtazapine,-inf to -366,percentage,percentage,7.14285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 725131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorhexidine,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorhexidine,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mineral oil,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mineral oil,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bicarbonate ion,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45775351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bicarbonate ion,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45775351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fusidate,-inf to -366,count,numeric,12,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fusidate,-inf to -366,percentage,percentage,28.5714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,kaolin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 984801
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,kaolin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 984801
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,triamcinolone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,triamcinolone,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loperamide,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991876
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loperamide,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991876
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin E,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin E,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,capsaicin,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,capsaicin,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betahistine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19020124
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betahistine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19020124
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olanzapine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 785788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olanzapine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 785788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,itraconazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,itraconazole,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703653
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,-inf to -366,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,-inf to -366,percentage,percentage,11.9047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phenol,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phenol,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,piperazine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19046291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,piperazine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19046291
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,-inf to -366,count,numeric,16,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,-inf to -366,percentage,percentage,38.0952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dimethicone 350,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dimethicone 350,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norelgestromin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518198
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norelgestromin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518198
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,orotic acid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,orotic acid,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129638
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sumatriptan,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sumatriptan,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glycine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 962398
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glycine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 962398
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pantothenic acid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pantothenic acid,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alginic acid,-inf to -366,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alginic acid,-inf to -366,percentage,percentage,21.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olive oil,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42900448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olive oil,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42900448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levocetirizine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1136422
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levocetirizine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1136422
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ispaghula husk,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ispaghula husk,-inf to -366,percentage,percentage,9.52380952380952,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alverine,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alverine,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,-inf to -366,count,numeric,13,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,-inf to -366,percentage,percentage,30.952380952381,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,valacyclovir,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1717704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,valacyclovir,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1717704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,petrolatum,-inf to -366,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,petrolatum,-inf to -366,percentage,percentage,19.047619047619,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,econazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 940864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,econazole,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 940864
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lecithin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19042345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lecithin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19042345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cinnarizine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097481
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cinnarizine,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097481
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propoxyphene,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propoxyphene,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metformin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1503297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metformin,-inf to -366,percentage,percentage,2.38095238095238,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1503297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aluminum hydroxide,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aluminum hydroxide,-inf to -366,percentage,percentage,4.76190476190476,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diazepam,-inf to -366,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diazepam,-inf to -366,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ephedrine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1143374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ephedrine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1143374
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,chloramphenicol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,chloramphenicol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,epinephrine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1343916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,epinephrine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1343916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ethinyl estradiol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ethinyl estradiol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"estrogens, conjugated (USP)",-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,"estrogens, conjugated (USP)",-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,magnesium sulfate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19093848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,magnesium sulfate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19093848
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Streptococcus pneumoniae,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,Streptococcus pneumoniae,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012408
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,fluticasone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,fluticasone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin alcohols,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43531973
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin alcohols,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43531973
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cholecalciferol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cholecalciferol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,furosemide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,furosemide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lidocaine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lidocaine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ethamsylate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049350
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ethamsylate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049350
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,floxacillin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,floxacillin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,amoxicillin,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,amoxicillin,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,desmopressin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1517070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,desmopressin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1517070
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,flumethasone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,flumethasone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,povidone-iodine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,povidone-iodine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750087
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,erythromycin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,erythromycin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,mefenamate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1197736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,mefenamate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1197736
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,mometasone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,mometasone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,buclizine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19081195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,buclizine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19081195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ibuprofen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ibuprofen,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,phenoxyethanol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19058343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,phenoxyethanol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19058343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,minocycline,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1708880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,minocycline,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1708880
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,amlodipine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,amlodipine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,miconazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,miconazole,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cefotetan,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1774932
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cefotetan,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1774932
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,gestodene,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,gestodene,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ciprofloxacin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ciprofloxacin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,codeine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,codeine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,medroxyprogesterone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,medroxyprogesterone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,chlorpheniramine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,chlorpheniramine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,fusidate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,fusidate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,acetaminophen,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,acetaminophen,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,betamethasone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,betamethasone,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,norethindrone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,norethindrone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clioquinol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 980867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clioquinol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 980867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,sumatriptan,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,sumatriptan,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,hydrocortisone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,hydrocortisone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,trimethoprim,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,trimethoprim,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,atropine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 914335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,atropine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 914335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propoxyphene,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propoxyphene,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,diphenoxylate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 930916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,diphenoxylate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 930916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chloramphenicol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chloramphenicol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,iodine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1780601
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,iodine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1780601
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ethinyl estradiol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ethinyl estradiol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,calcium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,calcium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ferrous sulfate,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ferrous sulfate,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrotalcite,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19002230
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrotalcite,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19002230
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,polidocanol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40175900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,polidocanol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40175900
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,citrate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,citrate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,dothiepin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,dothiepin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gentamicin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45892419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gentamicin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45892419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ascorbic acid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ascorbic acid,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lanolin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lanolin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,benzalkonium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,benzalkonium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clavulanate,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clavulanate,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,molybdenum,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,molybdenum,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,thiamine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,thiamine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prilocaine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 951279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prilocaine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 951279
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,estradiol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,estradiol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lidocaine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lidocaine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diclofenac,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diclofenac,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cephalexin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cephalexin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mesalamine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 968426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mesalamine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 968426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxyzine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 777221
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxyzine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 777221
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amoxicillin,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amoxicillin,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,beclomethasone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,beclomethasone,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,zinc,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,zinc,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,doxycycline,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,doxycycline,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,erythromycin,-inf to -366,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,erythromycin,-inf to -366,percentage,percentage,50,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,biotin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,biotin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,magnesium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19124906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,magnesium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19124906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,riboflavin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,riboflavin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cetirizine,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cetirizine,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prochlorperazine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prochlorperazine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pyridoxine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pyridoxine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,penicillin V,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,penicillin V,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sodium chloride,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sodium chloride,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,polawax polysorbate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43532069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,polawax polysorbate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43532069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,phenoxyethanol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19058343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,phenoxyethanol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19058343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,zinc acetate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,zinc acetate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,metoclopramide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 906780
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,metoclopramide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 906780
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pseudoephedrine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pseudoephedrine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,zinc oxide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 911064
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,zinc oxide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 911064
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,manganese,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1394027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,manganese,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1394027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,soybean oil,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19070224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,soybean oil,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19070224
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sodium ironedetate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19001131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sodium ironedetate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19001131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,iron,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,iron,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,niacinamide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,niacinamide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,miconazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,miconazole,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefotetan,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1774932
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefotetan,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1774932
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,copper,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,copper,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,loratadine,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,loratadine,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ciprofloxacin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ciprofloxacin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cromolyn,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cromolyn,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,isopropyl myristate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,isopropyl myristate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,valproate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 745466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,valproate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 745466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lactulose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lactulose,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium chloride,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium chloride,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorpheniramine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorpheniramine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diltiazem,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1328165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diltiazem,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1328165
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ergocalciferol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19045045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ergocalciferol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19045045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salmeterol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salmeterol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorhexidine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorhexidine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mineral oil,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mineral oil,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fusidate,-inf to -366,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fusidate,-inf to -366,percentage,percentage,37.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,triamcinolone,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,triamcinolone,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,loperamide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991876
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,loperamide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991876
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin E,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin E,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chromium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19061821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chromium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19061821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ferrous gluconate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ferrous gluconate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396012
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,folic acid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,folic acid,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,levonorgestrel,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,levonorgestrel,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin A,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin A,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,selenium,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,selenium,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,carbamazepine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 740275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,carbamazepine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 740275
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pantothenic acid,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pantothenic acid,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gamma-linolenate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19086939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gamma-linolenate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19086939
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin B12,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin B12,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pholcodine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pholcodine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrocortisone,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrocortisone,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,trimethoprim,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,trimethoprim,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,petrolatum,-inf to -366,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,petrolatum,-inf to -366,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,piroxicam,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1146810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,piroxicam,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1146810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,atropine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 914335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,atropine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 914335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,propoxyphene,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,propoxyphene,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153664
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,glucose,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1560524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,glucose,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1560524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diphenoxylate,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 930916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diphenoxylate,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 930916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aluminum hydroxide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aluminum hydroxide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,phosphorus,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19043395
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,phosphorus,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19043395
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mebeverine,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mebeverine,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,magnesium hydroxide,-inf to -366,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 992956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,magnesium hydroxide,-inf to -366,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 992956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,dihydrocodeine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,dihydrocodeine,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cholecalciferol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cholecalciferol,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,naproxen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,naproxen,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prednisolone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prednisolone,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clavulanate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clavulanate,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amoxicillin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amoxicillin,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,beclomethasone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,beclomethasone,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,penicillin V,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,penicillin V,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,albuterol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,albuterol,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,varenicline,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 780442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,varenicline,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 780442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,metronidazole,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,metronidazole,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,omeprazole,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,omeprazole,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fusidate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fusidate,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,-365 to -31,percentage,percentage,25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,acetaminophen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,acetaminophen,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,betamethasone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,betamethasone,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,norethindrone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,norethindrone,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alendronate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alendronate,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,diazepam,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,diazepam,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,etonogestrel,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1519936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,etonogestrel,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1519936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,epinephrine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1343916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,epinephrine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1343916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,imipramine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 778268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,imipramine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 778268
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clotrimazole,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clotrimazole,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous sulfate,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous sulfate,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citrate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citrate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tranexamic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tranexamic acid,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium bicarbonate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939506
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium bicarbonate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939506
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,naproxen,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,naproxen,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prednisolone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prednisolone,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,furosemide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,furosemide,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,coal tar,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000995
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,coal tar,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000995
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,enoxaparin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1301025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,enoxaparin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1301025
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,floxacillin,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,floxacillin,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,-365 to -31,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,-365 to -31,percentage,percentage,14.5833333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gabapentin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797399
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gabapentin,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797399
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prochlorperazine,-365 to -31,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prochlorperazine,-365 to -31,percentage,percentage,6.25,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium chloride,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium chloride,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,venlafaxine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 743670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,venlafaxine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 743670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ibuprofen,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ibuprofen,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,-365 to -31,count,numeric,8,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,-365 to -31,percentage,percentage,16.6666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,adapalene,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 981774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,adapalene,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 981774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dalteparin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1301065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dalteparin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1301065
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zopiclone,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zopiclone,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzoyl peroxide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzoyl peroxide,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium carbonate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium carbonate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cromolyn,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cromolyn,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestrel,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521592
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestrel,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521592
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,simvastatin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,simvastatin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,domperidone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,domperidone,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nystatin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nystatin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium chloride,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium chloride,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitrofurantoin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitrofurantoin,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorpheniramine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorpheniramine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clarithromycin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clarithromycin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cyclizine,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 909358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cyclizine,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 909358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propranolol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propranolol,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fusidate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fusidate,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bisoprolol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bisoprolol,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,-365 to -31,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,-365 to -31,percentage,percentage,12.5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olanzapine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 785788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olanzapine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 785788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,coconut oil,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42898952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,coconut oil,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42898952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sumatriptan,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sumatriptan,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,-365 to -31,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,-365 to -31,percentage,percentage,10.4166666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alginic acid,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alginic acid,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin B12,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin B12,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbamide peroxide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 958999
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbamide peroxide,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 958999
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,-365 to -31,percentage,percentage,4.16666666666667,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydrocortisone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydrocortisone,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pholcodine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pholcodine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,piroxicam,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1146810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,piroxicam,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1146810
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitroglycerin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitroglycerin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,neomycin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,neomycin,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glucose,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1560524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glucose,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1560524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diazepam,-365 to -31,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diazepam,-365 to -31,percentage,percentage,8.33333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mebeverine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mebeverine,-365 to -31,percentage,percentage,2.08333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cholecalciferol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cholecalciferol,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,betamethasone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,betamethasone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,alendronate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,alendronate,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,hydrocortisone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,hydrocortisone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,iodine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1780601
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,iodine,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1780601
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ethinyl estradiol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ethinyl estradiol,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,calcium,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,calcium,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ascorbic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ascorbic acid,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,naproxen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,naproxen,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prednisolone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prednisolone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,molybdenum,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,molybdenum,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,thiamine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,thiamine,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diclofenac,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diclofenac,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cephalexin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cephalexin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mesalamine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 968426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mesalamine,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 968426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gliclazide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19059796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gliclazide,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19059796
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salicylic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salicylic acid,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pioglitazone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1525215
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pioglitazone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1525215
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,zinc,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,zinc,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,biotin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,biotin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,magnesium,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19124906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,magnesium,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19124906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,riboflavin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,riboflavin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gabapentin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797399
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gabapentin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797399
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pyridoxine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pyridoxine,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,penicillin V,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,penicillin V,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,venlafaxine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 743670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,venlafaxine,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 743670
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,manganese,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1394027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,manganese,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1394027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sildenafil,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sildenafil,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316262
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,exenatide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1583722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,exenatide,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1583722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,iron,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,iron,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,niacinamide,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,niacinamide,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,copper,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,copper,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ciprofloxacin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ciprofloxacin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,domperidone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,domperidone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorpheniramine,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorpheniramine,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ergocalciferol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19045045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ergocalciferol,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19045045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salmeterol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salmeterol,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fusidate,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fusidate,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,triamcinolone,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,triamcinolone,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin E,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin E,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,betamethasone,-365 to -31,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,betamethasone,-365 to -31,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chromium,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19061821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chromium,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19061821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,folic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,folic acid,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,levonorgestrel,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,levonorgestrel,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin A,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin A,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,selenium,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,selenium,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pantothenic acid,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pantothenic acid,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin B12,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin B12,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nifedipine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1318853
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nifedipine,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1318853
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,buprenorphine,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1133201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,buprenorphine,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1133201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,metformin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1503297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,metformin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1503297
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clindamycin,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clindamycin,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,phosphorus,-365 to -31,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19043395
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,phosphorus,-365 to -31,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19043395
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,-30 to -1,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,omeprazole,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,omeprazole,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fusidate,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fusidate,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,-30 to -1,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,betamethasone,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,betamethasone,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alendronate,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alendronate,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous sulfate,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous sulfate,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,-30 to -1,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,-30 to -1,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,-30 to -1,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,-30 to -1,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestrel,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521592
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestrel,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521592
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,simvastatin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,simvastatin,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bisoprolol,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bisoprolol,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,-30 to -1,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,-30 to -1,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,-30 to -1,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,-30 to -1,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ferrous fumarate,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ferrous fumarate,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,folic acid,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,folic acid,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,alendronate,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,alendronate,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clavulanate,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clavulanate,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amoxicillin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amoxicillin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,-30 to -1,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,-30 to -1,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,-30 to -1,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,-30 to -1,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,-30 to -1,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,0 to 0,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,0 to 0,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alendronate,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alendronate,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,0 to 0,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,0 to 0,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,0 to 0,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,0 to 0,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,0 to 0,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,0 to 0,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,0 to 0,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,simvastatin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,simvastatin,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bisoprolol,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bisoprolol,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,0 to 0,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,0 to 0,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,0 to 0,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,0 to 0,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,0 to 0,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ferrous fumarate,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ferrous fumarate,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,folic acid,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,folic acid,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,alendronate,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,alendronate,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,0 to 0,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,0 to 0,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,0 to 0,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,0 to 0,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,0 to 0,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,etidronate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1552929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,etidronate,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1552929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,erythromycin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,erythromycin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,zinc acetate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,zinc acetate,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alendronate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alendronate,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,1 to 30,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,salicylic acid,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 964407
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,1 to 30,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,1 to 30,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,1 to 30,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,1 to 30,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ciprofloxacin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ciprofloxacin,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,simvastatin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,simvastatin,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bisoprolol,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bisoprolol,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,1 to 30,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,1 to 30,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,1 to 30,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,1 to 30,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,1 to 30,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,etidronate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1552929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,etidronate,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1552929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ferrous fumarate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ferrous fumarate,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,folic acid,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,folic acid,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,alendronate,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,alendronate,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1557272
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,1 to 30,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,1 to 30,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,miconazole,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,miconazole,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ciprofloxacin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ciprofloxacin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrocortisone,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrocortisone,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pholcodine,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pholcodine,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,1 to 30,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,1 to 30,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ethinyl estradiol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ethinyl estradiol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,citalopram,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,citalopram,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fluticasone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fluticasone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,etidronate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1552929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,etidronate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1552929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,allopurinol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1167322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,allopurinol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1167322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prednisolone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prednisolone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ipratropium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112921
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ipratropium,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112921
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cephalexin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cephalexin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,floxacillin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,floxacillin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lymecycline,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,doxycycline,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,doxycycline,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,erythromycin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,erythromycin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cetirizine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cetirizine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,albuterol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,albuterol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,zinc acetate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,zinc acetate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,benzoyl peroxide,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,benzoyl peroxide,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,metronidazole,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,metronidazole,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,miconazole,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,miconazole,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,loratadine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,loratadine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cromolyn,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cromolyn,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,colchicine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1101554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,colchicine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1101554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,potassium hydroxyquinoline sulfate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,potassium hydroxyquinoline sulfate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055378
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nicotine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nicotine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,levonorgestrel,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,levonorgestrel,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,hydrocortisone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,hydrocortisone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nitroglycerin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nitroglycerin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chloramphenicol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chloramphenicol,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iodine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1780601
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iodine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1780601
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluconazole,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1754994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluconazole,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1754994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clotrimazole,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clotrimazole,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzydamine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19019620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzydamine,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19019620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,morphine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1110410
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,morphine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1110410
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hyaluronate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 787787
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hyaluronate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 787787
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium bicarbonate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939506
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium bicarbonate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939506
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polyethylene glycol 3350,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 986417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polyethylene glycol 3350,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 986417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,podofilox,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 947705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,podofilox,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 947705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dexamethasone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dexamethasone,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,naproxen,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,naproxen,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzalkonium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzalkonium,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prednisolone,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prednisolone,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clavulanate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clavulanate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,molybdenum,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,molybdenum,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,furosemide,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,furosemide,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium bicarbonate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium bicarbonate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cyclopentolate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 910232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cyclopentolate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 910232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lidocaine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lidocaine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diclofenac,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diclofenac,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,floxacillin,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,floxacillin,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lansoprazole,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lansoprazole,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,doxycycline,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,doxycycline,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,biotin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,biotin,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19124906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19124906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mometasone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mometasone,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prochlorperazine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prochlorperazine,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pyridoxine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pyridoxine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,doxazosin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1363053
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,doxazosin,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1363053
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ibuprofen,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ibuprofen,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phenoxyethanol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19058343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phenoxyethanol,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19058343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polawax polysorbate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43532069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polawax polysorbate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43532069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbomer homopolymer type c,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42898572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbomer homopolymer type c,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42898572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,promethazine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,promethazine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,terbinafine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1741309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,terbinafine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1741309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,manganese,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1394027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,manganese,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1394027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zopiclone,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zopiclone,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium carbonate,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium carbonate,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metronidazole,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metronidazole,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iron,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iron,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,miconazole,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,miconazole,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,copper,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,copper,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ciprofloxacin,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ciprofloxacin,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cromolyn,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cromolyn,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,isopropyl myristate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,isopropyl myristate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,valproate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 745466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,valproate,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 745466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobazam,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19050832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobazam,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19050832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lactulose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lactulose,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levetiracetam,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 711584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levetiracetam,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 711584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitrofurantoin,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitrofurantoin,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clarithromycin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clarithromycin,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nicotine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nicotine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ergocalciferol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19045045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ergocalciferol,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19045045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propranolol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propranolol,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorhexidine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorhexidine,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mineral oil,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mineral oil,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bicarbonate ion,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45775351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bicarbonate ion,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45775351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fusidate,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fusidate,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin E,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin E,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,eflornithine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,eflornithine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,31 to 365,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,31 to 365,percentage,percentage,12.2448979591837,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dydrogesterone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19040060
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dydrogesterone,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19040060
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dibucaine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dibucaine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olanzapine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 785788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olanzapine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 785788
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chromium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19061821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chromium,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19061821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,31 to 365,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,31 to 365,percentage,percentage,10.2040816326531,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,crotamiton,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 969276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,crotamiton,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 969276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,selenium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,selenium,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pantothenic acid,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pantothenic acid,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alginic acid,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alginic acid,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin B12,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin B12,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sennoside B,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19115055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sennoside B,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19115055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alverine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alverine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030751
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydrocortisone,31 to 365,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydrocortisone,31 to 365,percentage,percentage,8.16326530612245,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,31 to 365,percentage,percentage,6.12244897959184,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,petrolatum,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,petrolatum,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acyclovir,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acyclovir,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cinnarizine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097481
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cinnarizine,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097481
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diazepam,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diazepam,31 to 365,percentage,percentage,4.08163265306122,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phosphorus,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19043395
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phosphorus,31 to 365,percentage,percentage,2.04081632653061,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19043395
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,chloramphenicol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,chloramphenicol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,epinephrine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1343916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,epinephrine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1343916
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ethinyl estradiol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ethinyl estradiol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,citrate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,citrate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011034
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,butylscopolamine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,butylscopolamine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,etidronate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1552929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,etidronate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1552929
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lidocaine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lidocaine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,diclofenac,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,diclofenac,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cephalexin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cephalexin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,floxacillin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,floxacillin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,amoxicillin,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,amoxicillin,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,erythromycin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,erythromycin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,sodium chloride,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,sodium chloride,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,zinc acetate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,zinc acetate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,miconazole,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,miconazole,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ciprofloxacin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ciprofloxacin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,codeine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,codeine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,potassium chloride,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,potassium chloride,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049105
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,nitrofurantoin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,nitrofurantoin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,omeprazole,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,omeprazole,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,acetaminophen,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,acetaminophen,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,betamethasone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,betamethasone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,norethindrone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,norethindrone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,levocetirizine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1136422
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,levocetirizine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1136422
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,hydrocortisone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,hydrocortisone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,trimethoprim,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,trimethoprim,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,glucose,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1560524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,glucose,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1560524
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,norfloxacin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1721543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,norfloxacin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1721543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chloramphenicol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chloramphenicol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ethinyl estradiol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ethinyl estradiol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clotrimazole,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clotrimazole,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,butylscopolamine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,butylscopolamine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,polyethylene glycol 3350,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 986417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,polyethylene glycol 3350,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 986417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cyproterone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010792
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cyproterone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010792
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,allopurinol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1167322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,allopurinol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1167322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clavulanate,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clavulanate,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sibutramine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sibutramine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diclofenac,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diclofenac,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cephalexin,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cephalexin,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mesalamine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 968426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mesalamine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 968426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amoxicillin,31 to 365,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amoxicillin,31 to 365,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prochlorperazine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prochlorperazine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,penicillin V,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,penicillin V,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,terbinafine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1741309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,terbinafine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1741309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,metronidazole,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,metronidazole,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,miconazole,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,miconazole,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,loratadine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,loratadine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,colchicine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1101554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,colchicine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1101554
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lactulose,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lactulose,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,domperidone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,domperidone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,medroxyprogesterone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,medroxyprogesterone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salmeterol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salmeterol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorhexidine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorhexidine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bicarbonate ion,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45775351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bicarbonate ion,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45775351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,triamcinolone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,triamcinolone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,celecoxib,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1118084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,celecoxib,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1118084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sennoside B,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19115055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sennoside B,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19115055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrocortisone,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrocortisone,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pholcodine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pholcodine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,trimethoprim,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,trimethoprim,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,31 to 365,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,31 to 365,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sodium,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sodium,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mebeverine,31 to 365,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mebeverine,31 to 365,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,oxytetracycline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,oxytetracycline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ethinyl estradiol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ethinyl estradiol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,acetic acid,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929549
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,acetic acid,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929549
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clonidine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1398937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,clonidine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1398937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alpha tocopherol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19056802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,alpha tocopherol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19056802
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,methylprednisolone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1506270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,methylprednisolone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1506270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,citalopram,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,citalopram,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fluticasone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fluticasone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,tranexamic acid,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,tranexamic acid,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,bendroflumethiazide,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,dihydrocodeine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,dihydrocodeine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,sertraline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,sertraline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cholecalciferol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cholecalciferol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,naproxen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,naproxen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,allopurinol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1167322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,allopurinol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1167322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,dexamethasone,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,dexamethasone,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prednisolone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,prednisolone,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cyclopentolate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 910232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cyclopentolate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 910232
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,diclofenac,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,diclofenac,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cephalexin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cephalexin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,floxacillin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,floxacillin,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amoxicillin,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,amoxicillin,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,beclomethasone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,beclomethasone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,formoterol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,formoterol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,doxycycline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,doxycycline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,theophylline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1237049
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,theophylline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1237049
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cetirizine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cetirizine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,montelukast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,montelukast,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,silver sulfadiazine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,silver sulfadiazine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ibuprofen,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,albuterol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,albuterol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,psyllium,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,aspirin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,zopiclone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,zopiclone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,chlordiazepoxide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,chlordiazepoxide,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,calcium carbonate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,indomethacin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1178663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,indomethacin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1178663
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,metronidazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,metronidazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,loratadine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,loratadine,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cromolyn,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,cromolyn,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,simvastatin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,codeine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,codeine,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nystatin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nystatin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nitrofurantoin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nitrofurantoin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,medroxyprogesterone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,omeprazole,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,omeprazole,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nicotine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nicotine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,polymyxin B,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 948582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,polymyxin B,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 948582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,salmeterol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,salmeterol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fusidate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fusidate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,loperamide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991876
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,loperamide,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991876
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,baclofen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 715233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,baclofen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 715233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,lisinopril,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,acetaminophen,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,acetaminophen,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,betamethasone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,betamethasone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,norethindrone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,norethindrone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fexofenadine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,fexofenadine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,levonorgestrel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,levonorgestrel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,vitamin B12,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,vitamin B12,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ispaghula husk,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,ispaghula husk,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,hydrocortisone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,hydrocortisone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,atropine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 914335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,atropine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 914335
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nitroglycerin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,nitroglycerin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,neomycin,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,neomycin,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,diazepam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_anal_d_cohort,overall,overall,diazepam,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aluminum hydroxide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aluminum hydroxide,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985247
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diazepam,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diazepam,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mebeverine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mebeverine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phosphorus,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19043395
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,phosphorus,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19043395
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tiotropium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1106776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tiotropium,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1106776
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clindamycin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clindamycin,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium hydroxide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 992956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium hydroxide,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 992956
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,paraffin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,paraffin,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,azithromycin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1734104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,azithromycin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1734104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chloramphenicol,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chloramphenicol,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iodine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1780601
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iodine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1780601
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin D,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009405
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,oxytetracycline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,oxytetracycline,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ethinyl estradiol,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluconazole,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1754994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluconazole,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1754994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetic acid,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929549
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetic acid,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929549
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clotrimazole,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clotrimazole,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018544
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clonidine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1398937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clonidine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1398937
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzydamine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19019620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzydamine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19019620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous sulfate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous sulfate,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxocobalamin,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,morphine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1110410
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,morphine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1110410
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,butylscopolamine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40234201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,citalopram,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797617
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nefopam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19015602
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nefopam,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19015602
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluticasone,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ascorbic acid,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19011773
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peruvian balsam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,Peruvian balsam,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922976
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium citrate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 977968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium citrate,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 977968
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polyethylene glycol 3350,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 986417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,polyethylene glycol 3350,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 986417
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium bicarbonate,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939506
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium bicarbonate,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 939506
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,podofilox,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 947705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,podofilox,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 947705
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,drospirenone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1512674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,drospirenone,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1512674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dihydrocodeine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dihydrocodeine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lanolin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lanolin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sertraline,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cholecalciferol,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dexamethasone,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dexamethasone,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,naproxen,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,naproxen,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prednisolone,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prednisolone,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzalkonium,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzalkonium,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clavulanate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clavulanate,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1759842
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,molybdenum,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,molybdenum,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009896
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,furosemide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,furosemide,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasone,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasone,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium bicarbonate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium bicarbonate,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,thiamine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137312
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,estradiol,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1548195
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sibutramine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sibutramine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739363
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diclofenac,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,diclofenac,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cephalexin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cephalexin,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1786621
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,floxacillin,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,floxacillin,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,permethrin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,permethrin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,topiramate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 742267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,topiramate,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 742267
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxyzine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 777221
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydroxyzine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 777221
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,366 to inf,count,numeric,11,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amoxicillin,366 to inf,percentage,percentage,31.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lansoprazole,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lansoprazole,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 929887
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,366 to inf,count,numeric,11,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,beclomethasone,366 to inf,percentage,percentage,31.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobetasol,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ketoconazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985708
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ketoconazole,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985708
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ferrous fumarate,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,flumethasone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,flumethasone,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19055156
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,formoterol,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196677
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010696
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzyl benzoate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19036946
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,benzyl benzoate,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19036946
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,antazoline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 951237
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,antazoline,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 951237
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,doxycycline,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,doxycycline,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,biotin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,biotin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024770
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19124906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,magnesium,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19124906
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,riboflavin,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19062817
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cetirizine,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tramadol,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103314
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,tramadol,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103314
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ondansetron,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000560
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ondansetron,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000560
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mometasone,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mometasone,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prochlorperazine,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,prochlorperazine,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,montelukast,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bismuth subgallate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 937725
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bismuth subgallate,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 937725
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pyridoxine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pyridoxine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005046
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,duloxetine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 715259
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,duloxetine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 715259
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,penicillin V,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amitriptyline,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bismuth oxide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037706
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bismuth oxide,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037706
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,meloxicam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1150345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,meloxicam,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1150345
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norgestimate,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1515774
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium chloride,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium chloride,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 967823
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ibuprofen,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ibuprofen,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,albuterol,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbomer homopolymer type c,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42898572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,carbomer homopolymer type c,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42898572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,rizatriptan,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,rizatriptan,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154077
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,promethazine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,promethazine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc oxide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 911064
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zinc oxide,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 911064
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,haloperidol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,haloperidol,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,terbinafine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1741309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,terbinafine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1741309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,aspirin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,manganese,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1394027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,manganese,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1394027
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zopiclone,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,zopiclone,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19044883
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,menthol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 901656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,menthol,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 901656
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium carbonate,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,calcium carbonate,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metronidazole,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,metronidazole,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,amlodipine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1332418
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,water,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,water,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iron,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,iron,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1360067
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,niacinamide,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19018419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ulipristal,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40225722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ulipristal,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 40225722
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,miconazole,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,miconazole,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,copper,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,copper,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19071128
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,loratadine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,gestodene,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19097684
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ciprofloxacin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ciprofloxacin,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cromolyn,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cromolyn,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,isopropyl myristate,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,isopropyl myristate,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,valproate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 745466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,valproate,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 745466
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobazam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19050832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clobazam,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19050832
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,codeine,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lactulose,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lactulose,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levetiracetam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 711584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levetiracetam,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 711584
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nystatin,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nystatin,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,medroxyprogesterone,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitrofurantoin,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,nitrofurantoin,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorpheniramine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorpheniramine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clarithromycin,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clarithromycin,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1750500
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cyclizine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 909358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,cyclizine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 909358
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,366 to inf,count,numeric,7,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,omeprazole,366 to inf,percentage,percentage,20,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ranitidine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961047
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ranitidine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961047
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lorazepam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 791967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,lorazepam,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 791967
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,midazolam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 708298
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,midazolam,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 708298
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mirtazapine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 725131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mirtazapine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 725131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ergocalciferol,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19045045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,ergocalciferol,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19045045
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propranolol,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,propranolol,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorhexidine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chlorhexidine,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mineral oil,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,mineral oil,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bicarbonate ion,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45775351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,bicarbonate ion,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45775351
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fusidate,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fusidate,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,indapamide,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978555
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,azelastine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 934075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,azelastine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 934075
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin E,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin E,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19009540
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,potassium,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19049024
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,eflornithine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,eflornithine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 978236
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,366 to inf,count,numeric,9,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acetaminophen,366 to inf,percentage,percentage,25.7142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dibucaine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dibucaine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923840
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chromium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19061821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,chromium,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19061821
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,betamethasone,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,norethindrone,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clioquinol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 980867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,clioquinol,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 980867
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,folic acid,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,xylometazoline,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 943852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,xylometazoline,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 943852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fexofenadine,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levonorgestrel,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dimethicone 350,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,dimethicone 350,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 43012316
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,fluoxetine,366 to inf,percentage,percentage,8.57142857142857,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 755695
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin A,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sumatriptan,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sumatriptan,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1140643
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glycerin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,glycerin,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 961145
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,selenium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,selenium,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 966282
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,366 to inf,count,numeric,6,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,desogestrel,366 to inf,percentage,percentage,17.1428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pantothenic acid,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,pantothenic acid,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19026739
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alginic acid,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,alginic acid,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,quetiapine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 766814
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olive oil,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42900448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,olive oil,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42900448
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin B12,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,vitamin B12,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sennoside B,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19115055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sennoside B,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19115055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,levothyroxine,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1501700
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,trimethoprim,366 to inf,percentage,percentage,14.2857142857143,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydrocortisone,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,hydrocortisone,366 to inf,percentage,percentage,11.4285714285714,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,petrolatum,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,petrolatum,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acyclovir,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,acyclovir,366 to inf,percentage,percentage,2.85714285714286,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,neomycin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,neomycin,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_general_d_cohort,overall,overall,sodium,366 to inf,percentage,percentage,5.71428571428571,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19136048
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ethinyl estradiol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ethinyl estradiol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,oxytetracycline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clotrimazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clotrimazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ferrous sulfate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ferrous sulfate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1396131
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dothiepin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dothiepin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tranexamic acid,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1303425
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,bendroflumethiazide,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,drospirenone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1512674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,drospirenone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1512674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lanolin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19087317
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cholecalciferol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cholecalciferol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19095164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,naproxen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,naproxen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzalkonium,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clobetasone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clobetasone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lidocaine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lidocaine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,diclofenac,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,diclofenac,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,floxacillin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,floxacillin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,amoxicillin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,amoxicillin,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,beclomethasone,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ketoconazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985708
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ketoconazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 985708
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lymecycline,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19092353
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,erythromycin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,erythromycin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tramadol,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103314
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,tramadol,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1103314
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,mometasone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,mometasone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 905233
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,prochlorperazine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,prochlorperazine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,penicillin V,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,penicillin V,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1729720
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ibuprofen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ibuprofen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,albuterol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,zinc acetate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,zinc acetate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 979096
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,psyllium,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,aspirin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,aspirin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,benzoyl peroxide,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 918172
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,calcium carbonate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19035704
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,metronidazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,metronidazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,miconazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,miconazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ciprofloxacin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,ciprofloxacin,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1797513
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cromolyn,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,cromolyn,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1152631
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,codeine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,codeine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,nitrofurantoin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,nitrofurantoin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920293
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,omeprazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,omeprazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,propranolol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,dimethicone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916662
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,chlorhexidine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,chlorhexidine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,lisinopril,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,acetaminophen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,acetaminophen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,betamethasone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,betamethasone,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,norethindrone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,norethindrone,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1521369
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,xylometazoline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 943852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,xylometazoline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 943852
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,levonorgestrel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,levonorgestrel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,desogestrel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,desogestrel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1588000
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,hydrocortisone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,hydrocortisone,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,trimethoprim,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,trimethoprim,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,petrolatum,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19033354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,acyclovir,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,acyclovir,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1703687
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,diazepam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,diazepam,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,clindamycin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 997881
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,azithromycin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1734104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,azithromycin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1734104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_penile_d_cohort,overall,overall,paraffin,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19129738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,norfloxacin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1721543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,norfloxacin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1721543
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,azithromycin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1734104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,azithromycin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1734104
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chloramphenicol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chloramphenicol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 990069
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,oxytetracycline,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 925952
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ethinyl estradiol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ethinyl estradiol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1549786
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluconazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1754994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluconazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1754994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clotrimazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clotrimazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1000632
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,benzydamine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19019620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,benzydamine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19019620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxocobalamin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1377023
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cefaclor,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1768849
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aluminum chloride,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aluminum chloride,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957393
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,methylprednisolone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1506270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,methylprednisolone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1506270
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,dothiepin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,dothiepin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037989
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ammonium bicarbonate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 36878870
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,Ammonium bicarbonate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 36878870
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gentamicin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45892419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gentamicin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 45892419
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fluticasone,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149380
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ipecac,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1781321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ipecac,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1781321
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,digoxin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1326303
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bendroflumethiazide,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1316354
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,dihydrocodeine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,dihydrocodeine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1189596
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cyproterone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010792
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cyproterone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010792
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sertraline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sertraline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 739138
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,naproxen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,naproxen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115008
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,allopurinol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1167322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,allopurinol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1167322
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,dexamethasone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,dexamethasone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1518254
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,benzalkonium,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,benzalkonium,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 916460
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prednisolone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prednisolone,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1550557
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,trimeprazine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,trimeprazine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,furosemide,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 956874
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasone,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasone,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19005129
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium bicarbonate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium bicarbonate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19027080
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lidocaine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lidocaine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 989878
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diclofenac,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diclofenac,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1124300
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,floxacillin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19054936
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,permethrin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,permethrin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922868
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mesalamine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 968426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mesalamine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 968426
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxyzine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 777221
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydroxyzine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 777221
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amoxicillin,366 to inf,count,numeric,4,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amoxicillin,366 to inf,percentage,percentage,44.4444444444444,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1713332
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,beclomethasone,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,beclomethasone,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1115572
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,urea,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 906914
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,urea,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 906914
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,clobetasol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 998415
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ferrous fumarate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ferrous fumarate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1595799
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,doxycycline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,doxycycline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1738521
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,erythromycin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,erythromycin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1746940
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cetirizine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,cetirizine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1149196
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gabapentin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797399
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,gabapentin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 797399
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prochlorperazine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,prochlorperazine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 752061
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,montelukast,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,montelukast,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154161
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amiloride,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 991382
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,amitriptyline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 710062
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,orlistat,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 741530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,orlistat,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 741530
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ibuprofen,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1177480
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,albuterol,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1154343
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,psyllium,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 957797
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,varenicline,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 780442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,varenicline,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 780442
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,terbinafine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1741309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,terbinafine,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1741309
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,almond oil,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42900339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,almond oil,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 42900339
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,aspirin,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1112807
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,flunisolide,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1196514
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,citric acid,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 950435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,citric acid,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 950435
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,metronidazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,metronidazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1707164
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,miconazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,miconazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 907879
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,loratadine,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,loratadine,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1107830
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,isopropyl myristate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,isopropyl myristate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19003568
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,simvastatin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1539403
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,codeine,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1201620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lactulose,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lactulose,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 987245
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,domperidone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,domperidone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19037833
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nystatin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nystatin,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 922570
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,medroxyprogesterone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,medroxyprogesterone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1500211
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorpheniramine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorpheniramine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1192710
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,omeprazole,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 923645
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicotine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicotine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 718583
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,polymyxin B,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 948582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,polymyxin B,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 948582
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium citrate,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 976545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,potassium citrate,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 976545
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,propranolol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,propranolol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1353766
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,felbinac,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19100761
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salmeterol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,salmeterol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1137529
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorhexidine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,chlorhexidine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1790812
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mineral oil,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mineral oil,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 908523
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fusidate,366 to inf,count,numeric,3,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fusidate,366 to inf,percentage,percentage,33.3333333333333,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19010400
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,triamcinolone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,triamcinolone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 903963
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,lisinopril,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308216
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,bisoprolol,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1338005
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nedocromil,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1114620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nedocromil,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1114620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,366 to inf,count,numeric,5,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,acetaminophen,366 to inf,percentage,percentage,55.5555555555556,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1125315
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,celecoxib,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1118084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,celecoxib,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1118084
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,betamethasone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,betamethasone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 920458
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,folic acid,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,folic acid,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19111620
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,tamoxifen,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1436678
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,temazepam,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 836715
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fexofenadine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,fexofenadine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1153428
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,levonorgestrel,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,levonorgestrel,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1589505
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,crotamiton,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 969276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,crotamiton,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 969276
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nicorandil,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19014977
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,esomeprazole,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 904453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,esomeprazole,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 904453
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,alginic acid,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19030059
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin B12,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,vitamin B12,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1308738
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ispaghula husk,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,ispaghula husk,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19137031
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sennoside B,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19115055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,sennoside B,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19115055
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,trimethoprim,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,trimethoprim,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1705674
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrocortisone,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,hydrocortisone,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 975125
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pholcodine,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,pholcodine,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19024213
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,buprenorphine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1133201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,buprenorphine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1133201
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,366 to inf,count,numeric,2,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,nitroglycerin,366 to inf,percentage,percentage,22.2222222222222,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 1361711
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,neomycin,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,neomycin,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 915981
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,diazepam,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 723013
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mebeverine,366 to inf,count,numeric,1,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
1,cdmGold,summarised_large_scale_characteristics,PatientProfiles,0.6.2,cohort_name,hpv_outc_vulval_d_cohort,overall,overall,mebeverine,366 to inf,percentage,percentage,11.1111111111111,table_name &&& type &&& analysis &&& concept,drug_era &&& episode &&& standard &&& 19008994
